503651854	O
WGH	O

4959433	O

288418	O

2823104	O

7/31/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

A	O
,	O
WALINA	O

MRN	O
:	O

4959433	O

Age	O
:	O

32y	O

REGISTRATION	O
DATE	O
:	O

07/31/2004	O
11:24	O
AM	O

Provider	O
:	O

PADA	O
MEEDHUANG	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

07/31/2004	O
12:58	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

S	O
/	O
P	O
MVA	O

Diagnosis	O
:	O

head	B-disease
trauma	I-disease
-	O
mva	O

Treatment	O
Rendered	O
:	O

history	O
,	O
physical	O
,	O
neuro	O
exam	O
normal	O

Discharge	O
Medications	O
:	O

tylenol	O
as	O
needed	O
.	O

refrain	O
from	O
motrin	O
at	O
this	O
time	O
.	O

Follow	O
up	O
Service	O
:	O

f	O
/	O
u	O
with	O
dr.	O
white	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

monitor	O
/	O
return	O
for	O
nausea	B-disease
/	O
vomiting	B-disease
,	O
headache	B-disease
,	O
visual	B-disease
/	I-disease
mental	I-disease
status	I-disease
changes	I-disease
or	O
other	B-disease
concerns	I-disease
.	O

PCP	O
Name	O
:	O

WHITE	O
,	O
ELVNO	O
R	O

Provider	O
Number	O
:	O

70468	O

This	O
report	O
was	O
created	O
by	O
MEEDHUANG	O
,	O
PADA	O
07/31/2004	O
12:59	O
PM	O

974381789	O

PUOMC	O

0520610	O

70648	O

390115	O

12/25/1996	O
12:00:00	O
AM	O

ATRIAL	B-disease
FIBRILLATION	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

LENKPRUSKIHKOOGLEKIH	O
,	O
NIEKERO	O
C	O

UNIT	O
NUMBER	O
:	O

449-50-82	O

ADMISSION	O
DATE	O
:	O

12/25/96	O

DISCHARGE	O
DATE	O
:	O

12/29/96	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Atrial	B-disease
fibrillation	I-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

History	O
of	O
multinodular	B-disease
goiter	I-disease
;	O
history	O
of	O
hypertension	B-disease
;	O
history	O
of	O
subtotal	O
thyroidectomy	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Electrical	O
cardioversion	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Lenkpruskihkooglekih	O
is	O
a	O
63-year-old	O
lady	O
with	O
a	O
history	O
of	O
frequent	B-disease
premature	I-disease
ventricular	I-disease
contractions	I-disease
and	O
infrequent	B-disease
short	I-disease
runs	I-disease
of	I-disease
non-sustained	I-disease
ventricular	I-disease
tachycardia	I-disease
(	O
one	O
four-beat	O
run	O
)	O
in	O
1991	O
,	O
for	O
which	O
several	O
antiarrhythmic	O
agents	O
including	O
Propranolol	O
,	O
Quinidine	O
,	O
Procainamide	O
,	O
Tenormin	O
,	O
Norpace	O
,	O
Corgard	O
,	O
and	O
Flecainide	O
were	O
used	O
,	O
but	O
were	O
stopped	O
because	O
of	O
intolerance	B-disease
.	O

At	O
that	O
time	O
,	O
she	O
had	O
clear	O
coronary	O
arteries	O
on	O
coronary	O
angiography	O
and	O
an	O
ejection	O
fraction	O
greater	O
than	O
50%	O
.	O

She	O
did	O
well	O
off	O
antiarrhythmic	O
agents	O
until	O
October	O
of	O
this	O
year	O
when	O
she	O
was	O
noted	O
to	O
have	O
atrial	B-disease
fibrillation	I-disease
with	O
a	B-disease
rapid	I-disease
ventricular	I-disease
rate	I-disease
after	O
several	O
days	O
of	O
decreased	B-disease
exercise	I-disease
tolerance	I-disease
.	O

She	O
was	O
started	O
on	O
Coumadin	O
and	O
had	O
a	O
failed	O
attempt	O
at	O
DC	O
electrical	O
cardioversion	O
on	O
11/16/96	O
.	O

She	O
has	O
been	O
on	O
Coumadin	O
since	O
and	O
has	O
continued	O
to	O
have	O
occasional	B-disease
palpitations	I-disease
and	O
mild	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
a	O
history	O
of	O
hypertension	B-disease
;	O
multinodular	B-disease
goiter	I-disease
;	O
subtotal	O
thyroidectomy	O
.	O

MEDICATIONS	O
:	O

Include	O
Cardizem	O
CD	O
180	O
mg	O
daily	O
;	O
Monopril	O
10	O
mg	O
daily	O
;	O
Digoxin	O
.25	O
mg	O
daily	O
;	O
and	O
Lasix	O
40	O
mg	O
every	O
other	O
day	O
.	O

ALLERGIES	O
:	O

To	O
Quinidine	O
,	O
Procardia	O
,	O
and	O
sulfa	O
antibiotics	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	O
,	O
blood	O
pressure	O
was	O
200/100	O
;	O
heart	O
rate	O
120	O
per	O
minute	O
(	O
atrial	B-disease
fibrillation	I-disease
)	O
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
anxious	B-disease
.	O

There	O
was	O
no	O
neck	B-disease
vein	I-disease
distension	I-disease
or	O
carotid	B-disease
bruits	I-disease
.	O

Heart	O
sounds	O
were	O
normal	O
.	O

The	O
lungs	O
were	O
clear	O
.	O

The	O
abdominal	O
examination	O
was	O
benign	O
.	O

There	O
was	O
no	O
peripheral	B-disease
edema	I-disease
.	O

Pulses	O
were	O
all	O
easily	O
palpable	O
.	O

LABORATORY	O
DATA	O
:	O

A	O
12-lead	O
electrocardiogram	O
showed	O
atrial	B-disease
fibrillation	I-disease
with	O
a	O
QT	O
interval	O
of	O
.46	O
seconds	O
.	O

There	O
were	O
diffuse	B-disease
ST	I-disease
segment	I-disease
and	I-disease
T-wave	I-disease
abnormalities	I-disease
,	O
which	O
were	O
nonspecific	O
.	O

A	O
complete	O
blood	O
count	O
,	O
electrolytes	O
,	O
BUN	O
and	O
creatinine	O
were	O
within	O
normal	O
limits	O
.	O

INR	O
was	O
elevated	O
at	O
2.5	O
.	O

An	O
echocardiogram	O
was	O
performed	O
,	O
which	O
showed	O
completely	O
normal	O
left	O
ventricular	O
systolic	O
function	O
with	O
an	O
ejection	O
fraction	O
calculated	O
at	O
.74	O
.	O

There	O
was	O
no	O
evidence	O
of	O
left	B-disease
ventricular	I-disease
hypertrophy	I-disease
or	O
asymmetric	B-disease
septal	I-disease
hypertrophy	I-disease
,	O
which	O
had	O
been	O
an	O
issue	O
that	O
had	O
been	O
raised	O
on	O
an	O
echocardiogram	O
in	O
Ownra	O
Cin	O
,	O
New	O
Mexico	O
on	O
12/06/96	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
started	O
on	O
Propafenone	O
300	O
mg	O
three	O
times	O
a	O
day	O
and	O
underwent	O
an	O
attempt	O
at	O
electrical	O
cardioversion	O
after	O
seven	O
doses	O
of	O
this	O
.	O

This	O
failed	O
,	O
despite	O
one	O
shock	O
at	O
300	O
joules	O
and	O
two	O
shocks	O
at	O
360	O
joules	O
.	O

The	O
Propafenone	O
was	O
stopped	O
,	O
and	O
the	O
patient	O
was	O
changed	O
to	O
Amiodarone	O
400	O
mg	O
t.i.d.	O
,	O
which	O
was	O
continued	O
for	O
two	O
days	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
on	O
Amiodarone	O
200	O
mg	O
daily	O
on	O
12/29/96	O
.	O

An	O
electrocardiogram	O
showed	O
no	O
evidence	O
of	O
QT	B-disease
prolongation	I-disease
prior	O
to	O
discharge	O
,	O
and	O
pulmonary	O
function	O
tests	O
will	O
be	O
performed	O
before	O
the	O
patient	O
goes	O
home	O
today	O
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
Dr.	O
Ther	O
Ludzjesc	O
at	O
Shiekeu	O
Hospital	O
Medical	O
Centers	O
in	O
Connecticut	O
.	O

In	O
addition	O
,	O
she	O
will	O
return	O
to	O
this	O
hospital	O
in	O
early	O
February	O
for	O
repeat	O
attempt	O
at	O
electrical	O
cardioversion	O
on	O
Amiodarone	O
.	O

She	O
will	O
continue	O
her	O
Coumadin	O
until	O
then	O
and	O
arrangements	O
for	O
her	O
readmission	O
can	O
be	O
made	O
through	O
Dr.	O
Iceca	O
Rhaltkaaispehbreun	O
's	O
office	O
here	O
.	O

MEDICATIONS	O
:	O

Other	O
than	O
the	O
addition	O
of	O
Amiodarone	O
200	O
mg	O
daily	O
,	O
will	O
be	O
the	O
same	O
as	O
her	O
admission	O
medications	O
.	O

STA	O
BODEJOVE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

ICECA	O
RHALTKAAISPEHBREUN	O
,	O
M.D.	O

cc	O
:	O

Dr.	O
Ther	O
Ludzjesc	O
Director	O
,	O
Section	O
of	O
Cardiology	O
Shiekeu	O
Hospital	O
Medical	O
Centers	O
NC	O

TR	O
:	O

sip	O

DD	O
:	O

12/29/96	O

TD	O
:	O

12/29/96	O
10:03	O
A	O

cc	O
:	O

ICECA	O
RHALTKAAISPEHBREUN	O
,	O
M.D.	O

500472963	O

PUOMC	O

9506800	O

464389	O

651486	O

9/20/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

FYFEUARDFEL	O
,	O
TADE	O

MRN	O
:	O

9506800	O

Age	O
:	O

65y	O

REGISTRATION	O
DATE	O
:	O

09/20/2000	O
12:41	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
FYFEUARDFEL	O
,	O
TADE	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ph	O
University	O
Of	O
Medical	O
Center	O
on	O
09/20/2000	O
12:41	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
ABD	B-disease
PAIN	I-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
PH	O
UNIVERSITY	O
OF	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
FONG	O
,	O
CONEY	O
N	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
PERFORATION	B-disease
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
639-873-2993	O
.	O

Admission	O
Date	O
:	O

2016-07-18	O

Discharge	O
Date	O
:	O

2016-07-21	O

Date	O
of	O
Birth	O
:	O

1969-11-05	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Penicillins	O

Attending	O
:	O
Daniel	O
Z.	O
H.	O
Walton	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Dyspnea	B-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O

History	O
of	O
Present	O
Illness	O
:	O

46	O
-	O
yo-man	O
w/	O
active	O
cocaine	O
use	O
presents	O
w/	O
LE	B-disease
edema	I-disease
.	O

10	O
days	O
ago	O
,	O
he	O
developed	O
b/l	B-disease
LE	I-disease
edema	I-disease
that	O
has	O
gotten	O
progressively	O
worse	O
until	O
now	O
.	O

Three	O
days	O
ago	O
,	O
he	O
developed	O
dyspnea	B-disease
on	O
exertion	O
when	O
climbing	O
stairs	O
,	O
assoc	O
w/	O
2-pillow	B-disease
orthopnea	I-disease
and	O
PND	B-disease
.	O

He	O
denies	O
any	B-disease
recent	I-disease
chest	I-disease
pain	I-disease
,	O
palpitations	B-disease
,	O
headache	B-disease
,	O
confusion	B-disease
,	O
weakness	B-disease
,	O
numbness	B-disease
,	O
abd	B-disease
pain	I-disease
,	O
or	O
hematuria	B-disease
.	O

No	O
recent	B-disease
viral	I-disease
syndromes	I-disease
or	O
URI	B-disease
s.	I-disease

He	O
does	O
admit	O
to	O
cocaine	O
use	O
last	O
night	O
.	O

Today	O
,	O
his	O
wife	O
convinced	O
him	O
to	O
present	O
to	O
the	O
Deanna	O
for	O
evaluation	O
.	O

In	O
the	O
Deanna	O
,	O
his	O
BP	O
was	O
230/170	O
.	O

BNP	O
was	O
elevated	O
at	O
7500	O
.	O

CXR	O
revealed	O
evidence	O
of	O
cardiomegaly	B-disease
and	O
pulm	B-disease
edema	I-disease
.	O

He	O
was	O
treated	O
w/	O
ASA	O
325	O
mg	O
,	O
lasix	O
10	O
mg	O
IV	O
,	O
and	O
hydralazine	O
10	O
mg	O
IV	O
x	O
2	O
.	O

He	O
responded	O
well	O
to	O
lasix	O
w/	O
good	O
UOP	O
,	O
but	O
diastolic	O
BP	O
remained	O
elevated	B-disease
at	O
170	O
,	O
prompting	O
initiation	O
of	O
nitroprusside	O
gtt	O
.	O

He	O
is	O
now	O
admitted	O
to	O
the	O
CCU	O
for	O
further	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

none	O

Social	O
History	O
:	O

significant	O
for	O
current	O
tobacco	O
use	O
.	O

Drinks	O
3-4	O
beers	O
a	O
few	O
times	O
weekly	O
,	O
no	O
h/o	O
withdrawal	B-disease
symptoms	I-disease
,	O
seizures	B-disease
or	O
DT	B-disease
s.	I-disease

Snorts	O
cocaine	O
1-2	O
times	O
monthly	O
.	O

Never	O
injected	O
drugs	O
.	O

Family	O
History	O
:	O

There	O
is	O
no	O
family	O
history	O
of	O
premature	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
or	O
sudden	B-disease
death	I-disease
.	O

Physical	O
Exam	O
:	O

VS	O
:	O
T,	O
BP	O
181/122	O
,	O
HR	O
84	O
,	O
RR	O
12	O
,	O
O2	O
98%	O
2L/m	O

Gen	O
:	O
lying	O
flat	O
in	O
bed	O
,	O
pleasant	O
and	O
conversational	O
,	O
NAD	B-disease

HEENT	O
:	O
NCAT	B-disease
.	O

Sclera	B-disease
anicteric	I-disease
.	O

PERRL	O
,	O
EOMI	O
.	O

OP	O
clear	O
w/	O
MMM	O
.	O

Neck	O
:	O
Supple	O
with	O
JVP	O
of	O
8	O
cm	O
.	O

CV	O
:	O
reg	O
s1	O
,	O
loud	B-disease
s2	I-disease
,	O
+	O
2/6	B-disease
systolic	I-disease
murmur	I-disease
radiating	I-disease
to	I-disease
axilla	I-disease
,	O
no	O
s3/s4/r	B-disease

Pulm	O
:	O
CTA	O
b/l	O
w/	O
no	O
crackles	B-disease
or	O
wheezing	B-disease

Abd	O
:	O
obese	B-disease
,	O
+BS	O
,	O
soft	O
,	O
NTND	B-disease
.	O

Ext	O
:	O
warm	O
,	O
2+	O
DP	O
b/l	O
,	O
2+	B-disease
pitting	I-disease
edema	I-disease
to	I-disease
knees	I-disease
b/l	I-disease

Neuro	O
:	O
a/o	O
x	O
3	O
,	O
CN	O
04-04	O
intact	O

Pertinent	O
Results	O
:	O

2016-07-18	O
05:30	O
PM	O

WBC	O
-	O
7.7	O
RBC	O
-	O
5.00	O
HGB	O
-	O
15.0	O
HCT	O
-	O
42.8	O
MCV	O
-	O
86	O
MCH	O
-	O
30.0	O
MCHC	O
-	O
35.0	O
RDW	O
-	O
14.6	O

2016-07-18	O
05:30	O
PM	O

PLT	O
COUNT	O
-	O
315	O

2016-07-18	O
05:30	O
PM	O

CK-MB	O
-	O
4	O
proBNP	O
-	O
7489	O
*	O

2016-07-18	O
05:30	O
PM	O

cTropnT	O
-	O
0.02	O
*	O

2016-07-18	O
05:30	O
PM	O

ALT(SGPT)	O
-	O
77	O
*	O
AST(SGOT)	O
-	O
60	O
*	O
CK(CPK)	O
-	O
195	O
*	O
ALK	O
PHOS	O
-	O
104	O
AMYLASE	O
-	O
100	O
TOT	O
BILI	O
-	O
0.4	O

EKG	O
demonstrated	O
NSR	O
at	O
87	O
bpm	O
,	O
nl	O
axis	O
,	O
nl	O
int	O
,	O
LVH	B-disease
w/	O
strain	B-disease
pattern	I-disease
,	O
no	O
ischemic	B-disease
changes	I-disease
.	O

CXR	O
:	O

Moderate	B-disease
to	I-disease
severe	I-disease
enlargement	I-disease
of	I-disease
the	I-disease
cardiac	I-disease
silhouette	I-disease
,	O
and	O
particularly	O
the	O
left	O
atrium	O
accompanied	O
by	O
pulmonary	B-disease
vascular	I-disease
congestion	I-disease
and	O
mild	B-disease
pulmonary	I-disease
edema	I-disease
consistent	O
with	O
heart	B-disease
failure	I-disease
.	O

Conclusions	O
:	O

The	O
left	O
atrium	O
is	O
moderately	B-disease
dilated	I-disease
.	O

There	O
is	O
moderate	B-disease
symmetric	I-disease
left	I-disease
ventricular	I-disease
hypertrophy	I-disease
with	O
mild	B-disease
cavity	I-disease
dilation	I-disease
and	O
severe	B-disease
global	I-disease
hypokinesis	I-disease
.	O

No	O
left	B-disease
ventricular	I-disease
thrombus	I-disease
is	O
seen	O
.	O

Tissue	O
Doppler	O
imaging	O
suggests	O
an	B-disease
increased	I-disease
left	I-disease
ventricular	I-disease
filling	I-disease
pressure	I-disease
(	O
PCWP	O
>	O
18	O
mmHg	O
).	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	B-disease
dilated	I-disease
with	O
severe	B-disease
free	I-disease
wall	I-disease
hypokinesis	I-disease
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
minimally	B-disease
thickened	I-disease
.	O

No	O
aortic	B-disease
stenosis	I-disease
or	O
aortic	B-disease
regurgitation	I-disease
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal	O
.	O

There	O
is	O
no	O
mitral	B-disease
valve	I-disease
prolapse	I-disease
.	O

Mild	B-disease
(	I-disease
1+	I-disease
)	I-disease
mitral	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

There	O
is	O
moderate	B-disease
pulmonary	I-disease
artery	I-disease
systolic	I-disease
hypertension	I-disease
.	O

There	O
is	O
a	B-disease
very	I-disease
small	I-disease
circumferential	I-disease
pericardial	I-disease
effusion	I-disease
.	O

IMPRESSION	O
:	O
Moderate	B-disease
symmetric	I-disease
eft	I-disease
ventricular	I-disease
hypertrophy	I-disease
with	O
severe	B-disease
global	I-disease
biventricular	I-disease
hypokinesis	I-disease
c/w	O
diffuse	B-disease
process	I-disease
(	O
toxin	B-disease
,	O
metabolic	O
,	O
cannot	O
exclude	O
myocarditis	B-disease
;	O
in	O
the	O
absence	O
of	O
LVH	B-disease
on	O
ECG	O
,	O
an	B-disease
infiltrative	I-disease
process	I-disease
should	O
also	O
be	O
considered	O
).	O

Mild	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

Moderate	B-disease
pulmonary	I-disease
arterial	I-disease
hypertension	I-disease
.	O

Very	B-disease
small	I-disease
circumferential	I-disease
pericardial	I-disease
effusion	I-disease
.	O

Possible	O
abnormality	B-disease
on	I-disease
the	I-disease
aortic	I-disease
valve	I-disease
as	O
described	O
above	O
without	O
aortic	B-disease
regurgitation	I-disease
.	O

If	O
clinically	O
indicated	O
a	O
TEE	O
would	O
be	O
better	O
able	O
to	O
define	O
an	B-disease
abnormality	I-disease
of	I-disease
the	I-disease
aortic	I-disease
valve	I-disease
.	O

Brief	O
Hospital	O
Course	O
:	O

46	O
-	O
yo-man	O
w/	O
cocaine	O
abuse	O
presents	O
w/	O
LE	B-disease
edema	I-disease
and	O
DOE	B-disease
likely	O
from	O
diastolic	B-disease
heart	I-disease
failure	I-disease
in	O
the	O
setting	O
of	O
cocaine	O
use	O
complicated	O
by	O
hypertensive	B-disease
urgency	I-disease
.	O

Hypertensive	B-disease
urgency	I-disease
:	O

BP	O
230/170	O
on	O
presentation	O
,	O
most	O
likely	O
from	O
chronic	B-disease
HTN	I-disease
exacerbated	O
by	O
cocaine	O
use	O
.	O

No	O
signs	O
of	O
end-organ	B-disease
damage	I-disease
at	O
present	O
except	O
for	O
elevated	B-disease
creatinine	I-disease
,	O
which	O
is	O
more	O
likely	O
a	B-disease
chronic	I-disease
problem	I-disease
.	O

The	O
patient	O
was	O
started	O
on	O
labetalol	O
and	O
Lisinopril	O
.	O

His	O
blood	O
pressure	O
was	O
taken	O
down	O
from	O
230	O
systolic	O
to	O
approx	O
160	O
systolic	O
/	O
100	O
diastolic	O
on	O
discharge	O
.	O

His	B-disease
lower	I-disease
extremity	I-disease
edema	I-disease
improved	O
with	O
diuresis	O
.	O

An	O
echo	O
performed	O
on	O
admission	O
showed	O
an	O
LF	O
EF	O
of	O
25%	O
.	O

It	O
is	O
hoped	O
with	O
good	O
blood	O
pressure	O
control	O
and	O
use	O
of	O
an	O
ACE-I	O
with	O
follow	O
up	O
in	O
addition	O
to	O
cocaine	O
abstaining	O
will	O
improved	O
his	O
cardiac	O
function	O
.	O

Renal	B-disease
Failure	I-disease
:	O
creatinine	O
on	O
admission	O
was	O
1.6	O
Likely	O
acute	B-disease
hypertensive	I-disease
nephropathy	I-disease
plus	O
probalbe	O
long-standing	B-disease
hypertensive	I-disease
disease	I-disease
.	O

discharged	O
on	O
ACE-I	O
.	O

Substance	O
Use	O
:	O
Social	O
work	O
saw	O
patient	O
and	O
counceled	O
him	O
regarding	O
substance	O
abuse	O
.	O

Discharged	O
with	O
Margaret	O
Hallock	O
,	O
cardiology	O
follow	O
up	O
as	O
well	O
as	O
scheduled	O
appointment	O
with	O
a	O
new	O
PCP	O
@	O
Newton	O
Health	O
Center	O
.	O

Medications	O
on	O
Admission	O
:	O

none	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	O
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Hydrochlorothiazide	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Labetalol	O
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
120	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Lisinopril	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
:	O

-	O
hypertensive	B-disease
emergency	I-disease

-	O
ARF	B-disease

-	O
mild	B-disease
transaminitis	I-disease
likely	O
03-25	O
etoh	O
and	O
cocaine	O
abuse	O

-	O
cocaine	O
abuse	O

-	O
lower	B-disease
extremity	I-disease
edema	I-disease
improved	O

Discharge	O
Condition	O
:	O

well	O

Discharge	O
Instructions	O
:	O

You	O
came	O
in	O
with	O
hypertensive	B-disease
emergency	I-disease
.	O

You	O
were	O
treated	O
with	O
medications	O
to	O
improve	O
your	O
blood	O
pressure	O
.	O

Notably	O
you	O
were	O
discharged	O
on	O
:	O

1.	O
Lisinopril	O
20	O
mg	O
daily	O

2.	O
HCTZ	O
25	O
mg	O
daily	O

3.	O
Labetalol	O
400	O
mg	O
bid	O

4.	O
ASA	O
162mg	O
daily	O

It	O
is	O
extremely	O
important	O
for	O
you	O
to	O
take	O
these	O
medications	O
.	O

It	O
is	O
very	O
important	O
that	O
you	O
followup	O
with	O
your	O
cardiology	O
.	O

Please	O
return	O
to	O
the	O
Deanna	O
if	O
you	O
experience	O
SOB	B-disease
,	O
chest	B-disease
pain	I-disease
,	O
fevers	B-disease
,	O
chills	B-disease
,	O
dizziness	B-disease
,	O
decreased	B-disease
urine	I-disease
output	I-disease
.	O

It	O
is	O
also	O
very	O
important	O
that	O
you	O
abstain	O
from	O
cocaine	O
use	O
.	O

Followup	O
Instructions	O
:	O

Please	O
see	O
Dr.	O
Villani	O
on	O
Monday	O
2016-07-25	O
at	O
10:00	O
in	O
Smith	O
7th	O
.	O

It	O
is	O
extremely	O
important	O
for	O
you	O
to	O
keep	O
this	O
appointment	O
.	O

You	O
have	O
a	O
Primary	O
Care	O
Physician	O
B.	O
Schumacher	O
on	O
07-29	O
@	O
1:45	O
pm	O
.	O

Please	O
arrive	O
1	O
hour	O
prior	O
to	O
the	O
appointment	O
to	O
complete	O
the	O
Free	O
Care	O
Application	O
there	O
.	O

You	O
need	O
to	O
bring	O
a	O
picture	O
ID	O
,	O
proof	O
of	O
citizenship	O
,	O
proof	O
of	O
address	O
.	O

The	O
Clinci	O
phone	O
number	O
is	O
(	O
754	O
)	O
280-1011	O

Please	O
followup	O
with	O
Dr.	O
Lesha	O
Lefebvre	O
on	O
08-15	O
at	O
10:30	O
am	O
.	O

His	O
number	O
is	O
(	O
532-803-1162	O
.	O

His	O
secretary	O
can	O
help	O
you	O
clarify	O
your	O
insurance	O
.	O

Ralph	O
Katherine	O
MD	O
31-164	O

Completed	O
by	O
:	O
Terry	O
Smith	O
MD	O
12-201	O
2016-07-21	O
@	O
1848	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jennifer	O
Applebee	O
on	O
:	O
Sandra	O
2016-07-21	O
9:54	O
PM	O

(	O
End	O
of	O
Report	O
)	O

060376519	O
DH	O

0649031	O

323495	O

3838556	O

4/5/2003	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SELCFARST	O
,	O
NAORLY	O

MRN	O
:	O

0649031	O

Age	O
:	O

49y	O

REGISTRATION	O
DATE	O
:	O

04/05/2003	O
11:47	O
AM	O

Provider	O
:	O

STIEGE	O
,	O
M.D.	O
TLANDJESC	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Discharge	O
Date	O
/	O
Time	O
:	O

04/05/2003	O
22:06	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

DIZZINESS	B-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
dizziness	B-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Benign	B-disease
positional	I-disease
vertigo	I-disease
vs	O
labyrinthitis	B-disease

Treatment	O
Rendered	O
:	O

Head	O
CT	O
negative	O
.	O

Discharge	O
Medications	O
:	O

Meclizine	O
25	O
mg	O
po	O
bid	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
to	O
ED	O
or	O
call	O
PCP	O
if	O
symptoms	B-disease
worsen	O
or	O
if	O
fever	B-disease
with	O
headache	B-disease
.	O

Pt	O
d	O
/	O
c&apos;d	O
home	O
in	O
stable	O
condition	O
.	O

PCP	O
Name	O
:	O

GUYNLORDSMANTDOUET	O
,	O
RYLA	O
B	O

Provider	O
Number	O
:	O

26596	O

This	O
report	O
was	O
created	O
by	O
TLANDJESC	O
,	O
IECELANE	O
,	O
M.D.	O
04/05/2003	O
10:09	O
PM	O

817406016	O
RWH	O

3154334	O

554691	O

3547577	O

7/6/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

JEMSKOP	O
,	O
COT	O

MRN	O
:	O

3154334	O

Age	O
:	O

54y	O

REGISTRATION	O
DATE	O
:	O

07/06/2005	O
11:11	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
JEMSKOP	O
,	O
COT	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
07/06/2005	O
11:11	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
CP	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
admitted	O
as	O
an	O
inpatient	O
to	O
Ro	O
Woodma	O
Healthcare	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
KOTEDAIZREKE	O
,	O
LILA	O
and	O
the	O
preliminary	O
admitting	O
diagnosis	O
is	O
CP	B-disease
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

TITCHEAGNERO	O
,	O
TO	O

Provider	O
Number	O
:	O

98076	O

Admission	O
Date	O
:	O

2011-02-06	O

Discharge	O
Date	O
:	O

2011-02-08	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Pohl	O
is	O
a	O
53	O
-	O
year-old	O
male	O
with	O
history	O
of	O
alcohol	O
use	O
and	O
hypertension	B-disease
.	O

He	O
was	O
found	O
in	O
his	O
apartment	O
lobby	O
"	O
shouting	O
"	O
and	O
very	B-disease
agitated	I-disease
.	O

The	O
patient	O
states	O
that	O
he	O
recalls	O
going	O
out	O
alone	O
to	O
a	O
cafe	O
the	O
evening	O
prior	O
to	O
admission	O
.	O

There	O
he	O
recalls	O
having	O
pizza	O
and	O
two	O
glasses	O
of	O
red	O
wine	O
.	O

The	O
patient	O
told	O
other	O
staff	O
that	O
he	O
had	O
a	O
few	O
cocktails	O
and	O
drinking	O
a	O
few	O
more	O
glasses	O
of	O
wine	O
when	O
he	O
ran	O
into	O
some	O
friends	O
at	O
a	O
bar	O
.	O

He	O
denies	O
any	O
other	O
drug	O
or	O
toxin	O
ingestion	O
.	O

He	O
does	O
not	O
recall	O
walking	O
home	O
,	O
but	O
he	O
states	O
that	O
the	O
way	O
is	O
well	O
known	O
to	O
him	O
.	O

He	O
has	O
no	O
further	O
recollection	O
,	O
until	O
he	O
presented	O
to	O
the	O
emergency	O
room	O
.	O

He	O
by	O
emergency	O
room	O
report	O
,	O
was	O
found	O
in	O
his	O
apartment	O
lobby	O
agitated	B-disease
.	O

EMS	O
was	O
called	O
and	O
the	O
patient	O
was	O
taken	O
to	O
the	O
emergency	O
room	O
.	O

Blood	O
alcohol	O
level	O
was	O
383	O
.	O

Agitated	B-disease
in	O
emergency	O
room	O
requiring	O
4	O
leather	O
restraints	O
,	O
received	O
5	O
mg	O
of	O
Haldol	O
,	O
2	O
mg	O
of	O
Ativan	O
.	O

He	O
became	O
hypotensive	B-disease
in	O
the	O
emergency	O
room	O
with	O
a	O
systolic	O
blood	O
pressure	O
in	O
the	O
80	O
's	O
and	O
had	O
decreased	B-disease
respiratory	I-disease
rate	I-disease
.	O

He	O
received	O
a	O
normal	O
saline	O
bolus	O
of	O
2	O
liters	O
of	O
good	O
blood	O
pressure	O
response	O
.	O

The	O
patient	O
was	O
then	O
admitted	O
to	O
the	O
medical	O
Intensive	O
Care	O
Unit	O
for	O
observation	O
of	O
his	O
blood	O
pressure	O
and	O
then	O
transferred	O
to	O
our	O
service	O
on	O
medicine	O
when	O
the	O
blood	O
pressures	O
remained	O
stable	O
overnight	O
.	O

The	O
patient	O
denies	O
any	B-disease
chest	I-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
dysuria	B-disease
,	O
diarrhea	B-disease
,	O
bright	B-disease
red	I-disease
blood	I-disease
per	I-disease
rectum	I-disease
.	O

He	O
does	O
complain	O
of	O
cold	B-disease
symptoms	I-disease
times	O
one	O
week	O
.	O

The	O
patient	O
states	O
in	O
the	O
past	O
that	O
he	O
has	O
participated	O
in	O
several	O
alcohol	O
treatment	O
programs	O
,	O
most	O
recently	O
Star	O
which	O
is	O
similar	O
Alcoholics	O
Anonymous	O
.	O

The	O
patient	O
admits	O
that	O
he	O
has	O
had	O
many	O
stressors	O
in	O
his	O
life	O
lately	O
.	O

His	O
job	O
as	O
a	O
computer	O
programmer	O
is	O
unstable	O
.	O

His	O
brother	O
is	O
mentally	B-disease
handicapped	I-disease
and	O
might	O
be	O
sent	O
away	O
from	O
his	O
instate	O
institution	O
.	O

He	O
is	O
also	O
concerned	O
about	O
the	O
threat	O
of	O
war	O
and	O
is	O
ready	O
to	O
"	O
move	O
to	O
Madagascar	O
".	O

He	O
states	O
that	O
he	O
primarily	O
relies	O
on	O
friends	O
.	O

In	O
the	O
past	O
,	O
he	O
has	O
been	O
very	B-disease
depressed	I-disease
and	O
has	O
seen	O
a	O
counselor	O
at	O
Greenfield	O
Community	O
College	O
Community	O
Health	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-disease
.	O

2.	O
History	O
of	O
colonic	B-disease
polyps	I-disease
times	O
3	O
,	O
benign	O
in	O
2007	O
,	O
repeat	O
colonoscopy	O
due	O
to	O
in	O
2010	O
.	O

3.	O
History	O
of	O
right	B-disease
inguinal	I-disease
hernia	I-disease
in	O
2002	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

SOCIAL	O
HISTORY	O
:	O

Positive	O
tobacco	O
,	O
10	O
pack	O
year	O
history	O
,	O
quit	O
for	O
8	O
years	O
in	O
his	O
40	O
's	O
and	O
now	O
no	O
cigarettes	O
for	O
one	O
week	O
using	O
no	O
pharmacal	O
therapy	O
.	O

Positive	O
for	O
ETOH	O
(	O
10	O
glasses	O
a	O
week	O
),	O
positive	O
for	O
drugs	O
,	O
marijuana	O
in	O
college	O
.	O

He	O
denies	O
any	O
IV	O
drug	O
use	O
.	O

The	O
patient	O
currently	O
lives	O
lone	O
in	O
Malden	O
.	O

He	O
came	O
out	O
here	O
for	O
college	O
at	O
BU	O
and	O
works	O
as	O
a	O
computer	O
programmer	O
.	O

Primarily	O
the	O
family	O
lives	O
in	O
Wisconsin	O
.	O

The	O
patient	O
has	O
only	O
male	O
sexual	O
partners	O
and	O
in	O
the	O
last	O
six	O
months	O
has	O
two	O
regular	O
partners	O
who	O
reportedly	O
are	O
human	B-disease
immunodeficiency	I-disease
virus	I-disease
negative	O
and	O
no	O
IV	O
drug	O
use	O
.	O

He	O
uses	O
condoms	O
consistently	O
.	O

Major	O
stressors	O
in	O
his	O
life	O
include	O
unstable	O
job	O
,	O
brother	O
is	O
mentally	B-disease
handicapped	I-disease
,	O
war	O
.	O

ALLERGIES	O
:	O
No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Lisinopril	O
5	O
mg	O
p.o.	O
q.d.	O

2.	O
Mavik	O
question	O
of	O
dosage	O
.	O

3.	O
Hydrochlorothiazide	O
question	O
of	O
dosage	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

1.	O
Ranitidine	O
150	O
mg	O
b.i.d.	O

2.	O
Thiamine	O
100	O
mg	O
q.d.	O

3.	O
Folic	O
acid	O
1	O
mg	O
q.	O
d.	O

4.	O
Multivitamin	O

PHYSICAL	O
EXAMINATION	O
:	O

Vitals	O
on	O
admission	O
:	O
Please	O
refer	O
to	O
addendum	O
.	O

Vital	O
signs	O
were	O
stable	O
.	O

Systolic	O
blood	O
pressure	O
in	O
the	O
120	O
's	O
to	O
130	O
's.	O

Pulse	O
in	O
the	O
60	O
's	O
to	O
70	O
's.	O

The	O
patient	O
was	O
a	O
thin	O
well-appearing	O
man	O
who	O
was	O
visibly	B-disease
restless	I-disease
in	O
bed	O
.	O

Neurological	O
:	O

He	O
was	O
alert	O
and	O
oriented	O
times	O
3	O
and	O
with	O
slightly	B-disease
pressured	I-disease
speech	I-disease
.	O

He	O
states	O
that	O
mood	O
is	O
depressed	B-disease
.	O

He	O
denies	O
auditory	B-disease
,	I-disease
visual	I-disease
or	I-disease
tactile	I-disease
hallucinations	I-disease
.	O

Cranial	O
nerves	O
II-XII	O
are	O
grossly	O
intact	O
,	O
5/5	O
strength	O
in	O
all	O
extremities	O
,	O
sensation	O
is	O
intact	O
in	O
all	O
extremities	O
.	O

Head	O
,	O
ears	O
,	O
eyes	O
,	O
nose	O
and	O
throat	O
:	O
Atraumatic	B-disease
and	O
normocephalic	O
.	O

Sclerae	O
were	O
anicteric	B-disease
.	O

Oropharynx	O
was	O
benign	O
without	O
exudate	B-disease
.	O

Neck	O
:	O

Supple	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
.	O

NO	O
murmurs	B-disease
,	O
rubs	B-disease
or	O
gallops	B-disease
.	O

Chest	O
:	O

Rare	B-disease
crackles	I-disease
on	I-disease
the	I-disease
right	I-disease
base	I-disease
,	O
otherwise	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Abdomen	O
:	O

Positive	O
bowel	O
sounds	O
,	O
nontender	B-disease
and	O
nondistended	B-disease
.	O

No	O
hepatosplenomegaly	B-disease
.	O

Extremities	O
:	O

He	O
had	O
Dorsalis	O
pedis	O
in	O
radial	O
pulses	O
,	O
hands	B-disease
and	I-disease
feet	I-disease
notably	I-disease
tremulous	I-disease
without	O
asterixis	B-disease
.	O

No	O
stigmata	B-disease
of	O
IV	O
drug	O
use	O
.	O

LABORATORY	O
DATA	O
:	O

CBC	O
:	O
White	O
blood	O
cell	O
count	O
is	O
8.8	O
,	O
hematocrit	O
35.5	O
platelets	O
266	O
,	O
PT	O
13	O
,	O
PT-T	O
23.3	O
,	O
INR	O
was	O
1.1	O
.	O

Chem-7	O
:	O
Sodium	O
145	O
,	O
potassium	O
3.4	O
,	O
chloride	O
116	O
,	O
bicarb	O
21	O
,	O
BUN	O
12	O
,	O
creatinine	O
0.6	O
,	O
glucose	O
96	O
,	O
calcium	O
7.2	O
,	O
phos	O
3.6	O
,	O
magnesium	O
1.7	O
.	O

Liver	O
function	O
tests	O
:	O
ALT	O
38	O
,	O
AST	O
34	O
,	O
alk	O
phos	O
is	O
107	O
,	O
albumin	O
is	O
3.2	O
,	O
peak	O
bili	O
is	O
0.3	O
,	O
amylase	O
31	O
,	O
and	O
lipase	O
is	O
32	O
.	O

UA	O
was	O
negative	O
.	O

Urine	O
tox	O
was	O
negative	O
.	O

Serum	O
tox	O
was	O
positive	O
for	O
ETOH	O
at	O
383	O
,	O
otherwise	O
negative	O
.	O

Serum	O
osmolality	O
was	O
38397	O
,	O
calculated	O
osmolality	O
gap	O
was	O
21	O
.	O

Radiology	O
:	O

chest	O
x-ray	O
from	O
02-07	O
had	O
linear	B-disease
atelectasis	I-disease
in	I-disease
right	I-disease
lower	I-disease
lobe	I-disease
with	O
no	O
evidence	O
of	O
a	B-disease
band-like	I-disease
opacity	I-disease
in	I-disease
the	I-disease
left	I-disease
lower	I-disease
lobe	I-disease
which	O
was	O
evident	O
on	O
the	O
chest	O
x-ray	O
on	O
02-06	O
.	O

CT	O
of	O
the	O
head	O
on	O
02-06	O
was	O
negative	O
for	O
hemorrhage	B-disease
.	O

There	O
was	O
bran	B-disease
atrophy	I-disease
and	O
right	B-disease
temporal	I-disease
encephalomalacia	I-disease
.	O

ASSESSMENT	O
AND	O
PLAN	O
:	O

Mr.	O
Pohl	O
is	O
a	O
53	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
ETOH	O
,	O
hypertension	B-disease
who	O
presented	O
int	O
he	O
emergency	O
room	O
with	O
increased	B-disease
agitation	I-disease
,	O
like	O
secondary	O
to	O
ETOH	B-disease
intoxication	I-disease
and	O
developed	O
subsequent	B-disease
hypotension	I-disease
,	O
systolic	O
blood	O
pressures	O
in	O
the	O
80	O
's,	O
status	O
post	O
Ativan	O
and	O
Haldol	O
,	O
but	O
was	O
responsive	O

to	O
fluid	O
resuscitation	O
at	O
4	O
liters	O
and	O
was	O
admitted	O
to	O
the	O
CMED	O
CCU	O
for	O
hemodynamic	O
monitoring	O
.	O

On	O
hospital	O
day	O
#2	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Medicine	O
Ludlow	O
Team	O
.	O

Plan	O
for	O
patient	O
regarding	O
cardiac	O
,	O
unlike	O
hypotension	B-disease
of	I-disease
cardiac	I-disease
origin	I-disease
.	O

The	O
patient	O
responded	O
well	O
to	O
fluid	O
resuscitation	O
.	O

Elevated	B-disease
CK	I-disease
on	O
02-07	O
is	O
likely	O
secondary	O
to	O
mild	B-disease
rhabdomyolysis	I-disease
.	O

The	O
patient	O
was	O
hemodynamically	O
stable	O
overnight	O
in	O
the	O
CMED	O
CCU	O
.	O

We	O
decided	O
to	O
discontinue	O
telemetry	O
and	O
held	O
all	O
hypertension	O
medications	O
including	O
Lisinopril	O
,	O
Mavik	O
,	O
hydrochlorothiazide	O
.	O

2.	O
For	O
pulmonary	O
,	O
the	O
patient	O
had	O
a	O
good	O
O2	O
saturations	O
on	O
room	O
air	O
.	O

He	O
had	O
atelectasis	B-disease
in	I-disease
the	I-disease
right	I-disease
lower	I-disease
lobe	I-disease
by	O
chest	O
x-ray	O
.	O

We	O
encouraged	O
activity	O
and	O
patient	O
out	O
of	O
bed	O
.	O

3.	O
Gastrointestinal	O
:	O

The	O
patient	O
on	O
ranitidine	O
150	O
mg	O
p.o.	O
b.i.d.	O
for	O
gastrointestinal	O
prophylaxis	O
.	O

4.	O
Urology	O
:	O
Foley	O
was	O
discontinued	O
in	O
the	O
CMED	O
CCU	O
at	O
12	O
p.m.	O

The	O
patient	O
was	O
urinating	O
without	O
difficulty	B-disease
.	O

We	O
gave	O
the	O
patient	O
bathroom	O
privileges	O
.	O

5.	O
FEN	O
:	O

We	O
continued	O
IV	O
fluids	O
at	O
100	O
cc	O
per	O
hour	O
for	O
one	O
liter	O
secondary	O
to	O
a	O
concern	O
for	O
rhabdomyolysis	B-disease
plus	O
kidney	O
protective	O
effects	O
.	O

K	O
was	O
3.4	O
,	O
repleted	O
,	O
potassium	O
chloride	O
40	O
mEq	O
times	O
1	O
dose	O
p.o.	O

Calcium	O
with	O
7.2	O
corrected	O
to	O
less	O
than	O
8.0,	O
completed	O
calcium	O
carbonate	O
at	O
500	O
mg	O
blood	O
pressure.o.	O
t.i.d.	O
while	O
in	O
the	O
hospital	O
.	O

Mag	O
was	O
1.7	O
,	O
repleted	O
with	O
magnesium	O
oxide	O
with	O
400	O
mg	O
p.o.	O
times	O
one	O
dose	O
.	O

Diet	O
as	O
tolerated	O
.	O

6.	O
Substance	O
use	O
and	O
psychiatry	O
:	O

The	O
patient	O
states	O
that	O
he	O
was	O
willing	O
to	O
speak	O
with	O
someone	O
from	O
addiction	O
services	O
.	O

We	O
were	O
concerned	O
regarding	O
possibly	O
binge	O
drinking	O
or	O
ETOH	O
abuse	O
.	O

The	O
patient	O
seemed	O
notably	B-disease
anxious	I-disease
and	O
depressed	B-disease
.	O

It	O
is	O
possible	O
that	O
the	O
patient	O
is	O
self	O
medicating	O
for	O
underlying	B-disease
psychiatric	I-disease
disorder	I-disease
.	O

We	O
will	O
monitor	O
for	O
signs	O
of	O
alcohol	B-disease
withdrawal	I-disease
according	O
to	O
the	O
CIWA	O
scale	O
.	O

We	O
will	O
given	O
valium	O
5	O
mg	O
p.o.	O
q.	O
3	O
hours	O
for	O
withdrawal	B-disease
.	O

We	O
will	O
consult	O
addiction	O
service	O
in	O
the	O
a.m.	O

We	O
will	O
consider	O
psychiatry	O
consult	O
in	O
the	O
future	O
to	O
assess	O
for	O
underlying	B-disease
anxiety	I-disease
disorder	I-disease
or	O
depression	B-disease
.	O

DISPOSITION	O
:	O

The	O
patient	O
may	O
be	O
discharge	O
Harry	O
02-08	O
pending	O
observations	O
for	O
delirium	B-disease
tremens	I-disease
after	O
discussion	O
with	O
primary	O
care	O
physician	O
,	O
Dr.	O
Blue	O
who	O
knows	O
the	O
patient	O
well	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
transferred	O
to	O
medicine	O
service	O
on	O
hospital	O
day	O
#2	O
after	O
remaining	O
hemodynamically	O
stable	O
in	O
the	O
CMED	O
CCU	O
overnight	O
.	O

1.	O
Blood	O
pressure	O
:	O

The	O
patient	O
's	O
blood	O
pressure	O
remained	O
stable	O
on	O
hospital	O
day	O
#2	O
through	O
hospital	O
day	O
#3	O
status	O
post	O
IV	O
hydration	O
with	O
systolic	O
blood	O
pressures	O
in	O
the	O
120	O
's	O
to	O
130	O
's.	O

We	O
continued	O
to	O
hold	O
the	O
patient	O
's	O
home	O
blood	O
pressure	O
medications	O
.	O

The	O
patient	O
was	O
asymptomatic	B-disease
without	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
and	O
no	O
mental	B-disease
status	I-disease
changes	I-disease
.	O

2.	O
Substance	O
abuse	O
:	O

On	O
Hospital	O
day	O
#2	O
through	O
hospital	O
day	O
#3	O
,	O
the	O
patient	O
had	O
mild	B-disease
tremor	I-disease
on	I-disease
hands	I-disease
,	O
but	O
improved	O
over	O
hospital	O
course	O
.	O

The	O
patient	O
became	O
notably	B-disease
less	I-disease
anxious	I-disease
throughout	O
hospital	O
stay	O
.	O

CIWA	O
scale	O
over	O
night	O
was	O
1	O
for	O
tremor	B-disease
and	O
the	O
patient	O
did	O
not	O
require	O
any	O
Valium	O
for	O
alcohol	B-disease
withdrawal	I-disease
.	O

We	O
believe	O
that	O
the	O
patient	O
is	O
able	O
to	O
be	O
discharged	O
and	O
to	O
follow	O
up	O
with	O
Dr.	O
Sandra	O
Rose	O
,	O
addiction	O
services	O
as	O
an	O
outpatient	O
.	O

Call	O
for	O
further	O
referral	O
.	O

3.	O
FEN	O
:	O

Calcium	O
carbonate	O
500	O
mg	O
p.o.	O
t.i.d.	O
,	O
Mag	O
oxide	O
400	O
mg	O
p.o.	O
times	O
one	O
dose	O
,	O
potassium	O
chloride	O
repleted	O
40	O
mEq	O
times	O
one	O
dose	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
ETOH	B-disease
intoxication	I-disease
.	O

2.	O
Hypertension	B-disease
.	O

3.	O
History	O
of	O
colonic	B-disease
polyp	I-disease
times	O
3	O
,	O
benign	O
in	O
2007	O
,	O
repeat	O
colonoscopy	O
due	O
in	O
2010	O
.	O

4.	O
History	B-disease
of	I-disease
right	I-disease
inguinal	I-disease
hernia	I-disease
in	O
2002	O
.	O

DISCHARGE	O
STATUS	O
:	O

Home	O
.	O

FOLLOW	O
UP	O
:	O

Follow	O
up	O
with	O
Dr.	O
Marcia	O
Bender	O
to	O
be	O
arranged	O
by	O
the	O
patient	O
.	O

The	O
patient	O
will	O
also	O
call	O
clinical	O
nurse	O
specialist	O
,	O
Sandra	O
Rose	O
at	O
(	O
968	O
)	O
347-9868	O
for	O
further	O
referral	O
to	O
addiction	O
services	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Return	O
to	O
home	O
medications	O
:	O

1.	O
Lisinopril	O
5	O
mg	O
p.o.q.d.	O

2.	O
Mavik	O
unknown	O
dosage	O
.	O

3.	O
Hydrochlorothiazide	O
unknown	O
dosage	O
.	O

MARK	O
T	O
Ragin	O
,	O
M.D.	O
34-329	O

Dictated	O
By	O
:	O
Alice	O
T.	O
Mahoney	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-02-08	O
12:05	O

T	O
:	O
2011-02-08	O
12:15	O

JOB	O
#:	O
77892	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Carlson	O
on	O
:	O
SUN	O
2011-02-20	O
1:40	O
PM	O

(	O
End	O
of	O
Report	O
)	O

337702516	O
WGH	O

9387380	O

310695	O

271735	O

9/15/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

FREIERMLINKENEIGHCAABLINFARST	O
,	O
ANEA	O

UNIT	O
NUMBER	O
:	O

008-08-33	O

ADMISSION	O
DATE	O
:	O

09/15/2000	O

DISCHARGE	O
DATE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
on	O
July	O
12th	O
for	O
a	O
chole	O
with	O
a	O
principle	O
diagnosis	O
of	O
recurrent	B-disease
biliary	I-disease
colic	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
42	O
year	O
old	O
with	O
recurrent	B-disease
biliary	I-disease
colic	I-disease
.	O

She	O
has	O
had	O
ultrasound	B-disease
proven	I-disease
gallstones	I-disease
for	O
ten	O
years	O
,	O
seen	O
on	O
an	O
earlier	O
obstetric	O
ultrasound	O
.	O

The	O
patient	O
has	O
had	O
no	O
symptoms	B-disease
until	O
approximately	O
two	O
years	O
ago	O
when	O
she	O
began	O
having	O
classic	B-disease
biliary	I-disease
colic	I-disease
pain	I-disease
with	O
right	B-disease
upper	I-disease
quadrant	I-disease
epigastric	I-disease
pain	I-disease
radiating	O
to	O
midback	O
with	O
nausea	B-disease
,	O
but	O
without	O
vomiting	B-disease
.	O

Onset	O
was	O
an	O
hour	O
to	O
1	O
hour	O
after	O
meals	O
,	O
worse	O
with	O
greasy	O
meals	O
,	O
lasting	O
five	O
minutes	O
to	O
two	O
hours	O
.	O

Episodes	B-disease
have	O
been	O
increasing	O
in	O
frequency	O
over	O
the	O
last	O
few	O
months	O
.	O

She	O
has	O
had	O
no	O
fevers	B-disease
,	O
chills	B-disease
,	O
respiratory	B-disease
symptoms	I-disease
,	O
diarrhea	B-disease
,	O
bright	B-disease
red	I-disease
blood	I-disease
per	I-disease
rectum	I-disease
or	O
melena	B-disease
.	O

She	O
has	O
not	O
found	O
any	O
relieve	O
with	O
any	O
over	O
the	O
counter	O
medications	O
.	O

She	O
has	O
no	O
family	O
history	O
of	O
gallbladder	B-disease
or	O
pancreatic	B-disease
disease	I-disease
.	O

She	O
has	O
had	O
no	O
significant	O
weight	B-disease
loss	I-disease
.	O

No	O
anorexia	B-disease
.	O

An	O
ultrasound	O
on	O
1/25/00	O
showed	O
six	B-disease
gallstones	I-disease
without	O
cholecystitis	B-disease
.	O

She	O
has	O
no	O
history	O
of	O
liver	B-disease
disease	I-disease
,	O
hepatitis	B-disease
.	O

The	O
patient	O
is	O
from	O
45	O
Sidewonly	O
Blvd	O
,	O
Fresa	O
Loharanleah	O
,	O
Maryland	O
.	O

Has	O
lived	O
in	O
896	O
Lokatspur	O
Pkwy	O
,	O
Ingrich	O
Vepobuffh	O
,	O
Indiana	O
for	O
25	O
years	O
and	O
works	O
as	O
a	O
teaching	O
assistant	O
in	O
a	O
second	O
grade	O
in	O
Satlnonew	O
Rollglend	O
Pabridrham	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
a	O
left	O
ear	O
operation	O
approximately	O
30	O
years	O
ago	O
with	O
left	O
TM	O
reconstruction	O
in	O
December	O
1999	O
at	O
Hitch	O
Hospital	O
.	O

MEDS	O
ON	O
ADMISSION	O
:	O

Only	O
multivitamins	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denies	O
tobacco	O
and	O
/	O
or	O
alcohol	O
use	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Noncontributory	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
a	O
healthy	O
appearing	O
female	O
looking	O
her	O
stated	O
age	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

She	O
is	O
anicteric	B-disease
without	O
rash	B-disease
or	O
HEENT	O
.	O

Significant	O
for	O
left	B-disease
TM	I-disease
scarring	I-disease
without	O
acute	B-disease
inflammation	I-disease
or	O
drainage	B-disease
.	O

Oropharynx	O
is	O
moist	O
.	O

No	O
lymphadenopathy	B-disease
is	O
noted	O
.	O

Thyroid	O
is	O
nonpalpable	O
.	O

She	O
is	O
without	O
bruits	B-disease
or	O
JVD	B-disease
.	O

Lungs	O
are	O
bilaterally	O
clear	O
to	O
auscultation	O
.	O

Cardiac	O
exam	O
;	O
she	O
has	O
positive	O
S1	O
,	O
S2	O
without	O
murmur	B-disease
,	O
rub	B-disease
or	O
gallop	B-disease
.	O

Rate	O
was	O
75	O
.	O

Abdomen	O
is	O
soft	O
and	O
nontender	B-disease
without	O
hepatosplenomegaly	B-disease
or	O
mass	B-disease
.	O

She	O
has	O
no	O
rebound	B-disease
or	O
guarding	B-disease
.	O

Her	O
rectal	O
exam	O
is	O
guaiac	O
negative	O
.	O

Her	O
extremities	O
are	O
without	O
normal	O
limits	O
with	O
+2	O
pulses	O
throughout	O
.	O

She	O
is	O
neurologically	O
intact	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
the	O
lap	O
coli	O
with	O
an	O
intraoperative	O
cholangiogram	O
by	O
Dr.	O
Sterp	O
under	O
general	O
anesthesia	O
.	O

A	O
separate	O
operative	O
note	O
has	O
been	O
dictated	O
.	O

Operative	O
course	O
and	O
recovery	O
were	O
without	O
complication	B-disease
.	O

The	O
patient	O
was	O
admitted	O
to	O
floor	O
.	O

The	O
patient	O
was	O
afebrile	B-disease
,	O
vital	O
signs	O
were	O
stable	O
.	O

She	O
is	O
taking	O
po	O
&apos;s	O
.	O

She	O
is	O
ambulatory	O
.	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
with	O
a	O
follow	O
up	O
appointment	O
with	O
Dr.	O
Sterp	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Percocet	O
5	O
mg	O
in	O
325	O
mg	O
one	O
to	O
two	O
tabs	O
po	O
q4	O
to	O
6	O
prn	O
pain	B-disease
.	O

The	O
patient	O
will	O
be	O
discharged	O
in	O
stable	O
condition	O
.	O

Follow	O
up	O
as	O
mentioned	O
will	O
be	O
with	O
Dr.	O
Sterp	O
.	O

______________________	O
SANTDEL	O
GLOTZRHALT	O
,	O
M.D.	O

TR	O
:	O

sxu	O

DD	O
:	O

09/15/2000	O

TD	O
:	O

09/21/2000	O
10:58	O
P	O

cc	O
:	O

MINAQUEENALT	O
MASHINEUSSHA	O
STERP	O
,	O
M.D.	O

105732749	O

FIH	O

7017973	O

715894	O

55714	O

9/10/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

STERPKOTENEISH	O
,	O
LYDELL	O
A	O

UNIT	O
NUMBER	O
:	O

712-67-96	O

ADMISSION	O
DATE	O
:	O

09/10/1999	O

DISCHARGE	O
DATE	O
:	O

09/14/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Pancreatic	B-disease
carcinoma	I-disease
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Laparoscopy	O
with	O
biopsy	O
for	O
diagnosis	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Sterpkoteneish	O
is	O
a	O
69-year-old	O
woman	O
,	O
who	O
over	O
the	O
past	O
six	O
months	O
has	O
noted	O
increasing	B-disease
pain	I-disease
in	I-disease
her	I-disease
left	I-disease
upper	I-disease
quadrant	I-disease
radiating	O
to	O
the	O
back	O
.	O

She	O
described	O
the	B-disease
pain	I-disease
as	O
being	O
exacerbated	O
by	O
eating	O
and	O
described	O
an	B-disease
associated	I-disease
weight	I-disease
loss	I-disease
.	O

She	O
presented	O
to	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Tlandtaze	O
,	O
in	O
Aersing	O
Rocuch	O
Sun	O
,	O
who	O
obtained	O
a	O
CT	O
scan	O
,	O
which	O
demonstrated	O
a	B-disease
mass	I-disease
in	O
the	O
tail	O
of	O
the	O
pancreas	O
.	O

She	O
was	O
then	O
referred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
under	O
the	O
El	O
Memorial	O
and	O
was	O
seen	O
by	O
Dr.	O
Blinjesc	O
,	O
who	O
scheduled	O
her	O
for	O
an	O
exploratory	O
laparoscopy	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
significant	O
for	O
spinal	B-disease
stenosis	I-disease
and	O
a	O
series	O
of	O
operations	O
including	O
repair	O
of	O
a	B-disease
ureteral	I-disease
stricture	I-disease
;	O
cataract	O
implants	O
;	O
two	O
partial	O
hysterectomies	O
;	O
and	O
an	O
appendectomy	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Oxycontin	O
10	O
mg	O
PO	O
q.day	O
.	O

Darvocet	O
.	O

Estratab	O
.	O

Aspirin	O
325	O
mg	O
PO	O
q.day	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
blood	O
pressure	O
was	O
150/86	O
;	O
pulse	O
82	O
;	O
respirations	O
16	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Heart	O
:	O

regular	O
S1	O
and	O
S2	O
;	O
no	O
murmurs	B-disease
.	O

Abdomen	O
:	O

soft	O
;	O
nontender	O
;	O
no	O
palpable	B-disease
masses	I-disease
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
through	O
same	O
day	O
surgery	O
and	O
taken	O
to	O
the	O
operating	O
room	O
where	O
Dr.	O
Blinjesc	O
,	O
assisted	O
by	O
Dr.	O
Zockbeathe	O
,	O
performed	O
a	O
diagnostic	O
laparoscopy	O
with	O
peritoneal	O
washings	O
.	O

Findings	O
included	O
no	B-disease
gross	I-disease
evidence	I-disease
seating	I-disease
in	I-disease
the	I-disease
abdominal	I-disease
wall	I-disease
;	O
one	B-disease
nodule	I-disease
on	O
the	O
posterior	O
surface	O
of	O
the	O
right	O
lobe	O
of	O
the	O
liver	O
;	O
one	B-disease
nodule	I-disease
in	O
the	O
inferior	O
edge	O
of	O
the	O
falciform	O
ligament	O
.	O

Specimens	O
sent	O
to	O
pathology	O
included	O
peritoneal	O
washings	O
and	O
permanent	O
specimens	O
from	O
the	O
liver	O
and	O
falciform	B-disease
nodules	I-disease
.	O

There	O
were	O
no	O
complications	B-disease
,	O
and	O
the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

Postoperatively	O
,	O
the	O
patient	O
had	O
some	B-disease
abdominal	I-disease
bloating	I-disease
with	O
evidence	O
of	O
subcutaneous	B-disease
emphysema	I-disease
over	I-disease
the	I-disease
abdomen	I-disease
.	O

She	O
was	O
uncomfortable	B-disease
and	O
slow	O
to	O
have	O
bowel	O
movements	O
,	O
although	O
she	O
did	O
have	O
flatus	O
.	O

She	O
tolerated	O
a	O
full	O
diet	O
well	O
,	O
but	O
continued	O
to	O
have	O
abdominal	B-disease
cramping	I-disease
and	O
a	B-disease
mild	I-disease
ileus	I-disease
for	O
the	O
following	O
three	O
days	O
.	O

She	O
was	O
treated	O
with	O
repeated	O
Fleet	O
&apos;s	O
enemas	O
,	O
and	O
on	O
postoperative	O
day	O
three	O
,	O
she	O
had	O
a	O
number	O
of	O
bowel	O
movements	O
,	O
was	O
considerably	O
more	O
comfortable	O
,	O
and	O
deemed	O
ready	O
for	O
discharge	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Was	O
excellent	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Included	O
aspirin	O
325	O
mg	O
PO	O
q.day	O
.	O

Percocet	O
one	O
to	O
two	O
whenever	O
necessary	O
q.	O
four	O
to	O
six	O
hours	O
for	O
pain	B-disease
.	O

Estratab	O
one	O
PO	O
q.day	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
cytopathology	O
specimens	O
had	O
been	O
negative	O
,	O
and	O
surgical	O
pathology	O
specimens	O
were	O
still	O
pending	O
.	O

She	O
was	O
instructed	O
to	O
call	O
Dr.	O
Blinjesc	O
for	O
the	O
results	O
of	O
these	O
tests	O
and	O
to	O
follow	O
up	O
with	O
him	O
for	O
further	O
management	O
if	O
necessary	O
.	O

STA	O
BODEJOVE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

______________________________	O
LONSHI	O
OCK	O
,	O
M.D.	O

TR	O
:	O

hjr	O

DD	O
:	O

09/14/1999	O

TD	O
:	O

09/17/1999	O
2:26	O
P	O

cc	O
:	O

LONSHI	O
OCK	O
,	O
M.D.	O

cc	O
:	O

Telshey	O
K.	O
Swatlleebtik	O
,	O
M.D.	O
Rinime	O
Hawnspantkote	O
Arkansas	O

517414339	O

PUOMC	O

4351342	O

88500	O

099515	O

12/26/1996	O
12:00:00	O
AM	O

HYPERPARATHYROIDISM	B-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

HOUGHTJESCSLEM	O
,	O
RIESHINJIN	O
R	O

UNIT	O
NUMBER	O
:	O

948-14-32	O

ADMISSION	O
DATE	O
:	O

12/26/96	O

DISCHARGE	O
DATE	O
:	O

01/01/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

hyperparathyroidism	B-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
status	O
post	O
mitral	O
valve	O
replacement	O
,	O

2.	O
hypertension	B-disease
,	O

3.	O
atrial	B-disease
fibrillation	I-disease
,	O

4.	O
hypertrophic	B-disease
obstructive	I-disease
cardiomyopathy	I-disease
,	O

5.	O
osteoarthritis	B-disease
,	O

6.	O
right	B-disease
cheek	I-disease
basal	I-disease
cell	I-disease
carcinoma	I-disease
,	O

7.	O
glaucoma	B-disease
,	O

8.	O
non-insulin	B-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease
,	O

9.	O
status	O
post	O
laparoscopic	O
cholecystectomy	O
,	O

10.	O
status	O
post	O
dilation	O
and	O
curettage	O
,	O

11.	O
status	O
post	O
cataract	O
surgery	O
,	O

12.	O
status	O
post	O
left	O
breast	O
biopsy	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Parathyroidectomy	O
on	O
12-27-96	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
83-year-old	O
female	O
who	O
presents	O
for	O
surgical	O
evaluation	O
for	O
her	B-disease
hyperparathyroidism	I-disease
.	O

This	O
is	O
an	O
83-year-old	O
female	O
with	O
a	O
history	O
of	O
hypertrophic	B-disease
obstructive	I-disease
cardiomyopathy	I-disease
,	O
status	O
post	O
mitral	O
valve	O
replacement	O
in	O
1988	O
,	O
chronic	B-disease
atrial	I-disease
fibrillation	I-disease
,	O
hypertension	B-disease
,	O
who	O
presents	O
for	O
parathyroidectomy	O
.	O

In	O
August	O
of	O
1996	O
while	O
the	O
patient	O
was	O
at	O
Retelk	O
County	O
Medical	O
Center	O
for	O
replacement	O
of	O
her	O
knees	O
bilaterally	O
,	O
and	O
on	O
preoperative	O
evaluation	O
she	O
was	O
noted	O
to	O
have	O
a	B-disease
high	I-disease
calcium	I-disease
and	O
therefore	O
the	O
surgery	O
was	O
canceled	O
.	O

Further	O
testing	O
revealed	O
hyperparathyroidism	B-disease
as	O
evidenced	O
by	O
an	B-disease
elevated	I-disease
PTH	I-disease
.	O

The	O
patient	O
reports	O
no	O
masses	B-disease
in	I-disease
her	I-disease
neck	I-disease
.	O

She	O
has	O
noticed	O
some	O
generalized	B-disease
hoarseness	I-disease
in	I-disease
her	I-disease
voice	I-disease
for	O
the	O
past	O
5-6	O
months	O
.	O

In	O
addition	O
,	O
she	O
has	O
some	B-disease
dysphagia	I-disease
,	O
particularly	O
has	O
had	O
some	B-disease
difficulties	I-disease
with	I-disease
swallowing	I-disease
.	O

She	O
has	O
been	O
seen	O
by	O
Dr.	O
Tokbelb	O
,	O
her	O
primary	O
care	O
physician	O
in	O
Itgreenredan	O
Hospital	O
,	O
and	O
also	O
Dr.	O
Kotefyfechird	O
,	O
her	O
cardiologist	O
,	O
and	O
also	O
an	O
endocrinologist	O
at	O
Retelk	O
County	O
Medical	O
Center	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
status	O
post	O
mitral	O
valve	O
replacement	O
in	O
1988	O
.	O

She	O
has	O
a	O
St.	O
Jude	O
&apos;s	O
mechanical	O
valve	O
and	O
has	O
been	O
on	O
Coumadin	O
since	O
then	O
,	O

2.	O
hypertension	B-disease
,	O
she	O
has	O
had	O
hypertension	B-disease
for	O
15	O
years	O
,	O

3.	O
atrial	B-disease
fibrillation	I-disease
,	O
she	O
is	O
status	O
post	O
cardioversion	O
3-25-94	O
,	O

4.	O
hypertrophic	B-disease
obstructive	I-disease
cardiomyopathy	I-disease
,	O

5.	O
osteoarthritis	B-disease
;	O
she	O
is	O
to	O
receive	O
bilateral	O
total	O
knee	O
replacements	O
at	O
some	O
time	O
in	O
the	O
near	O
future	O
,	O

6.	O
right	B-disease
cheek	I-disease
basal	I-disease
cell	I-disease
carcinoma	I-disease
to	O
be	O
removed	O
in	O
the	O
future	O
,	O

7.	O
history	O
of	O
glaucoma	B-disease
,	O

8.	O
non	B-disease
insulin	I-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease
which	O
was	O
diagnosed	O
in	O
March	O
,	O
1995	O
,	O

9.	O
shingles	B-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

1.	O
laparoscopic	O
cholecystectomy	O
03/93	O
by	O
Dr.	O
Sapmal	O
,	O

2.	O
dilation	O
and	O
curettage	O
in	O
1992	O
for	O
polyps	B-disease
,	O

3.	O
left	O
breast	O
biopsy	O
which	O
was	O
benign	O
,	O

4.	O
cataract	O
surgery	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Lopid	O
600	O
mg	O
PO	O
b.i.d.	O
,	O

2.	O
K-Dur	O
20	O
mg	O
PO	O
q.day	O
,	O

3.	O
Lasix	O
40	O
mg	O
PO	O
q.day	O
,	O

4.	O
Coumadin	O
2.5	O
mg	O
PO	O
q.day	O
which	O
was	O
last	O
taken	O
two	O
days	O
prior	O
to	O
admission	O
,	O

5.	O
Norvasc	O
500	O
mg	O
PO	O
q.day	O
,	O

6.	O
Digoxin	O
.25	O
mg	O
PO	O
q.day	O
,	O

7.	O
Lopressor	O
50	O
mg	O
PO	O
b.i.d.	O
,	O

8.	O
Glucotrol	O
10	O
XL	O
qam	O
,	O

9.	O
Timoptic	O
0.5%	O
b.i.d.	O
to	O
both	O
eyes	O
,	O

10.	O
Pilocarpine	O
gel	O
qhs	O
to	O
both	O
eyes	O
.	O

FAMILY	O
HISTORY	O
:	O

There	O
is	O
no	O
family	O
history	O
of	O
parathyroid	B-disease
or	I-disease
thyroid	I-disease
diseases	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
widowed	O
.	O

She	O
lives	O
alone	O
but	O
is	O
completely	O
independent	O
.	O

She	O
visits	O
her	O
daughter	O
once	O
a	O
week	O
.	O

No	O
ethanol	O
or	O
tobacco	O
use	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
review	O
of	O
systems	O
is	O
significant	O
for	O
a	O
history	O
of	O
dyspnea	B-disease
on	I-disease
exertion	I-disease
.	O

At	O
present	O
,	O
she	O
can	O
walk	O
one	O
to	O
two	O
blocks	O
before	O
having	O
to	O
stop	O
because	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

When	O
walking	O
outside	O
,	O
she	O
stops	O
multiple	O
times	O
because	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

She	O
sleeps	O
with	O
two	O
pillows	O
at	O
night	O
.	O

She	O
gets	O
short	B-disease
of	I-disease
breath	I-disease
walking	O
up	O
steps	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	O
examination	O
,	O
she	O
is	O
a	O
pleasant	O
woman	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Her	O
pulse	O
is	O
72	O
,	O
irregularly	O
irregular	O
,	O
blood	O
pressure	O
96/60	O
,	O
temperature	O
97.9	O
,	O
respirations	O
18	O
.	O

The	O
head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
examination	O
is	O
notable	O
for	O
pupils	O
which	O
have	O
irregular	B-disease
border	I-disease
and	O
are	O
very	B-disease
sluggishly	I-disease
reactive	I-disease
.	O

The	O
patient	O
reports	O
that	O
she	O
will	O
have	O
revision	O
of	O
cataract	O
surgery	O
.	O

Neck	O
and	O
lungs	O
are	O
unremarkable	O
.	O

Cardiovascular	O
exam	O
:	O

III	B-disease
/	I-disease
VI	I-disease
systolic	I-disease
click	I-disease
and	O
irregularly	B-disease
irregular	I-disease
rhythm	I-disease
.	O

The	O
abdomen	O
was	O
benign	O
.	O

She	O
is	O
guaiac	O
negative	O
on	O
rectal	O
examination	O
.	O

Extremities	O
:	O

unremarkable	O
.	O

LABORATORY	O
DATA	O
:	O

Admission	O
white	O
blood	O
count	O
4.3	O
,	O
hematocrit	O
31.0	O
,	O
electrolytes	O
were	O
all	O
within	O
normal	O
limits	O
,	O
glucose	O
218	O
,	O
prothrombin	O
time	O
on	O
admission	O
was	O
15.1	O
with	O
INR	O
of	O
1.5	O
,	O
partial	O
thromboplastin	O
time	O
23.3	O
.	O

The	O
electrocardiogram	O
showed	O
atrial	B-disease
fibrillation	I-disease
with	O
slow	B-disease
ventricular	I-disease
response	I-disease
and	O
digitalis	B-disease
effect	I-disease
as	O
well	O
as	O
left	B-disease
ventricular	I-disease
hypertrophy	I-disease
.	O

IMPRESSION	O
ON	O
ADMISSION	O
:	O

Impression	O
was	O
that	O
this	O
was	O
an	O
83-year-old	O
female	O
with	O
cardiac	B-disease
history	I-disease
,	O
dyspnea	B-disease
on	I-disease
exertion	I-disease
,	O
increased	B-disease
calcium	I-disease
and	O
hyperparathyroidism	B-disease
who	O
presents	O
for	O
parathyroidectomy	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

On	O
the	O
day	O
of	O
admission	O
,	O
the	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
for	O
parathyroidectomy	O
.	O

The	O
right	O
superior	O
parathyroid	O
gland	O
was	O
found	O
to	O
be	O
markedly	B-disease
enlarged	I-disease
and	O
consistent	O
with	O
an	B-disease
adenoma	I-disease
.	O

Her	O
right	O
superior	O
parathyroid	O
gland	O
was	O
removed	O
and	O
the	O
rest	O
of	O
her	O
parathyroid	O
glands	O
were	O
left	O
in	O
place	O
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
well	O
and	O
was	O
able	O
to	O
cough	O
and	O
phonate	O
completely	O
with	O
no	O
changes	B-disease
from	O
preoperative	O
.	O

The	O
plan	O
was	O
to	O
start	O
her	O
on	O
heparin	O
and	O
Coumadin	O
and	O
discontinue	O
her	O
heparin	O
when	O
her	O
Coumadin	O
levels	O
became	O
therapeutic	O
as	O
judged	O
by	O
the	O
prothrombin	O
time	O
/	O
INR	O
.	O

However	O
,	O
on	O
postoperative	O
day	O
number	O
two	O
,	O
the	O
patient	O
in	O
the	O
afternoon	O
noticed	O
some	B-disease
tingling	I-disease
in	I-disease
her	I-disease
hands	I-disease
and	O
also	O
some	B-disease
tingling	I-disease
hear	I-disease
her	I-disease
perioral	I-disease
region	I-disease
.	O

She	O
had	O
a	O
negative	O
Chvostek	O
&apos;s	O
and	O
negative	O
Trousseau	O
&apos;s	O
sign	O
.	O

She	O
had	O
no	O
muscular	B-disease
weakness	I-disease
noted	O
.	O

An	O
ionized	O
calcium	O
was	O
drawn	O
which	O
was	O
low	O
at	O
1.0	O
.	O

As	O
a	O
result	O
,	O
the	O
patient	O
was	O
started	O
on	O
Os-Cal	O
250	O
mg	O
PO	O
q.i.d.	O
On	O
postoperative	O
day	O
number	O
three	O
,	O
her	O
ionized	O
calcium	O
was	O
1.06	O
and	O
her	O
Os-Cal	O
was	O
increased	O
to	O
500	O
q.i.d.	O

However	O
,	O
her	B-disease
ionized	I-disease
calcium	I-disease
decreased	I-disease
to	O
0.97	O
and	O
she	O
was	O
given	O
one	O
amp	O
of	O
calcium	O
gluconate	O
.	O

On	O
postoperative	O
day	O
number	O
five	O
,	O
the	O
patient	O
felt	O
fine	O
and	O
had	O
an	O
INR	O
of	O
1.9	O
with	O
a	O
prothrombin	O
time	O
of	O
16.6	O
.	O

Her	O
calcium	O
was	O
8.5	O
,	O
albumin	O
3.6	O
,	O
and	O
phosphate	O
4.5	O
.	O

She	O
had	O
had	O
no	O
further	O
episodes	O
of	O
tingling	B-disease
in	I-disease
her	I-disease
fingers	I-disease
after	O
the	O
initial	O
episode	O
which	O
had	O
prompted	O
us	O
originally	O
to	O
draw	O
the	O
ionized	O
calcium	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Coumadin	O
5	O
mg	O
PO	O
q.day	O
,	O
then	O
she	O
will	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
and	O
decide	O
the	O
dosage	O
thereafter	O
,	O

2.	O
Lopid	O
600	O
mg	O
PO	O
b.i.d.	O
,	O

3.	O
K-Dur	O
20	O
mg	O
PO	O
q.day	O
,	O

4.	O
Os-Cal	O
500	O
mg	O
PO	O
q.i.d.	O
,	O

5.	O
Rocaltrol	O
0.25	O
mg	O
PO	O
b.i.d.	O
,	O

6.	O
Lasix	O
40	O
mg	O
PO	O
q.day	O
,	O

7.	O
Norvasc	O
5	O
mg	O
PO	O
q.day	O
,	O

8.	O
Digoxin	O
.25	O
mg	O
PO	O
q.day	O
,	O

9.	O
Lopressor	O
50	O
mg	O
PO	O
b.i.d.	O
,	O

10.	O
Glucotrol	O
10	O
mg	O
qam	O
.	O

FOLLOW	O
UP	O
:	O

For	O
follow	O
up	O
,	O
the	O
patient	O
is	O
to	O
call	O
for	O
an	O
appointment	O
with	O
Dr.	O
Sapmal	O
.	O

In	O
addition	O
,	O
she	O
is	O
to	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
to	O
check	O
her	O
prothrombin	O
time	O
/	O
INR	O
as	O
well	O
as	O
calcium	O
,	O
albumin	O
and	O
phosphate	O
levels	O
.	O

She	O
will	O
be	O
sent	O
home	O
with	O
home	O
Arnsperni	O
Health	O
.	O

LENNI	O
BREUTZOLN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

_____________________	O
RIEEA	O
SAPMAL	O
,	O
M.D.	O

TR	O
:	O

hzu	O

DD	O
:	O

New	O
Years	O
Day	O

TD	O
:	O

01/06/97	O
2:48	O
P	O

cc	O
:	O

RIEEA	O
ODEE	O
SAPMAL	O
,	O
M.D.	O
CEALME	O
LEOE	O
MARESSYTHE	O
Dr.	O
Tokbelb	O
Welle	O
Health	O
Sonsant	O
.	O

Admission	O
Date	O
:	O

2016-11-21	O

Discharge	O
Date	O
:	O

2016-11-30	O

Date	O
of	O
Birth	O
:	O

1953-10-19	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O
CCU	O

CHIEF	O
COMPLAINT	O
AND	O
HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Jackson	O
is	O
a	O
63-year-old	O
male	O
with	O
squamous	B-disease
cell	I-disease
carcinoma	I-disease
of	O
the	O
floor	O
of	O
mouth	O
(	O
stage	B-disease
T2	I-disease
N0	I-disease
)	O
that	O
was	O
biopsied	O
by	O
his	O
dentist	O
.	O

Pathology	O
was	O
reviewed	O
revealing	O
invasive	B-disease
squamous	I-disease
cell	I-disease
carcinoma	I-disease
.	O

He	O
presented	O
on	O
2016-11-21	O
for	O
resection	O
.	O

He	O
was	O
admitted	O
on	O
2016-11-21	O
following	O
his	O
surgery	O
.	O

He	O
underwent	O
a	O
joint	O
procedure	O
by	O
Otolaryngology	O
and	O
Plastic	O
Surgery	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Includes	O
hypertension	B-disease
and	O
chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Polypectomy	O
in	O
2011	O
,	O
tooth	O
extraction	O
(	O
all	O
)	O
in	O
1980	O
,	O
and	O
hernia	B-disease
in	O
1977	O
.	O

ALLERGIES	O
:	O

TOMATO	O
(	O
causing	O
anaphylaxis	B-disease
)	O
and	O
TETANUS	O
SHOT	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Triamterene/hydrochlorothiazide	O
37.5/25	O
mg	O
one	O
tablet	O
by	O
mouth	O
once	O
daily	O
and	O
lorazepam	O
1	O
mg	O
three	O
times	O
daily	O
as	O
needed	O
(	O
for	O
anxiety	B-disease
)	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
has	O
a	O
half-pack	O
per	O
day	O
smoking	O
history	O
and	O
drinks	O
approximately	O
three	O
to	O
four	O
alcoholic	O
beverages	O
per	O
day	O
.	O

PROCEDURES	O
PERFORMED:	O

1.	O
Tracheostomy	O
.	O

2.	O
Diagnostic	O
laryngoscopy	O
and	O
biopsy	O
.	O

3.	O
Bilateral	O
supraomohyoid	O
neck	O
dissection	O
.	O

4.	O
Resection	O
of	O
floor	O
of	O
mouth	B-disease
tumor	I-disease
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

Surgeon	O
was	O
Dr.	O
Kelsey	O
K	O
Sanchez	O
.	O

Assistant	O
was	O
Dr.	O
Justin	O
K..	O
Velez	O
.	O

Frozen	O
section	O
sent	O
to	O
pathology	O
revealing	O
invasive	B-disease
squamous	I-disease
cell	I-disease
carcinoma	I-disease
.	O

No	O
complications	B-disease
.	O

The	O
Plastic	O
Team	O
then	O
took	O
over	O
for	O
reconstruction	O
consisting	O
of	O
radial	O
forearm	O
free	O
flap	O
to	O
floor	O
of	O
mouth	O
.	O

Surgeon	O
was	O
Dr.	O
Jude.	O
Christopher	O
Swinney	O
.	O

Total	O
intravenous	O
fluids	O
of	O
7300	O
cc	O
.	O

Estimated	B-disease
blood	I-disease
loss	I-disease
of	O
300	O
cc	O
.	O

Urine	O
output	O
of	O
900	O
cc	O
.	O

No	O
complications	B-disease
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
prepared	O
for	O
an	O
attempted	O
percutaneous	O
endoscopic	O
gastrostomy	O
tube	O
.	O

The	O
percutaneous	O
endoscopic	O
gastrostomy	O
was	O
unsuccessful	O
,	O
and	O
the	O
procedure	O
was	O
converted	O
to	O
an	O
open	O
gastrostomy	O
tube	O
which	O
then	O
proceeded	O
without	O
complications	B-disease
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
postoperatively	O
.	O

He	O
was	O
sedated	O
and	O
ventilated	O
by	O
his	O
tracheostomy	O
6	O
cuff	O
Shiley	O
tube	O
.	O

He	O
had	O
three	O
Westwood-Pocasset	O
drains	O
-	O
two	O
in	O
the	O
neck	O
and	O
one	O
in	O
his	O
right	O
arm	O
.	O

G-tube	O
was	O
to	O
gravity	O
,	O
Foley	O
to	O
gravity	O
,	O
left	O
radial	O
A-line	O
.	O

The	O
flap	O
was	O
pink	O
with	O
a	O
strong	O
Doppler	O
signal	O
.	O

He	O
underwent	O
flap	O
checks	O
every	O
15	O
minutes	O
initially	O
with	O
a	O
dextran	O
infusion	O
.	O

He	O
was	O
placed	O
on	O
Unasyn	O
3	O
grams	O
IV	O
q.6h.	O

Nothing	O
by	O
mouth	O
initially	O
with	O
morphine	O
as	O
needed	O
for	O
pain	B-disease
and	O
Ativan	O
around	O
the	O
clock	O
for	O
delirium	O
tremens	O
prophylaxis	O
.	O

In	O
addition	O
,	O
he	O
received	O
metoprolol	O
q.4.h.	O
,	O
a	O
regular	O
insulin	O
sliding	O
scale	O
,	O
and	O
adequate	O
gastrointestinal	O
prophylaxis	O
with	O
Protonix	O
.	O

Postoperative	O
laboratories	O
revealed	O
sodium	O
was	O
134	O
,	O
potassium	O
was	O
4.1	O
,	O
chloride	O
was	O
102	O
,	O
bicarbonate	O
was	O
28	O
,	O
blood	O
urea	O
nitrogen	O
was	O
18	O
,	O
creatinine	O
was	O
0.8	O
,	O
and	O
glucose	O
was	O
148	O
.	O

Calcium	O
was	O
7.6	O
.	O

Magnesium	O
was	O
2.2	O
.	O

Complete	O
blood	O
count	O
revealed	O
white	O
count	O
was	O
5.4	O
,	O
hematocrit	O
was	O
31.3	O
,	O
and	O
platelets	O
were	O
160	O
.	O

ALT	O
was	O
14	O
,	O
AST	O
was	O
31	O
,	O
alkaline	O
phosphatase	O
was	O
42	O
,	O
total	O
bilirubin	O
was	O
0.9	O
,	O
albumin	O
was	O
2.2	O
.	O

A	O
chest	O
x-ray	O
postoperatively	O
showed	O
clear	O
lung	O
fields	O
.	O

Tracheostomy	O
tube	O
in	O
good	O
position	O
.	O

No	O
pneumothorax	B-disease
.	O

By	O
systems	O
:	O

CMED	O
CSRU	O
and	O
Plastic	O
Surgery	O
flap	O
checks	O
,	O
tracheostomy	O
care	O
,	O
and	O
Westwood-Pocasset	O
management.	O

Cardiovascular	O
:	O

Lopressor	O
5	O
intravenously	O
q.4.h.	O

Respiratory	O
:	O

Nebulizers	O
as	O
needed	O
,	O
weaning	O
from	O
ventilation	O
.	O

Gastrointestinal	O
:	O

Medications	O
per	O
gastrostomy	O
tube	O
on	O
postoperative	O
day	O
one	O
.	O

Genitourinary	O
:	O

Foley	O
catheter	O
for	O
strict	O
monitoring	O
of	O
ins	O
and	O
outs	O
.	O

Hematologic	O
:	O

Hematocrit	O
stable	O
.	O

Infectious	O
Disease	O
:	O

Unasyn	O
for	O
antibiotic	O
coverage	O
.	O

Flap	O
checks	O
carried	O
out	O
q.2h.	O
initially	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
showing	O
positive	B-disease
biphasic	I-disease
Doppler	I-disease
signals	I-disease
.	O

Pink	O
flap	O
with	O
good	O
refill	O
.	O

Right	O
arm	O
neurovascularly	O
intact	O
.	O

He	O
was	O
weaned	O
from	O
ventilation	O
on	O
postoperative	O
day	O
one	O
to	O
pressure	O
support	O
ventilation	O
and	O
then	O
to	O
spontaneous	O
breathing	O
on	O
postoperative	O
day	O
two	O
.	O

His	O
Westwood-Pocasset	O
output	O
for	O
postoperative	O
day	O
one	O
on	O
the	O
left	O
was	O
60	O
,	O
right	O
neck	O
93	O
,	O
in	O
the	O
arm	O
20	O
.	O

Tube	O
feedings	O
were	O
started	O
48	O
hours	O
after	O
the	O
procedure	O
.	O

The	O
cuff	O
on	O
his	O
tracheostomy	O
tube	O
was	O
put	O
down	O
on	O
11-23	O
,	O
postoperative	O
day	O
two	O
which	O
he	O
tolerated	O
well	O
with	O
minimal	B-disease
secretions	I-disease
and	O
a	O
strong	O
adequate	O
cough	O
.	O

Due	O
to	O
bed	O
issues	O
,	O
he	O
was	O
transferred	O
from	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
on	O
postoperative	O
day	O
three	O
.	O

His	O
tube	O
feedings	O
were	O
advanced	O
.	O

He	O
was	O
out	O
of	O
bed	O
to	O
a	O
chair	O
.	O

He	O
continued	O
with	O
pulmonary	O
toilet	O
and	O
q.2h.	O
flap	O
checks	O
.	O

The	O
Westwood-Pocasset	O
in	O
his	O
right	O
arm	O
was	O
removed	O
on	O
2016-11-25	O
.	O

His	O
tracheostomy	O
was	O
changed	O
to	O
a	O
6	O
cuffless	O
Shiley	O
on	O
2016-11-26	O
and	O
sutures	O
in	O
place	O
with	O
a	O
3-0	O
silk	O
.	O

The	O
patient	O
tolerated	O
this	O
procedure	O
well	O
.	O

This	O
is	O
the	O
end	O
of	O
part	O
1	O
of	O
this	O
dictation	O
summary	O
for	O
Patricia	O
Jackson	O
.	O

To	O
be	O
continued	O
in	O
a	O
separate	O
dictation	O
.	O

Nola	O
Daniel	O
,	O
Hawaii	O
31699	O

Dictated	O
By:Joe	O
C.	O
Roa	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O

2016-11-30	O
10:56:11	O

T	O
:	O

2016-11-30	O
11:44:01	O

Job#	O
:	O

77004	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Michael	O
Z	O
Waldroup	O
on	O
:	O

MON	O
2016-12-19	O
10:13	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-08-14	O

Discharge	O
Date	O
:	O

2017-08-23	O

Date	O
of	O
Birth	O
:	O

1943-08-23	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Sulfonamides	O

Attending	O
:	O
Marcus	O
W.	O
Kelley	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Transfer	O
from	O
Athol	O
Memorial	O
Hospital	O
for	O
acute	O
on	O
chronic	B-disease
respiratory	I-disease
distress	I-disease
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Lumbar	O
puncture	O
on	O
08-16	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Lockley	O
is	O
a	O
73	O
yo	O
male	O
with	O
a	O
complicated	O
past	O
medical	O
history	O
,	O
recently	O
discharged	O
from	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
on	O
08-02	O
following	O
a	O
prolonged	O
admission	O
for	O
STEMI	B-disease
,	O
respiratory	B-disease
failure	I-disease
felt	O
secondary	O
to	O
pulmonary	B-disease
edema	I-disease
requiring	O
intubation	O
and	O
subsequent	O
tracheostomy	O
02-22	O
failure	B-disease
to	I-disease
wean	I-disease
,	O
sepsis	B-disease
and	O
C.difficile	B-disease
colitis	I-disease
treated	O
with	O
Vancomycin	O
and	O
Flagyl	O
with	O
a	O
course	O
of	O
Levophed	O
.	O

He	O
was	O
discharged	O
to	O
Athol	O
Memorial	O
Hospital	O
for	O
continued	O
weaning	O
.	O

Per	O
Dr.	O
John	O
C.	O
Corrigan	O
Mental	O
Health	O
Center	O
,	O
patient	O
remained	O
ventilator	B-disease
dependent	I-disease
,	O
intermittently	O
on	O
PS	O
20/5	O
and	O
back	O
on	O
AC	O
15/5/500/0.35	O
on	O
08-08	O
.	O

At	O
OSH	O
,	O
sputum	O
cultures	O
grew	O
Pseudomonas	B-disease
and	O
MRSA	B-disease
,	O
and	O
he	O
was	O
restarted	O
on	O
Zosyn	O
(	O
08-08	O
)	O
and	O
Vancomycin	O
(	O
08-09	O
).	O

He	O
completed	O
his	O
course	O
of	O
Vancomycin	O
on	O
2017-08-10	O
.	O

However	O
,	O
today	O
around	O
17:45	O
,	O
while	O
being	O
moved	O
by	O
the	O
nursing	O
staff	O
,	O
Mr.	O
Lockley	O
Bosche	O
started	O
coughing	B-disease
.	O

Suctioned	O
X	O
1	O
,	O
mucus	O
not	O
cleared	O
.	O

He	O
then	O
became	O
dusky	B-disease
and	O
cyanotic	B-disease
,	O
and	O
stopped	B-disease
breathing	I-disease
on	O
his	O
own	O
.	O

A	O
code	O
was	O
called	O
,	O
+	O
pulse	O
.	O

Patient	O
placed	O
on	O
FiO2	O
100%	O
.	O

Vitals	O
reportedly	O
HR	O
88-98	O
,	O
BP	O
150/80	O
.	O

ABG	O
done	O
on	O
FiO2	O
100%	O
7.36/66/417/98%	O
.	O

At	O
Vencor	O
Hospital	O
,	O
BP	B-disease
dropped	I-disease
to	O
90	O
,	O
and	O
patient	O
was	O
started	O
on	O
NS	O
IVF	O
,	O
with	O
improvement	O
in	O
BP	O
.	O

EKG	O
without	O
acute	B-disease
changes	I-disease
.	O

He	O
was	O
transferred	O
to	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
John	O
for	O
further	O
management	O
on	O
AC	O
,	O
RR	O
15	O
,	O
PEEP	O
5	O
,	O
Vt	O
500	O
,	O
Fi02	O
1.0	O
.	O

In	O
John	O
,	O
BP	O
80/60	O
,	O
HR	O
80	O
.	O

Continued	O
on	O
IVF	O
(	O
received	O
total	O
2300	O
cc	O
)	O
,	O
with	O
improved	O
BP	O
to	O
SBP	O
105-118	O
.	O

Stool	O
sent	O
for	O
C.diff	B-disease
and	O
given	O
Flagyl	O
500	O
mg	O
PO	O
X	O
1	O
dose	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Non-small	B-disease
cell	I-disease
lung	I-disease
cancer	I-disease
s/p	O
XRT	O
and	O
chemotherapy	O
in	O
French	O
Guiana	O
,	O
s/p	O
right	O
pneumonectomy	O
in	O
2016-09-21	O
for	O
recurrence	B-disease
.	O

Chronic	B-disease
left	I-disease
pleural	I-disease
effusion	I-disease
.	O

2.	O
SSS	B-disease
status	O
post	O
PM/ICD	O
placement	O

3.	O
COPD/bronchiectasis	B-disease

4.	O
Hypertension	B-disease

5.	O
CAD	B-disease
,	O
with	O
known	O
TO	O
RCA	O
.	O

6.	O
CHF	B-disease
with	O
EF	O
25%	O
on	O
last	O
echo	O
on	O
2017-07-19	O

7.	O
BPH	B-disease

8.	O
Depression	B-disease

9.	O
Left	B-disease
femoral	I-disease
AV	I-disease
fistula	I-disease
2017-04-19	O

10.	O
Recent	B-disease
MRSA	I-disease
pneumonia	I-disease
and	O
sepsis	B-disease
2017-07-21	O
,	O
treated	O
with	O
Vancomycin	O

11.	O
C.	B-disease
difficile	I-disease
colitis	I-disease
treated	O
with	O
Flagyl	O
(	O
completed	O
08-10	O
)	O

12.	O
Status	O
post	O
PEG	O
tube	O
placement	O
2017-07-21	O

13.	O
Status	O
post	O
tracheostomy	O
2017-07-21	O
02-22	O
failure	B-disease
to	I-disease
wean	I-disease

14.	O
Status	O
post	O
partial	O
colectomy	O
1972	O

Social	O
History	O
:	O

Son	O
is	O
next	O
of	O
kin	O
.	O

See	O
below	O
for	O
contact	O
information	O
.	O

He	O
has	O
been	O
living	O
at	O
The	O
Cooley	O
Dickinson	O
Hospital	O
House	O
since	O
2017-08-02	O
.	O

Per	O
Dr.	O
John	O
C.	O
Corrigan	O
Mental	O
Health	O
Center	O
,	O
at	O
baseline	O
,	O
patient	O
not	O
interactive	O
.	O

Opens	O
eyes	O
spontaneously	O
,	O
withdraws	O
to	O
painful	O
stimulus	O
.	O

Family	O
History	O
:	O

Non-contributory	O

Physical	O
Exam	O
:	O

PHYSICAL	O
EXAM	O
on	O
admission	O
:	O

VITALS	O
:	O

BP	O
90s-118/47-59	O
,	O
HR	O
80-90s	O
.	O

Vent	O
:	O

AC	O
,	O
RR	O
15	O
,	O
PEEP	O
5	O
,	O
Vt	O
500	O
cc	O
,	O
FiO2	O
1.0	O
.	O

GEN	O
:	O

Intubated	O
,	O
opens	O
eyes	O
,	O
responds	O
to	O
painful	O
stimulus	O
.	O

HEENT	O
:	O

Pupils	B-disease
minimally	I-disease
reactive	I-disease
.	O

Sclera	B-disease
anicteric	I-disease
.	O

NECK	O
:	O

Unable	O
to	O
assess	O
JVP	O
.	O

RESP	O
:	O

Bronchial	B-disease
breathing	I-disease
over	I-disease
right	I-disease
hemithorax	I-disease
.	O

Ronchorous	B-disease
breath	I-disease
sounds	I-disease
left	I-disease
chest	I-disease
.	O

Limited	O
examination	O
.	O

CVS	O
:	O

RRR	O
.	O

Normal	O
S1	O
,	O
S2	O
.	O

+	O
S4	B-disease
.	O

No	O
murmur	B-disease
appreciated	O
.	O

GI	O
:	O

PEG	O
in	O
place	O
,	O
site	O
without	O
drainage	B-disease
.	O

BS	O
present	O
,	O
hypoactive	B-disease
.	O

Abdomen	O
soft	O
.	O

No	O
grimacing	B-disease
with	O
palpation	O
.	O

CMED	O
:	O

Foley	O
in	O
place	O
.	O

EXT	O
:	O

2+	B-disease
edema	I-disease
both	I-disease
upper	I-disease
extremities	I-disease
,	O
sacral	B-disease
edema	I-disease
.	O

Cool	B-disease
extremities	I-disease
.	O

Good	O
pedal	O
pulses	O
peripherally	O
.	O

NEURO	O
:	O

Limited	O
examination	O
.	O

Withdraws	O
to	O
painful	O
stimulus	O
.	O

Moves	O
all	O
4	O
extremities	O
.	O

Pertinent	O
Results	O
:	O

LABS	O
:	O

WBC	O
-	O
4.9	O
RBC	O
-	O
2.92	O
*	O
HGB	O
-	O
8.8	O
*	O
HCT	O
-	O
26.2	O
*	O
MCV	O
-	O
90	O
MCH	O
-	O
30.1	O
MCHC	O
-	O
33.5	O
RDW	O
-	O
18.5	O
*	O
NEUTS	O
-	O
86.5	O
*	O
LYMPHS	O
-	O
7.5	O
*	O
MONOS	O
-	O
4.7	O
EOS	O
-	O
1.2	O
BASOS	O
-	O
0.1	O
PLT	O
COUNT	O
-	O
145	O
*	O
GLUCOSE	O
-	O
91	O
UREA	O
N	O
-	O
21	O
*	O
CREAT	O
-	O
0.6	O
SODIUM	O
-	O
143	O
POTASSIUM	O
-	O
4.2	O
CHLORIDE	O
-	O
106	O
TOTAL	O
CO2	O
-	O
32	O
ANION	O
GAP	O
-	O
9	O
LACTATE	O
-	O
1.4	O
K+	O
-	O
3.9	O

ABG	O
:	O

2017-08-14	O
07:30	O
PM	O
TYPE	O
-	O
ART	O
PO2	O
-	O
468	O
*	O
PCO2	O
-	O
44	O
PH	O
-	O
7.50	O
*	O
TOTAL	O
CO2	O
-	O
36	O
*	O
BASE	O
XS	O
-	O
10	O
INTUBATED	O
-	O
INTUBATED	O

EKG	O
(	O
at	O
Athol	O
Memorial	O
Hospital	O
,	O
17:11	O
)	O
:	O

Atrial	B-disease
fibrillation	I-disease
,	O
occasional	O
V-paced	O
,	O
rate	O
74	O
.	O

Normal	O
axis	O
.	O

Old	B-disease
TWI	I-disease
V4-6	I-disease
.	O

EKG	O
in	O
John	O
:	O

Afib	B-disease
,	O
occasional	O
V-paced	O
,	O
rate	O
83	O
bpm	O
.	O

Normal	O
axis	O
.	O

Long	B-disease
QT	I-disease
interval	I-disease
(	O
QTc	O
462	O
ms	O
).	O

ST	B-disease
depressions	I-disease
V4	I-disease
,	I-disease
5	I-disease
.	O

Mild	B-disease
ST	I-disease
elevation	I-disease
in	I-disease
V3	I-disease
.	O

Old	B-disease
TWI	I-disease
V4-6	I-disease
.	O

****************	O

IMAGING	O
:	O

2017-08-14	O
CXR	O
:	O

ETT	O
in	O
correct	O
position	O
.	O

PM	O
wires	O
in	O
good	O
position	O
.	O

S/p	O
right	O
pneumonectomy	O
.	O

Blunting	B-disease
of	I-disease
left	I-disease
CPA	I-disease
likely	O
effusion	B-disease
.	O

New	B-disease
lower	I-disease
left	I-disease
lateral	I-disease
CW	I-disease
opacity	I-disease
,	O
likely	O
loculated	B-disease
pleural	I-disease
fluid	I-disease
.	O

2017-07-19	O
ECHO	O
:	O

Left-to-right	B-disease
shunt	I-disease
across	I-disease
the	I-disease
interatrial	I-disease
septum	I-disease
.	O

LVEF	O
25%	O
.	O

Resting	O
WMA	O
include	O
mid	B-disease
to	I-disease
distal	I-disease
septal	I-disease
akinesis	I-disease
,	O
apical	B-disease
akinesis	I-disease
,	O
inferior	B-disease
akinesis/hypokinesis	I-disease
,	O
and	O
mid	B-disease
to	I-disease
distal	I-disease
anterolateral	I-disease
hypokinesis	I-disease
/	O
akinesis	B-disease
.	O

No	O
definite	O
apical	B-disease
thrombus	I-disease
seen	O
(	O
cannot	O
exclude	O
).	O

01-22+	O
AR	B-disease
.	O

Trivial	B-disease
MR	I-disease
.	O

1+	O
TR	B-disease
.	O

2017-08-16	O
CT	O
head	O
:	O

New	B-disease
rounded	I-disease
low-density	I-disease
area	I-disease
measuring	O
2.5	O
cm	O
in	O
left	O
basal	O
ganglia	O
,	O
which	O
partially	O
extends	O
to	O
the	O
left	O
thalamus	O
,	O
probably	O
representing	O
subacute	B-disease
infarction	I-disease
.	O

On	O
this	O
head	O
CT	O
without	O
contrast	O
,	O
the	O
evaluation	O
is	O
limited	O
.	O

2017-08-16	O
CTA	O
chest	O
:	O

No	O
evidence	O
for	O
pulmonary	B-disease
embolism	I-disease
.	O

Findings	O
consistent	O
with	O
failure	B-disease
or	O
fluid	B-disease
overload	I-disease
.	O

Development	O
of	O
small	B-disease
loculated	I-disease
pleural	I-disease
fluid	I-disease
collection	I-disease
along	I-disease
the	I-disease
periphery	I-disease
of	O
the	O
left	O
major	O
fissure	O
or	O
so-called	B-disease
pseudotumor	I-disease
,	O
consistent	O
with	O
the	O
recent	O
chest	O
x-ray	O
.	O

Unchanged	O
appearance	O
of	O
right	O
pneumonectomy	O
.	O

2017-08-16	O
ECHO	O
:	O

The	O
left	O
atrium	O
is	O
normal	O
in	O
size	O
.	O

Overall	O
LVEF	O
is	O
difficult	O
to	O
assess	O
due	O
to	O
poor	O
echo	O
windows	O
although	O
the	O
basal	O
LV	O
appeas	O
hyperdynamic	B-disease
without	O
regional	B-disease
contraction	I-disease
abnormality	I-disease
(	O
suspect	O
significant	O
improvement	O
compared	O
to	O
prior	O
study	O
dated	O
2017-07-18	O
).	O

No	O
masses	B-disease
or	O
thrombi	B-disease
are	O
seen	O
in	O
the	O
left	O
ventricle	O
(	O
due	O
to	O
poor	O
echo	O
windows	O
cannot	O
fully	O
exclude	O
).	O

The	O
ascending	O
aorta	O
is	O
mildly	B-disease
dilated	I-disease
.	O

There	O
is	O
no	O
aortic	B-disease
valve	I-disease
stenosis	I-disease
.	O

Mild	B-disease
(	I-disease
1+	I-disease
)	I-disease
aortic	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

Trivial	B-disease
mitral	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

The	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
impaired	B-disease
relaxation	I-disease
.	O

There	O
is	O
a	B-disease
small	I-disease
pericardial	I-disease
effusion	I-disease
.	O

There	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade	B-disease

2017-08-17	O
EEG	O
:	O

Markedly	B-disease
abnormal	I-disease
portable	I-disease
EEG	I-disease
due	O
to	O
the	B-disease
voltage	I-disease
suppression	I-disease
over	I-disease
the	I-disease
left	I-disease
hemisphere	I-disease
and	O
due	O
to	O
the	B-disease
bursts	I-disease
of	I-disease
generalized	I-disease
slowing	I-disease
and	O
right	B-disease
hemisphere	I-disease
slowing	I-disease
.	O

The	B-disease
first	I-disease
abnormality	I-disease
raises	O
the	O
possibility	O
of	O
material	B-disease
(	I-disease
such	I-disease
as	I-disease
subdural	I-disease
fluid	I-disease
)	I-disease
interposed	I-disease
between	I-disease
the	I-disease
brain	I-disease
and	O
recording	O
electrodes	O
or	O
widespread	B-disease
cortical	I-disease
dysfunction	I-disease
on	I-disease
that	I-disease
side	I-disease
.	O

Anatomic	O
correlation	O
would	O
be	O
of	O
interest	O
if	O
clinically	O
indicated	O
.	O

The	B-disease
generalized	I-disease
slowing	I-disease
indicates	O
a	B-disease
non	I-disease
specific	I-disease
dysfunction	I-disease
in	I-disease
midline	I-disease
structures	I-disease
.	O

There	O
was	O
also	O
evidence	O
of	O
subcortical	B-disease
dysfunction	I-disease
on	I-disease
the	I-disease
right	I-disease
side	I-disease
.	O

No	O
epileptiform	B-disease
features	I-disease
were	O
seen	O
.	O

MICRO	O
DATA	O
:	O

2017-08-17	O
STOOL	O
CLOSTRIDIUM	O
DIFFICILE	O
TOXIN	O
ASSAY	O
-	O
PENDING	O

2017-08-16	O
CSF	O
;	O
SPINAL	O
FLUID	O
GRAM	O
STAIN	O
-	O
neg	O
FLUID	O
CULTURE	O
-	O
neg	O
;	O
FUNGAL	O
CULTURE	O
-	O
PENDING	O
;	O
ACID	O
FAST	O
CULTURE	O
-	O
PENDING	O
;	O
VIRAL	O
CULTURE	O
-	O
PENDING	O

2017-08-15	O
SPUTUM	O
CULTURE	O
-	O
PRELIMINARY	O
{	O
PSEUDOMONAS	B-disease
AERUGINOSA	I-disease
}	O

2017-08-15	O
BLOOD	O
CULTURE	O
NGTD	O

2017-08-15	O
URINE	O
CULTURE	O
-	O
FINAL	O

2017-08-15	O
BLOOD	O
CULTURE	O
NGTD	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Lockley	O
was	O
admitted	O
with	O
respiratory	B-disease
failure	I-disease
,	O
thought	O
to	O
be	O
related	O
to	O
mucus	B-disease
plugging	I-disease
as	O
well	O
as	O
a	B-disease
pseudomonal	I-disease
pneumonia	I-disease
.	O

Both	O
of	O
these	O
etiologies	O
were	O
treated	O
,	O
and	O
he	O
continued	O
to	O
oxygenate	O
and	O
ventilate	O
well	O
on	O
his	O
usual	O
ventilator	O
settings	O
.	O

However	O
,	O
the	O
issue	O
that	O
dominated	O
the	O
admission	O
was	O
his	B-disease
recent	I-disease
acute	I-disease
decline	I-disease
in	I-disease
mental	I-disease
status	I-disease
.	O

He	O
was	O
thoroughly	O
evaluated	O
by	O
neurology	O
and	O
underwent	O
head	O
CT	O
,	O
MRI	O
,	O
LP	O
,	O
and	O
EEG	O
.	O

This	O
work-up	O
demonstrated	O
a	B-disease
small	I-disease
left	I-disease
basal	I-disease
ganglia	I-disease
infarct	I-disease
,	O
likely	O
cardioembolic	B-disease
.	O

However	O
,	O
they	O
felt	O
this	O
event	O
could	O
not	O
account	O
for	O
his	B-disease
new	I-disease
,	I-disease
severe	I-disease
global	I-disease
deficit	I-disease
;	O
this	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
a	B-disease
more	I-disease
pervasive	I-disease
process	I-disease
,	O
likely	O
anoxic	B-disease
encephalopathy	I-disease
,	O
for	O
which	O
the	O
prognosis	O
is	O
extremely	O
grim	O
.	O

This	O
was	O
discussed	O
at	O
length	O
in	O
several	O
family	O
meetings	O
involving	O
the	O
patient	O
's	O
wife	O
,	O
son	O
,	O
primary	O
care	O
doctor	O
,	O
ICU	O
attending	O
,	O
and	O
neurology	O
consultant	O
in	O
the	O
presence	O
of	O
a	O
Asian	O
interpreter	O
.	O

The	O
end	O
result	O
of	O
these	O
discussion	O
was	O
that	O
the	O
patient	O
's	O
wishes	O
would	O
not	O
be	O
consistent	O
with	O
this	O
new	O
level	O
of	O
functioning	O
from	O
which	O
he	O
had	O
little	O
hope	O
of	O
recovery	O
;	O
the	O
family	O
decided	O
to	O
make	O
him	O
comfort	O
measures	O
only	O
.	O

He	O
was	O
disconnected	O
from	O
the	O
ventilator	O
and	O
all	O
medications	O
beyond	O
a	O
morphine	O
drip	O
were	O
stopped	O
,	O
and	O
he	O
expired	O
shortly	O
thereafter	O
.	O

The	O
family	O
was	O
present	O
.	O

Medications	O
on	O
Admission	O
:	O

Jevity	O
1.2	O
65	O
mL	O
/	O
hour	O
continuous	O
with	O
water	O
240	O
cc	O
q	O
8	O
hours	O

Lasix	O
40	O
mg	O
IV	O
QAM	O
(	O
given	O
08-14	O
)	O

Vancomycin	O
1	O
gm	O
IV	O
q	O
36	O
hours	O
(	O
last	O
dose	O
at	O
2000	O
on	O
08-13	O
)	O
.	O

Started	O
on	O
08-09	O
)	O

ASA	O
325	O
mg	O
PO	O
QD	O

Lansoprazole	O
30	O
mg	O
PO	O
QAM	O

Heparin	O
5000	O
units	O
SC	O
TID	O

Zosyn	O
4.5	O
gm	O
IV	O
q	O
8	O
hours	O
(	O
last	O
dose	O
on	O
08-14	O
at	O
1400	O
)	O
,	O
started	O
08-08	O
.	O

Metoprolol	O
37.5	O
mg	O
q	O
12	O
hours	O
(	O
last	O
dose	O
07/25	O
in	O
AM	O
)	O

Protein	O
/	O
Soy	O
supplement	O
2	O
scoops	O
q	O
12	O
hours	O

Ipratropium	O
/	O
Albuterol	O
inhaler	O
4	O
puffs	O
QID	O

Completed	O
course	O
of	O
Flagyl	O
07-25	O
-->	O
08-10	O
.	O

Discharge	O
Disposition	O
:	O

Expired	O

Discharge	O
Diagnosis	O
:	O

Anoxic	B-disease
encephalopathy	I-disease

Acute	B-disease
respiratory	I-disease
failure	I-disease

Chronic	B-disease
respiratory	I-disease
failure	I-disease

Pseudomonal	B-disease
pneumonia	I-disease

Volume	B-disease
overload	I-disease

Chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease

Bronchiectasis	B-disease

Hyponatremia	B-disease

Anemia	B-disease
of	I-disease
chronic	I-disease
disease	I-disease

Secondary	O
:	O

1.	O
Non-small	B-disease
cell	I-disease
lung	I-disease
cancer	I-disease
s/p	O
XRT	O
and	O
chemotherapy	O
in	O
Western	O
Sahara	O
,	O
s/p	O
right	O
pneumonectomy	O
in	O
2016-09-21	O
for	O
recurrence	B-disease
.	O

Chronic	B-disease
left	I-disease
pleural	I-disease
effusion	I-disease
.	O

2.	O
Sick	B-disease
Sinus	I-disease
Syndrome	I-disease
status	O
post	O
PM/ICD	O
placement	O

3.	O
COPD/bronchiectasis	B-disease

4.	O
Hypertension	B-disease

5.	O
CAD	B-disease
,	O
with	O
known	O
TO	O
RCA	O
.	O

6.	O
CHF	B-disease
with	O
EF	O
25%	O
on	O
last	O
echo	O
on	O
2017-07-19	O

7.	O
BPH	B-disease

8.	O
Depression	B-disease

9.	O
Left	B-disease
femoral	I-disease
AV	I-disease
fistula	I-disease
2017-04-19	O

10.	O
Recent	B-disease
MRSA	I-disease
pneumonia	I-disease
and	O
sepsis	B-disease
2017-07-21	O
,	O
treated	O
with	O
Vancomycin	O

11.	O
C.	B-disease
difficile	I-disease
colitis	I-disease
treated	O
with	O
Flagyl	O
(	O
completed	O
08-10	O
)	O

12.	O
Status	O
post	O
PEG	O
tube	O
placement	O
2017-07-21	O

13.	O
Status	O
post	O
tracheostomy	O
2017-07-21	O
02-22	O
failure	B-disease
to	I-disease
wean	I-disease

14.	O
Status	O
post	O
partial	O
colectomy	O
1972	O

Discharge	O
Condition	O
:	O

Expired	O

Johnnie	O
Callez	O
MD	O
61-750	O

Completed	O
by	O
:	O
Opal	O
Anne	O
MD	O
40-158	O
2017-08-23	O
@	O
2054	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Teresa	O
Loper	O
on	O
:	O
FRI	O
2017-09-22	O
4:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

095889687	O
WGH	O

9786774	O

224527	O

311732	O

10/24/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SOURS	O
,	O
NANONIFF	O
ELLMI	O

MRN	O
:	O

9786774	O

Age	O
:	O

31y	O

REGISTRATION	O
DATE	O
:	O

10/24/2001	O
07:57	O
AM	O

Provider	O
:	O

LICHEREANYVE	O
CHIRDKOTEKERTH	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/24/2001	O
10:07	O

Discharge	O
Status	O
:	O

Discharged	O
Condition	O
on	O
Discharge	O
:	O

Stable	O
Patient	O
States	O
Complaint	O
:	O

SWOLLEN	B-disease
PAINFUL	I-disease
L	I-disease
SIDE	I-disease
FC	I-disease

Diagnosis	O
:	O

L	B-disease
upper	I-disease
lip	I-disease
/	I-disease
L	I-disease
nostril	I-disease
abscess	I-disease

Treatment	O
Rendered	O
:	O

5	O
cc	O
of	O
purulent	B-disease
material	I-disease
drained	O
by	O
needle	O
aspiration	O

Discharge	O
Medications	O
:	O

Augmentin	O
875	O
mg	O
twice	O
a	O
day	O
for	O
10	O
days	O
.	O

Follow	O
up	O
Service	O
:	O

Please	O
see	O
your	O
PCP	O
in	O
follow	O
up	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Return	O
immediately	O
for	O
worsening	O
signs	O
of	O
infection	B-disease
(	O
increased	B-disease
swelling	I-disease
,	O
pain	B-disease
,	O
redness	B-disease
)	O
or	O
for	O
any	B-disease
neurologic	I-disease
changes	I-disease
(	O
blurry	B-disease
or	I-disease
double	I-disease
vision	I-disease
,	O
headaches	B-disease
,	O
trouble	B-disease
walking	I-disease
,	O
etc	O
)	O
.	O

PCP	O
Name	O
:	O

CLEV	O
,	O
NISHA	O

Provider	O
Number	O
:	O

53476	O

This	O
report	O
was	O
created	O
by	O
CHIRDKOTEKERTH	O
,	O
LICHEREANYVE	O
10/24/2001	O
10:09	O
AM	O

Admission	O
Date	O
:	O

2020-03-11	O

Discharge	O
Date	O
:	O

2020-03-23	O

Date	O
of	O
Birth	O
:	O

1946-04-03	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Penicillins	O

Attending	O
:	O
Ross	O
Z	O
Kenmore	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Transfer	O
from	O
Newton-Wellesley	O
Hospital	O
hospital	O
for	O
epidural	B-disease
abscess	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

1.	O
Partial	O
vertebrectomy	O
of	O
L3	O
and	O
L4	O
.	O

2.	O
Fusion	O
at	O
L3-L4	O
.	O

3.	O
Vertebral	O
Spacer	O
at	O
L3-L4	O
.	O

4.	O
Anterior	O
instrumentation	O
L3-L4	O
.	O

5.	O
Autograft	O
,	O
bone	O
morphogenic	O
protein	O
,	O
and	O
allograft	O
.	O

6.	O
Debridement	O

7.	O
Incision	O
and	O
drainage	O

8.	O
Echocardiogram	O

History	O
of	O
Present	O
Illness	O
:	O

73	O
yo	O
M	O
transferred	O
from	O
Newton-Wellesley	O
Hospital	O
hospital	O
for	O
epidural	B-disease
abscess	I-disease
.	O

Pt	O
has	O
h/o	O
colon	B-disease
can	I-disease
to	I-disease
liver	I-disease
,	O
s/p	O
resxn	O
with	O
serosal	B-disease
implants	I-disease
in	O
9/03	O
.	O

Pt	O
states	O
he	O
has	O
been	O
receiving	O
chemotherapy	O
up	O
until	O
1	O
week	O
ago	O
.	O

States	O
he	O
first	O
developed	O
back	B-disease
pain	I-disease
5	O
weeks	O
ago	O
but	O
was	O
still	O
able	O
to	O
ambulate	O
with	O
his	O
cane	O
.	O

Last	O
week	O
it	O
was	O
worse	O
and	O
he	O
was	O
seen	O
in	O
clinic	O
.	O

An	O
MRI	O
was	O
done	O
and	O
this	O
showed	O
a	B-disease
signal	I-disease
abno	I-disease
in	I-disease
L3	I-disease
L4	I-disease
?	O
disciitis	B-disease
vs	O
osteo	B-disease
without	O
a	B-disease
definitive	I-disease
epidural	I-disease
abscess	I-disease
.	O

Initially	O
on	O
Vanc	O
and	O
Cipro	O
on	O
Friday	O
but	O
then	O
seen	O
by	O
ID	O
who	O
reccommended	O
no	O
abx	O
but	O
a	O
bone	O
biopsy	O
,	O
blood	O
cx	O
.	O

He	O
was	O
also	O
seen	O
by	O
spine	O
who	O
repeated	O
the	O
MRI	O
and	O
this	O
showed	O
L3-4	B-disease
osteomyelitis	I-disease
and	O
discitis	B-disease
and	O
an	B-disease
epidural	I-disease
abscess	I-disease
,	O
5cm	O
.	O

He	O
was	O
subsequently	O
restared	O
on	O
Vancomycin	O
for	O
Corynebacterium	B-disease
in	O
blood	O
cx	O
from	O
Fri	O
;	O
Followup	O
cx	O
has	O
been	O
NGTD	O
.	O

CXR	O
also	O
showed	O
small	B-disease
pleural	I-disease
effusion	I-disease
and	O
attempt	O
was	O
made	O
to	O
tap	O
it	O
,	O
but	O
pt	O
did	O
not	O
tolerate	O
the	O
procedure	O
and	O
asked	O
that	O
it	O
be	O
deferred	O
.	O

He	O
did	O
undergo	O
a	O
CT-guided	O
aspiration	O
/	O
biopsy	O
at	O
the	O
L3-4	O
disc	O
space	O
on	O
2020-03-11	O
and	O
the	O
pt	O
was	O
transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
immediately	O
following	O
this	O
.	O

No	O
results	O
from	O
this	O
were	O
sent	O
.	O

Currently	O
pt	O
denies	O
sensory	B-disease
deficits	I-disease
or	O
weakness	B-disease
.	O

States	O
he	O
is	O
not	O
able	O
to	O
walk	O
because	O
of	O
severe	B-disease
pain	I-disease
.	O

States	O
pain	B-disease
is	O
worst	O
when	O
he	O
sits	O
up	O
or	O
twists	O
his	O
back	O
.	O

No	O
bowel	B-disease
or	I-disease
bladder	I-disease
incontinence	I-disease
.	O

Past	O
Medical	O
History	O
:	O

-	O
epidural	B-disease
abscess	I-disease

-	O
colon	B-disease
cancer	I-disease
with	O
mets	B-disease
to	I-disease
liver	I-disease
s/p	O
resection	O
09-07	O
.	O

Oncologist	O
is	O
Dr.	O
Rowles	O
.	O

-	O
CAD	B-disease
s/p	O
CABG	O
x4	O
in	O
'	O
03	O
.	O

-	O
hypercholesterolemia	B-disease

-	O
DM	B-disease
with	O
neuropathy	B-disease
.	O

-	O
persistent	B-disease
R	I-disease
foot	I-disease
ulcer	I-disease

Social	O
History	O
:	O

Lives	O
alone	O
in	O
apartment	O
in	O
Boston	O
.	O

Is	O
married	O
but	O
"	O
separated	O
"	O
from	O
his	O
wife	O
,	O
although	O
they	O
still	O
help	O
each	O
other	O
-	O

he	O
states	O
he	O
gives	O
her	O
one	O
of	O
his	O
pensions	O
and	O
she	O
helps	O
him	O
with	O
medicines	O
etc	O
.	O

Quit	O
tobacco	O
in	O
2003	O
after	O
smoking	O
1	O
ppd	O
for	O
"	O
a	O
very	O
long	O
time	O
".	O

Drank	O
ETOH	O
heavily	O
until	O
8	O
years	O
ago	O
when	O
he	O
quit	O
.	O

Denies	O
IVDU	O
.	O

Has	O
children	O
but	O
they	O
are	O
not	O
nearby	O
.	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

98.6	O
,	O
104/50	O
,	O
96	O
,	O
20	O
,	O
96%	O
RA	O

Gen	O
:	O
in	O
NAD	B-disease
,	O
but	O
winces	O
in	O
pain	B-disease
with	O
movements	O
of	O
his	O
back	O
.	O

HEENT	O
:	O
Clear	O
OP	O
,	O
MM	B-disease
very	I-disease
dry	I-disease
.	O

NECK	O
:	O
Supple	O
,	O
No	O
LAD	B-disease
,	O
No	O
JVD	B-disease

CHEST	O
:	O
Port	O
a	O
cath	O
in	O
R	O
chest	O
,	O
no	O
erythema	B-disease
or	O
tenderness	B-disease
.	O

CV	O
:	O
RR	O
,	O
NL	O
rate	O
.	O

NL	O
S1	O
,	O
S2	O
.	O

II/VI	B-disease
SEM	I-disease
at	I-disease
LSB	I-disease
with	O
radiation	B-disease
to	I-disease
apex	I-disease
.	O

LUNGS	O
:	O
+	O
crackles	B-disease
at	I-disease
L	I-disease
base	I-disease
>	O
R	O
base	O
.	O

ABD	O
:	O
Pt	O
very	B-disease
tense	I-disease
in	I-disease
abdomen	I-disease
(	O
states	O
belly	O
is	O
fine	O
,	O
but	O
he	O
is	O
weary	O
of	O
his	O
back	O
).	O

Well	B-disease
healed	I-disease
midline	I-disease
scar	I-disease
from	O
chest	O
down	O
to	O
pubis	O
.	O

No	O
HSM	B-disease
.	O

EXT	O
:	O
No	O
edema	B-disease
.	O

Dressing	O
c/d/i	O
over	O
R	B-disease
LE	I-disease
ulcer	I-disease
.	O

1	O
+	O
DP	O
pulses	O
BL	O

NEURO	O
:	O
A&Ox3	O
.	O

Appropriate	O
.	O

CN	O
02-17	O
grossly	O
intact	O
.	O

Preserved	O
sensation	O
throughout	O
.	O

5/5	O
strength	O
throughout	O
,	O
though	O
weary	O
of	O
moving	O
back	O
.	O

Back	O
:	O
+	O
ttp	B-disease
of	I-disease
lumbar	I-disease
spine	I-disease
and	I-disease
paraspinal	I-disease
muscles	I-disease
,	O
R	O
>	O
L	O
.	O

No	O
erythema	B-disease
or	O
swelling	B-disease
noted	O
.	O

CMED	O
CSRU	O
:	O
Listens	O
and	O
responds	O
to	O
questions	O
appropriately	O
,	O
pleasant	O

Pertinent	O
Results	O
:	O

Na	O
:	O
135	O
,	O
K	O
4.5	O
,	O
Cl	O
96	O
,	O
CO2	O
27	O
,	O
BUN	O
12	O
,	O
Cr	O
0.7	O
,	O
Glu	O
167	O
,	O
Ca	O
8.4	O
,	O
Vanco	O
trough	O
13	O
,	O
WBC	O
5.3	O
,	O
Hct	O
32.0	O
,	O
plt	O
330	O
,	O
INR	O
1.0	O
.	O

No	O
culture	O
data	O
was	O
sent	O
.	O

STUDIES	O
:	O

MRI	O
lumbar	O
spine	O
(	O
Youville	O
Hospital	O
2020-03-10	O
):	O
L3-4	B-disease
osteomyelitis	I-disease
,	O
discitis	B-disease
,	O
and	O
epidural	B-disease
abscess	I-disease
.	O

Degenerative	B-disease
changes	I-disease
including	O
multilevel	B-disease
central	I-disease
spinal	I-disease
stenosis	I-disease
.	O

Impression	B-disease
on	I-disease
the	I-disease
anterior	I-disease
aspect	I-disease
of	I-disease
the	I-disease
lower	I-disease
spinal	I-disease
cord	I-disease
at	I-disease
T11-12	I-disease
by	O
disc	B-disease
bulge	I-disease
.	O

Addendum	O
:	O
Findings	O
are	O
c/w	O
paraspinous	B-disease
extension	I-disease
of	I-disease
infection	I-disease
anteriorly	O
and	O
laterally	O
into	O
the	O
medial	O
aspects	O
of	O
the	O
psoas	O
muscles	O
bilaterally	O
at	O
the	O
L3	O
and	O
L4	O
levels	O
.	O

CXR	O
(	O
Youville	O
Hospital	O
2020-03-09	O
):	O
Persistent	B-disease
unchanged	I-disease
L	I-disease
mid	I-disease
and	I-disease
lower	I-disease
lung	I-disease
field	I-disease
airspace	I-disease
disease	I-disease
with	O
moderate	B-disease
L	I-disease
pleural	I-disease
effusion	I-disease
.	O

Brief	O
Hospital	O
Course	O
:	O

73	O
yo	O
M	O
transferred	O
from	O
Youville	O
Hospital	O
with	O
h/o	O
colon	B-disease
cancer	I-disease
with	O
known	B-disease
liver	I-disease
mets	I-disease
now	O
with	O
epidural	B-disease
abscess	I-disease
and	O
corynebacterium	B-disease
bacteremia	I-disease
:	O

#	O
Epidural	B-disease
abscess	I-disease
:	O
The	O
patient	O
was	O
evaluated	O
by	O
orthopedic	O
spine	O
consult	O
service	O
and	O
ID	O
.	O

He	O
was	O
continued	O
on	O
IV	O
vancomycin	O
throughout	O
his	O
course	O
and	O
had	O
therapeutic	O
troughs	O
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
OR	O
twice	O
with	O
orthopaedics	O
.	O

Please	O
see	O
the	O
operation	O
notes	O
for	O
details	O
about	O
the	O
surgeries	O
.	O

The	O
patient	O
was	O
briefly	O
admitted	O
to	O
the	O
ICU	O
for	O
low	B-disease
hematocrit	I-disease
and	O
hyponatremia	B-disease
immediately	O
following	O
the	O
surgery	O
but	O
was	O
then	O
transferred	O
back	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

The	O
patient	O
had	O
a	O
PICC	O
line	O
placed	O
and	O
will	O
continue	O
a	O
8	O
week	O
course	O
of	O
antibiotics	O
.	O

The	O
patient	O
will	O
also	O
wear	O
a	O
back	O
brace	O
at	O
all	O
times	O
while	O
out	O
of	O
bed	O
.	O

#	O
Candidemia	B-disease
:	O
The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
positive	O
blood	O
culture	O
from	O
03-12	O
.	O

The	O
patient	O
was	O
started	O
on	O
Diflucan	O
.	O

Ophthalmology	O
was	O
consulted	O
and	O
ruled	O
out	O
ocular	B-disease
spread	I-disease
.	O

The	O
patient	O
's	O
portocath	O
was	O
removed	O
.	O

The	O
tip	O
was	O
culture	O
negative	O
.	O

The	O
patient	O
will	O
get	O
a	O
total	O
of	O
a	O
two	O
week	O
course	O
of	O
Diflucan	O
.	O

#	O
Corynebacterium	B-disease
bacteremia	I-disease
:	O
presumably	O
Corynebacterium	B-disease
in	O
epidural	B-disease
abscess	I-disease
as	O
well	O
.	O

The	O
patient	O
had	O
no	O
blood	O
cultures	O
to	O
grow	O
corynebacterium	B-disease
while	O
hospitalized	O
.	O

#	O
Pleural	B-disease
effusion	I-disease
:	O
The	O
patient	O
was	O
noted	O
have	O
an	B-disease
effusion	I-disease
on	O
CXR	O
.	O

IP	O
was	O
consulted	O
and	O
did	O
a	O
thoracentesis	O
.	O

The	O
tap	O
was	O
negative	O
for	O
malignant	B-disease
cells	I-disease
.	O

A	O
repeat	O
CT	O
was	O
done	O
showing	O
nodular	B-disease
thickening	I-disease
along	O
the	O
right	O
major	O
and	O
minor	O
fissure	O
,	O
concerning	O
for	O
intrapleural	B-disease
tumor	I-disease
implants	I-disease
.	O

IP	O
reviewed	O
the	O
films	O
and	O
recommended	O
continue	O
oncologic	O
care	O
according	O
to	O

outpatient	O
course	O
and	O
pleurodesis	O
if	O
the	O
pt	O
becomes	O
symptomatic	B-disease
02-07	O
fluid	B-disease
accumulation	I-disease
.	O

The	O
patient	O
will	O
follow	O
up	O
with	O
his	O
oncologist	O
.	O

#	O
Foot	B-disease
ulcer	I-disease
:	O
diabetic	B-disease
ulcer	I-disease
s/p	O
surgery	O
but	O
never	O
healed	O
.	O

Wound	O
care	O
was	O
consulted	O
and	O
made	O
recommendations	O
for	O
ulcer	O
care	O
.	O

His	O
dressings	O
were	O
changed	O
by	O
the	O
nursing	O
staff	O
accordingly	O
.	O

#	O
Anemia	B-disease
:	O
His	O
HCT	O
remained	O
stable	O
post-surgery	O
.	O

The	O
patient	O
was	O
continued	O
on	O
his	O
iron	O
supplements	O
.	O

Medications	O
on	O
Admission	O
:	O

-	O
Iron	O
Sulfate	O
300	O
mg	O
po	O
tid	O

-	O
Procrit	O
40,000	O
units	O
SC	O
q	O
Friday	O

-	O
Lovenox	O
40	O
mg	O
SC	O
q24	O
for	O
DVT	O
ppx	O

-	O
Albuterol	O
/	O
Atrovent	O
nebs	O
q4	O

-	O
Morphine	O
2-4	O
mg	O
IV	O
q3-4	O
prn	O

-	O
Mylanta	O
30	O
cc	O
po	O
q6	O
prn	O

-	O
Pepcid	O
20	O
mg	O
po	O
daily	O

-	O
insulin	O
sliding	O
scale	O

-	O
glipizide	O
5	O
mg	O
po	O
bid	O

-	O
metformin	O
500	O
mg	O
po	O
bid	O

-	O
metoprolol	O
50	O
mg	O
po	O
daily	O

-	O
Vancomycin	O
1.5	O
gm	O
q	O
12	O
hours	O

Discharge	O
Medications	O
:	O

1.	O
Albuterol	O
Sulfate	O
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
.	O

2.	O
Ipratropium	O
Bromide	O
0.02	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Aluminum-Magnesium	O
Hydroxide	O
225-200	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
MLs	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

4.	O
Glipizide	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

5.	O
Miconazole	O
Nitrate	O
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

6.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
fever	B-disease
or	O
pain	B-disease
.	O

7.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

8.	O
Cepacol	O
2	O
mg	O
Lozenge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Lozenge	O
Mucous	O
membrane	O
PRN	O
(	O
as	O
needed	O
).	O

9.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

10.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

11.	O
Oxycodone	O
5	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-disease
for	O
14	O
days	O
.	O

12.	O
Fluconazole	O
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
7	O
days	O
.	O

13.	O
Oxycodone	O
10	O
mg	O
Tablet	O
Sustained	O
Release	O
12	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
12HR	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

14.	O
Bisacodyl	O
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

15.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Vancomycin	O
in	O
Dextrose	O
1	O
g	O
/	O
200	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
Q	O
12H	O
(	O
Every	O
12	O
Hours	O
):	O
To	O
finish	O
on	O
2020-05-12	O
.	O

17.	O
Pepcid	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

18.	O
Heparin	O
Lock	O
Flush	O
(	O
Porcine	O
)	O
100	O
unit	O
/	O
mL	O
Syringe	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
ML	O
Intravenous	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
:	O
10	O
ml	O
NS	O
followed	O
by	O
2	O
ml	O
of	O
100	O
Units	O
/	O
ml	O
heparin	O
(	O
200	O
units	O
heparin	O
)	O
each	O
lumen	O
Daily	O
and	O
PRN	O
.	O

Inspect	O
site	O
every	O
shift	O
.	O

19.	O
Insulin	O
Glargine	O
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
units	O
Subcutaneous	O
at	O
dinner	O
time	O
.	O

20.	O
Insulin	O
Lispro	O
(	O
Human	O
)	O
100	O
unit	O
/	O
mL	O
Cartridge	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
As	O
directed	O
by	O
sliding	O
scale-please	O
see	O
attached	O
scale	O
.	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnosis	O
:	O
Epidural	B-disease
abscess	I-disease

Secondary	O
diagnosis	O
:	O

-	O
colon	B-disease
cancer	I-disease
with	O
mets	B-disease
to	I-disease
liver	I-disease
s/p	O
resection	O
09-07	O
.	O

-	O
CAD	B-disease
s/p	O
CABG	O
x4	O
in	O
'	O
03	O
.	O

-	O
hypercholesterolemia	B-disease

-	O
DM	B-disease
with	O
neuropathy	B-disease
.	O

-	O
persistent	B-disease
R	I-disease
foot	I-disease
ulcer	I-disease

Discharge	O
Condition	O
:	O

Stable	O
,	O
afebrile	B-disease

Discharge	O
Instructions	O
:	O

You	O
were	O
diagnosed	O
with	O
an	B-disease
epidural	I-disease
abscess	I-disease
.	O

Continue	O
to	O
take	O
the	O
antibiotics	O
as	O
directed	O
.	O

Take	O
the	O
pain	O
medication	O
as	O
directed	O
and	O
do	O
not	O
drive	O
while	O
taking	O
this	O
medication	O
.	O

Call	O
the	O
doctor	O
or	O
return	O
to	O
the	O
Thomas	O
for	O
:	O

-	O
fever	B-disease
>	O
102	O

-	O
chest	B-disease
pain	I-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease

-	O
worsening	B-disease
pain	I-disease
or	O
weakness	B-disease
in	I-disease
your	I-disease
legs	I-disease
,	O
loss	B-disease
of	I-disease
bowel	I-disease
or	I-disease
bladder	I-disease
function	I-disease
or	O
any	B-disease
other	I-disease
concerning	I-disease
symptoms	I-disease
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Scott	O
Ann	O
,	O
MD	O
Phone	O
:(	O
921	O
)	O
538	O
8079	O
on	O
2020-04-30	O
at	O
11:00am	O
.	O

Please	O
follow	O
up	O
with	O
Dr	O
Erb	O
-	O
3/30/07	O
at	O
10:00am	O
.	O

Please	O
follow	O
up	O
with	O
Dr.	O
Rowles	O
,	O
your	O
oncologist	O
,	O
in	O
2-3	O
weeks	O

Brooke	O
Donna	O
MD	O
37-421	O

Completed	O
by	O
:	O
Jessica	O
POPE	O
MD	O
58-704	O
2020-03-23	O
@	O
1515	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Maryjane	O
WS	O
Hammond	O
on	O
:	O
FRI	O
2020-05-01	O
12:36	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-10-28	O

Discharge	O
Date	O
:	O

2015-11-13	O

Date	O
of	O
Birth	O
:	O

1941-08-30	O

Sex	O
:	O

F	O

Service	O
:	O
CARDIOTHORACIC	O

Allergies	O
:	O

Tape	O
/	O
Benadryl	O

Attending	O
:Jordan	O
U	O
Kostohryz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Chest	B-disease
discomfort	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2015-10-30	O
Left	O
Carotid	O
Stenting	O

2015-11-02	O
Coronary	O
Artery	O
Bypass	O
Graft	O
x	O
2	O
(	O
Lima	O
to	O
LAD	O
,	O
SVG	O
to	O
OM	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

Ms.	O
Bridge	O
is	O
a	O
74	O
y/o	O
female	O
admitted	O
to	O
outside	O
hospital	O
on	O
2015-10-21	O
with	O
chest	B-disease
discomfort	I-disease
,	O
vomiting	B-disease
and	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

Initial	O
EKG	O
showed	O
ST	B-disease
depressions	I-disease
,	O
but	O
cardiac	O
enzymes	O
were	O
not	O
elevated	B-disease
.	O

She	O
eventually	O
underwent	O
a	O
cardiac	O
cath	O
to	O
assess	O
coronary	B-disease
disease	I-disease
which	O
revealed	O
three	B-disease
vessel	I-disease
coronary	I-disease
artery	I-disease
disease	I-disease
.	O

She	O
was	O
then	O
transferred	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
for	O
surgical	O
intervention	O
.	O

Past	O
Medical	O
History	O
:	O

Coronary	B-disease
Artery	I-disease
Disease	I-disease
,	O
Hypertension	B-disease
,	O
Hyperlipidemia	B-disease
,	O
Diabetes	B-disease
Mellitus	I-disease
,	O
Hypothyroid	B-disease
,	O
h/o	O
Bilateral	B-disease
DVT	I-disease
's	I-disease
(	O
on	O
chronic	O
coumadin	O
therapy	O
),	O
Pleural	B-disease
disorder	I-disease
?	O
Sarcoidosis	B-disease
,	O
Gastritis	B-disease
,	O
B12	B-disease
deficiency	I-disease
,	O
Chronic	B-disease
renal	I-disease
insufficiency	I-disease
,	O
s/p	O
Appendectomy	O
,	O
s/p	O
Lap	O
cholectomy	O
,	O
s/p	O
Total	O
abdominal	O
hysterectomy	O

Social	O
History	O
:	O

Denies	O
tobacco	O
or	O
ETOH	O
use	O
.	O

Lives	O
wth	O
husband	O
.	O

Family	O
History	O
:	O

Mother	O
died	O
of	O
MI	B-disease
at	O
age	O
55	O
.	O

Brother	O
w/	O
CAD	B-disease
since	O
age	O
40	O
and	O
died	O
in	O
70	O
's	O
after	O
cardiac	O
surgery	O
.	O

Son	O
died	O
at	O
14	O
d/t	O
ASD	B-disease
.	O

Physical	O
Exam	O
:	O

Gen	O
:	O
NAD	B-disease

Neck	O
:	O
Supple	O
,	O
-	O
JVD	B-disease
,	O
-	O
Bruits	B-disease

Heart	O
:	O
RRR	O
-	O
c/r/m/g	B-disease

Lungs	O
:	O
CTAB	O
,	O
coarse	B-disease

Abd	O
:	O
Soft	O
,	O
NT/NT	B-disease
+	O
BS	O

Ext	O
:	O
Cool	O
,	O
1	O
+	O
pedal	O
pulses	O
,	O
-	O
varicosities	B-disease
,	O
-	O
edema	B-disease

Neuro	O
:	O
A&O	O
x	O
3	O
,	O
MAE	O
,	O
non-focal	O

Some	B-disease
rashes	I-disease
on	I-disease
ACW	I-disease
around	O
EKG	O
leads	O

Pertinent	O
Results	O
:	O

CNIS	O
10-29	O
:	O

1.	O
60-69%	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
right	I-disease
internal	I-disease
carotid	I-disease
artery	I-disease
.	O

2.	O
80-99%	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
left	I-disease
internal	I-disease
carotid	I-disease
artery	I-disease
.	O

Echo	O
11-02	O
:	O
PRE-BYPASS	O
:	O
Left	O
ventricular	O
wall	O
thickness	O
,	O
cavity	O
size	O
,	O
and	O
systolic	O
function	O
are	O
normal	O
(	O
LVEF>55%	O
).	O

Resting	B-disease
regional	I-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
include	O
mild	B-disease
apical	I-disease
hypokinesis	I-disease
.	O

The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
appear	O
structurally	O
normal	O
with	O
good	O
leaflet	O
excursion	O
and	O
no	O
aortic	B-disease
regurgitation	I-disease
.	O

The	O
mitral	O
valve	O
appears	O
structurally	O
normal	O
with	O
trivial	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

There	O
are	O
complex	B-disease
(>	I-disease
4	I-disease
mm	I-disease
)	I-disease
atheroma	I-disease
in	I-disease
the	I-disease
descending	I-disease
thoracic	I-disease
aorta	I-disease
.	O

Mild	B-disease
tricuspid	I-disease
regurgitation	I-disease
.	O

POST-BYPASS	O
:	O
Preserved	O
Kindred	O
/	O
North	O
Shore	O
-	O
ventricular	O
systolic	O
fxn	O
.	O

Trivial	B-disease
MR	I-disease
.	O

Edith	O
AI	O
.	O

Aorta	O
intact	O
.	O

CT	O
11-04	O
:	O
No	O
acute	B-disease
intracranial	I-disease
hemorrhage	I-disease
.	O

Findings	O
consistent	O
with	O
small	B-disease
vessel	I-disease
ischemic	I-disease
changes	I-disease
.	O

MRI	O
would	O
be	O
more	O
sensitive	O
for	O
the	O
detection	O
of	O
acute	B-disease
infarction	I-disease
.	O

CT	O
angiogram	O
demonstrates	O
no	O
stenosis	B-disease
or	O
aneurysm	B-disease
in	I-disease
the	I-disease
intracranial	I-disease
circulation	I-disease
.	O

Slight	B-disease
irregularity	I-disease
of	O
the	O
origin	O
of	O
the	O
right	O
vertebral	O
artery	O
may	O
be	O
atherosclerotic	B-disease
in	O
nature	O
.	O

Normal	O
contrast	O
enhancement	O
seen	O
in	O
the	O
left	O
common/internal	O
carotid	O
artery	O
stent	O
.	O

Mild	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
proximal	I-disease
right	I-disease
internal	I-disease
carotid	I-disease
artery	I-disease
.	O

4	B-disease
mm	I-disease
left	I-disease
upper	I-disease
lobe	I-disease
lung	I-disease
nodule	I-disease
.	O

In	O
the	O
absence	O
of	O
history	O
of	O
malignancy	B-disease
,	O
this	O
is	O
statistically	O
benign	O
.	O

One-year	O
followup	O
may	O
be	O
considered	O
.	O

CXR	O
11-06	O
:	O
Allowing	O
for	O
technical	O
changes	O
,	O
no	O
major	B-disease
adverse	I-disease
interval	I-disease
change	I-disease
has	O
occurred	O
.	O

Bibasilar	B-disease
subsegmental	I-disease
atelectasis	I-disease
together	O
with	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
appear	O
relatively	O
unchanged	O
.	O

The	O
mediastinum	O
appears	O
unchanged	O
.	O

Left-sided	O
subclavian	O
line	O
is	O
unchanged	O
in	O
position	O
.	O

There	O
is	O
evidence	O
of	O
prior	O
cardiac	O
surgery	O
.	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
WBC	O
-	O
8.8	O
RBC	O
-	O
2.79	O
*	O
Hgb	O
-	O
8.6	O
*	O
Hct	O
-	O
25.4	O
*	O
MCV	O
-	O
91	O
MCH	O
-	O
30.9	O
MCHC	O
-	O
33.8	O
RDW	O
-	O
15.6	O
*	O
Plt	O
Ct	O
-	O
583	O
*	O

2015-11-12	O
06:00	O
AM	O
BLOOD	O
WBC	O
-	O
7.7	O
RBC	O
-	O
2.73	O
*	O
Hgb	O
-	O
8.3	O
*	O
Hct	O
-	O
25.1	O
*	O
MCV	O
-	O
92	O
MCH	O
-	O
30.4	O
MCHC	O
-	O
33.1	O
RDW	O
-	O
15.5	O
Plt	O
Ct	O
-	O
528	O
*	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
Plt	O
Ct	O
-	O
583	O
*	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
PT	O
-	O
18.0	O
*	O
PTT	O
-	O
62.3	O
*	O
INR(PT)	O
-	O
1.7	O
*	O

2015-11-12	O
06:00	O
AM	O
BLOOD	O
PT	O
-	O
15.5	O
*	O
PTT	O
-	O
62.4	O
*	O
INR(PT)	O
-	O
1.4	O
*	O

2015-11-11	O
05:45	O
AM	O
BLOOD	O
PT	O
-	O
14.5	O
*	O
PTT	O
-	O
51.4	O
*	O
INR(PT)	O
-	O
1.3	O
*	O

2015-11-13	O
06:15	O
AM	O
BLOOD	O
Glucose	O
-	O
96	O
UreaN	O
-	O
20	O
Creat	O
-	O
1.6	O
*	O
Na	O
-	O
141	O
K	O
-	O
4.3	O
Cl	O
-	O
106	O
HCO3	O
-	O
24	O
AnGap	O
-	O
15	O

2015-11-12	O
06:00	O
AM	O
BLOOD	O
Glucose	O
-	O
85	O
UreaN	O
-	O
19	O
Creat	O
-	O
1.6	O
*	O
Na	O
-	O
140	O
K	O
-	O
4.4	O
Cl	O
-	O
105	O
HCO3	O
-	O
24	O
AnGap	O
-	O
15	O

2015-11-11	O
05:45	O
AM	O
BLOOD	O
Creat	O
-	O
1.6	O
*	O
K	O
-	O
4.7	O

2015-10-28	O
03:30	O
PM	O
BLOOD	O
Glucose	O
-	O
98	O
UreaN	O
-	O
26	O
*	O
Creat	O
-	O
1.6	O
*	O
Na	O
-	O
140	O
K	O
-	O
4.6	O
Cl	O
-	O
104	O
HCO3	O
-	O
27	O
AnGap	O
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

Ms.	O
Bridge	O
was	O
admitted	O
from	O
OSH	O
for	O
coronary	O
artery	O
bypass	O
surgery	O
.	O

She	O
underwent	O
usual	O
pre-operative	O
testing	O
along	O
with	O
carotid	O
ultrasound	O
.	O

CNIS	O
revealed	O
carotid	B-disease
stenosis	I-disease
and	O
she	O
ultimately	O
underwent	O
left	O
carotid	O
stenting	O
by	O
vascular	O
surgery	O
on	O
10-30	O
.	O

Please	O
see	O
report	O
for	O
details	O
.	O

On	O
11-02	O
she	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	O
coronary	O
artery	O
bypass	O
graft	O
x	O
2	O
.	O

Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O

She	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	O
monitoring	O
in	O
stable	O
condition	O
.	O

Later	O
on	O
op	O
day	O
sedation	O
was	O
weaned	O
,	O
she	O
awoke	O
neurologically	O
intact	O
and	O
was	O
extubated	O
.	O

On	O
post-op	O
day	O
one	O
chest	O
tubes	O
were	O
removed	O
and	O
beta	O
blockers	O
and	O
diuretics	O
were	O
initiated	O
.	O

She	O
was	O
gently	O
diuresed	O
towards	O
her	O
pre-op	O
weight	O
.	O

Also	O
on	O
this	O
day	O
she	O
was	O
transferred	O
to	O
the	O
SDU	O
.	O

Early	O
on	O
post-op	O
day	O
two	O
Ms.	O
Bridge	O
had	O
an	O
episode	O
of	O
aphasia	B-disease
.	O

She	O
underwent	O
an	O
immediate	O
head	O
CT	O
and	O
Neuro	O
consult	O
and	O
was	O
transferred	O
back	O
to	O
the	O
CSRU	O
.	O

CT	O
was	O
negative	O
and	O
she	O
returned	O
to	O
baseline	O
neuro	O
status	O
without	O
deficits	B-disease
by	O
arrival	O
to	O
CSRU	O
.	O

Neurology	O
concluded	O
episode	B-disease
was	O
most	O
concerning	O
for	O
TIA	B-disease
.	O

Epicardial	O
pacing	O
wires	O
were	O
removed	O
on	O
post-op	O
day	O
four	O
.	O

After	O
remaining	O
stable	O
in	O
the	O
CSRU	O
for	O
several	O
days	O
without	O
change	B-disease
in	I-disease
neuro	I-disease
status	I-disease
she	O
was	O
transferred	O
back	O
to	O
the	O
SDU	O
on	O
post-op	O
day	O
four	O
.	O

She	O
was	O
then	O
started	O
on	O
Heparin	O
with	O
transition	O
to	O
Coumadin	O
(	O
goal	O
INR	O
of	O
2-3	O
secondary	O
to	O
h/o	O
bilateral	B-disease
DVT	I-disease
's).	O

During	O
entire	O
post-op	O
course	O
she	O
was	O
followed	O
by	O
physical	O
therapy	O
for	O
strength	O
and	O
mobility	O
.	O

She	O
continued	O
to	O
improve	O
steadily	O
over	O
the	O
next	O
several	O
days	O
without	O
any	O
other	O
post-op	O

complications	B-disease
.	O

She	O
was	O
discharged	O
on	O
post-op	O
day	O
11	O
.	O

Medications	O
on	O
Admission	O
:	O

Meds	O
at	O
home	O
:	O
Coumadin	O
,	O
Levoxyl	O
,	O
Folate	O
,	O
Colace	O
,	O
Byetta	O
,	O
Verapamil	O
,	O
Lisinopril	O
,	O
Pravachol	O
,	O
Nexium	O
,	O
Lasix	O
,	O
Celexa	O

Meds	O
at	O
transfer	O
:	O
Levoxyl	O
,	O
Celexa	O
,	O
Folate	O
,	O
Lopressor	O
,	O
Colace	O
,	O
RISS	O
,	O
B12	O
,	O
Protonix	O
,	O
Lasix	O
,	O
Zocor	O
,	O
Verapamil	O
,	O
Lovenox	O
,	O
Lisinopril	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Levothyroxine	O
125	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Citalopram	O
20	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Clopidogrel	O
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Ferrous	O
Gluconate	O
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ascorbic	O
Acid	O
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

11.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

12.	O
Coumadin	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
Check	O
INR	O
11-15	O
with	O
results	O
called	O
to	O
Dr.	O
Lynn	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

13.	O
Tramadol	O
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

14.	O
Lasix	O
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
:	O
40	O
mg	O
daily	O
x	O
1	O
week	O
then	O
40	O
mg	O
every	O
other	O
day	O
as	O
prior	O
to	O
surgery	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-disease
Artery	I-disease
Disease	I-disease
s/p	O
Coronary	O
Artery	O
Bypass	O
Graft	O
x	O
2	O

Post-operative	B-disease
Transient	I-disease
Ischemic	I-disease
Attack	I-disease

Carotid	B-disease
Stenosis	I-disease
s/p	O
Left	O
Carotid	O
Stenting	O

PMH	O
:	O
Hypertension	B-disease
,	O
Hyperlipidemia	B-disease
,	O
Diabetes	B-disease
Mellitus	I-disease
,	O
Hypothyroid	B-disease
,	O
h/o	O
Bilateral	B-disease
DVT	I-disease
's,	I-disease
Pleural	B-disease
disorder	I-disease
?	O
Sarcoidosis	B-disease
,	O
Gastritis	B-disease
,	O
B12	B-disease
deficiency	I-disease
,	O
Chronic	B-disease
renal	I-disease
insufficiency	I-disease
,	O
s/p	O
Appendectomy	O
,	O
s/p	O
Lap	O
cholectomy	O
,	O
s/p	O
Total	O
abdominal	O
hysterectomy	O

Discharge	O
Condition	O
:	O

good	O

Discharge	O
Instructions	O
:	O

Patient	O
may	O
shower	O
,	O
no	O
baths	O
.	O

No	O
creams	O
,	O
lotions	O
or	O
ointments	O
to	O
incisions	B-disease
.	O

No	O
driving	O
for	O
at	O
least	O
one	O
month	O
.	O

No	O
lifting	O
more	O
than	O
10	O
lbs	O
for	O
at	O
least	O
10	O
weeks	O
from	O
the	O
date	O
of	O
surgery	O
.	O

Monitor	O
wounds	B-disease
for	O
signs	B-disease
of	I-disease
infection	I-disease
.	O
Please	O
call	O
with	O
any	O
concerns	O
or	O
questions	O
.	O

VVp	O
Instructions	O
:	O

Dr.	O
von	O
Sampson	O
in	O
4	O
weeks	O

Dr	O
Royer	O
in	O
2-3	O
weeks	O

Dr.	O
Lynn	O
in	O
1-2	O
weeks	O

Peterson	O
ver	O
Vasquez	O
MD	O
07-506	O

Completed	O
by	O
:	O
Theresa	O
Leonore	O
NP	O
80-BXH	O
2015-11-13	O
@	O
1100	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ruby	O
von	O
der	O
Smith	O
on:	O
WED	O
2015-12-09	O
3:34	O
PM	O

(	O
End	O
of	O
Report	O
)	O

843566350	O
RWH	O

0025596	O

526208	O

0555812	O

1/12/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KOTEA	O
,	O
TORTHEOA	O

MRN	O
:	O

0025596	O

Age	O
:	O

47y	O

REGISTRATION	O
DATE	O
:	O

01/12/2005	O
06:07	O
AM	O

Provider	O
:	O

THAA	O
WAGES	O

PRELMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Note	O

Date	O
/	O
Time	O
:	O

01/12/2005	O
09:17	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

MIGRAINES	B-disease
FOR	O
10	O
DAYS	O

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
headache	B-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Headache	B-disease

Treatment	O
Rendered	O
:	O

MD	O
evaluation	O
,	O
head	O
CT	O

Discharge	O
Medications	O
:	O

None	O

Follow	O
up	O
Service	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Ner	O

PCP	O
Name	O
:	O

ANERM	O
,	O
CHRETTA	O

Provider	O
Number	O
:	O

25911	O

This	O
report	O
was	O
created	O
by	O
WAGES	O
,	O
THAA	O
01/12/2005	O
09:18	O
AM	O

Admission	O
Date	O
:	O

2018-05-26	O

Discharge	O
Date	O
:	O

2018-05-31	O

Date	O
of	O
Birth	O
:	O

1935-11-10	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Codeine	O
/	O
Iodine	O

Attending	O
:	O
Derrick	O
L.	O
Mayo	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

large	B-disease
pericardial	I-disease
effusion	I-disease
,	O
transfer	O
from	O
OSH	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Thoracentesis	O
2018-05-27	O

History	O
of	O
Present	O
Illness	O
:	O

82	O
F	O
with	O
h/o	O
COPD	B-disease
,	O
CAD	B-disease
,	O
pafib	B-disease
and	O
SSS	B-disease
s/p	O
pacer	O
on	O
05-08	O
for	O
symptomatic	B-disease
pauses	I-disease
is	O
transferred	O
for	O
large	B-disease
pericardial	I-disease
effusion	I-disease
?	O
needing	O
drainage	O
and	O
CHF	B-disease
.	O

She	O
was	O
admitted	O
to	O
Cambridge	O
Hospital	O
2018-05-24	O
with	O
ARF	B-disease
(	O
Cr	O
3.5	O
up	O
from	O
0.9	O
)	O
and	O
SOB	B-disease
.	O

According	O
to	O
her	O
guardian	O
she	O
was	O
discharged	O
to	O
her	O
NH	O
for	O
a	O
few	O
days	O
after	O
her	O
pacer	O
was	O
placed	O
05-08	O
,	O
which	O
was	O
complicated	O
by	O
a	B-disease
PTX	I-disease
requiring	O
CT	O
placement	O
which	O
had	O
been	O
d/c	O
'd	O
in	O
the	O
hospital	O
after	O
resolution	O
of	O
her	B-disease
PTX	I-disease
.	O

She	O
had	O
some	O
nausea	B-disease
/	O
vomiting	B-disease
and	O
generally	O
was	O
taking	O
poor	O
pos	O
at	O
her	O
NH	O
.	O

There	O
had	O
been	O
some	O
concern	O
her	B-disease
nausea	I-disease
was	O
due	O
to	O
her	O
amiodarone	O
which	O
had	O
been	O
discontinued	O
about	O
1	O
week	O
ago	O
.	O

She	O
was	O
then	O
sent	O
to	O
Franklin	O
Medical	O
Center	O
05-24	O
with	O
lethargy	B-disease
and	O
n/v	B-disease
.	O

At	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
she	O
was	O
discovered	O
to	O
have	O
ARF	B-disease
,	O
a	B-disease
large	I-disease
pericardial	I-disease
effusion	I-disease
,	O
and	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
.	O

She	O
was	O
treated	O
with	O
IVF	O
for	O
her	B-disease
ARF	I-disease
.	O

She	O
underwent	O
a	O
TTE	O
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
today	O
(	O
05-26	O
)	O
showing	O
mod-lg	B-disease
circumferential	I-disease
pericardial	I-disease
effusion	I-disease
without	O
evidence	O
of	O
RV	B-disease
diastolic	I-disease
collapse	I-disease
and	O
no	O
MV	O
inflow	O
evidence	O
of	O
tamponade	B-disease
,	O
pacer	O
wire	O
located	O
in	O
RV	O
apex	O
.	O

There	O
was	O
still	O
concern	O
for	O
her	B-disease
effusion	I-disease
contributing	O
to	O
her	B-disease
SOB	I-disease
at	O
the	O
OSH	O
so	O
she	O
was	O
transferred	O
for	O
drainage	O
and	O
treatment	O
of	O
CHF	B-disease
.	O

Today	O
she	O
only	O
complains	O
of	O
some	B-disease
SOB	I-disease
,	O
which	O
she	O
says	O
remains	O
largely	O
unchanged	O
over	O
the	O
past	O
few	O
days	O
.	O

She	O
denies	O
any	B-disease
CP	I-disease
/	O
cough	B-disease
/	O
fever	B-disease
/	O
abd	B-disease
pain	I-disease
/	O
diarrhea	B-disease
/	O
black	B-disease
or	I-disease
bloody	I-disease
stools	I-disease
/	O
headache	B-disease
.	O

Past	O
Medical	O
History	O
:	O

htn	B-disease

afib	B-disease
,	O
SSS	B-disease

COPD	B-disease

CAD	B-disease

pacer	O
DDDR	O
(	O
Vitatron	O
CL860	O
)	O
placed	O
05-08	O
for	O
SSS	B-disease
with	O
symptomatic	B-disease
bradycardia	I-disease
,	O
c/b	O
R	B-disease
PTX	I-disease
requiring	O
chest	O
tube	O

GERD	B-disease

CVA	B-disease

hypothyroidism	B-disease

legally	B-disease
blind	I-disease

Social	O
History	O
:	O

NH	O
resident	O
,	O
guardian	O
Robert	O
Murrell	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

Exam	O
:	O
T	O
96.2	O
HR	O
70	O
BP	O
118/46	O
R	O
24	O
sat	O
90%	O
on	O
60%FM	O

pulsus	B-disease
parodoxus	I-disease
=	O
6-8	O
mm	O

gen	O
:	O
mild	B-disease
resp	I-disease
distress	I-disease
speaking	O
in	O
full	O
sentences	O
but	O
using	O
accessory	O
muscles	O

HEENT	O
:	O
mmm	O
,	O
JVP	O
at	O
14	O
cm	O
,	O
no	O
bruits	B-disease
,	O
supple	O

CV	O
:	O
RRR	O
,	O
02-19	O
sys	O
m	O
at	O
RUSB	O

pulm	O
:	O
no	O
BS	O
01-15	O
way	O
up	O
bilat	O
,	O
no	O
consolidation	B-disease

abd	O
:	O
s/nt/slightly	O
distended	B-disease
,	O
dec	B-disease
BS	I-disease
,	O
no	O
CVA	B-disease
tenderness	I-disease

ext	O
:	O
1+	B-disease
LE	I-disease
edema	I-disease

Pertinent	O
Results	O
:	O

ECG	O
:	O
a	O
paced	O
at	O
70	O
bpm	O
/	O
nml	O
axis	O
,	O
LBBB	B-disease
,	O
no	O
ST	B-disease
or	I-disease
TW	I-disease
changes	I-disease

CXR	O
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-26	O
:	O
bilateral	B-disease
pleural	I-disease
eff	I-disease
and	O
pericardial	B-disease
eff	I-disease

CT	O
chest	O
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-25	O
:	O
large	B-disease
pericardial	I-disease
effusion	I-disease
,	O
bilat	B-disease
pleural	I-disease
eff	I-disease
with	O
underlying	B-disease
consolidation	I-disease
which	O
could	O
represent	O
PNA	B-disease
vs.	O
atelectasis	B-disease

TTE	O
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-26	O
:	O
mod-lg	B-disease
circumferential	I-disease
pericardial	I-disease
eff	I-disease
,	O
no	O
evidence	O
of	O
RV	B-disease
diastolic	I-disease
collapse	I-disease
,	O
no	O
MV	O
inflow	O
evidence	O
of	O
tamponade	B-disease
,	O
pacer	O
lead	O
located	O
in	O
RV	O
apex	O

head	O
CT	O
at	O
Erich	O
Lindemann	O
Mental	O
Health	O
Center	O
05-24	O
:	O
atrophy	B-disease
,	O
dense	B-disease
calcification	I-disease
of	I-disease
the	I-disease
tentorium	I-disease
,	O
most	O
likely	O
of	O
metabolic	O
etiology	O

IMAGING	O
AT	O
Providence	O
Behavioral	O
Health	O
Hospital	O
:	O

ECHO	O
2018-05-28	O

IMPRESSION	O
:	O
Moderate	B-disease
to	I-disease
large	I-disease
pericardial	I-disease
effusion	I-disease
(	O
minimal	B-disease
fluid	I-disease
anteriorly	I-disease
(	O
1cm	O
),	O
?	O
bloody	B-disease
).	O

No	O
definite	B-disease
tamponade	I-disease
physiology	I-disease
.	O

Pacer	O
seen	O
in	O
RV	O
apex	O
,	O
but	O
cannot	O
exclude	O
perforation	B-disease
.	O

CXR	O
2018-05-30	O

FINDINGS	O
:	O
The	O
lung	O
volumes	O
are	O
Moderate	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
are	O
unchanged	O
.	O

Mild	B-disease
pulmonary	I-disease
edema	I-disease
is	O
unchanged	O
.	O

Lung	O
volumes	O
are	O
low	B-disease
.	O

Bibasilar	B-disease
atelectasis	I-disease
is	O
unchanged	O
.	O

IMPRESSION	O
:	O
Unchanged	B-disease
moderate	I-disease
bilateral	I-disease
pleural	I-disease
effusions	I-disease
and	O
mild	B-disease
CHF	I-disease
.	O

RENAL	O
US	O
2018-05-28	O

FINDINGS	O
:	O
The	O
right	O
kidney	O
measures	O
11	O
cm	O
in	O
length	O
,	O
the	O
left	O
kidney	O
measures	O
9.7	O
cm	O
in	O
length	O
.	O

No	O
hydronephrosis	B-disease
is	O
seen	O
.	O

No	O
urinary	B-disease
calculi	I-disease
are	O
seen	O
.	O

The	O
bladder	O
appears	O
unremarkable	O
and	O
contains	O
a	O
Foley	O
catheter	O
.	O

IMPRESSION	O
:	O
No	O
evidence	O
of	O
hydronephrosis	B-disease
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

82	O
y/o	O
f	O
w	O
h/o	O
afib	B-disease
,	O
SSS	B-disease
s/p	O
pacer	O
05-08	O
c/b	O
PTX	B-disease
requiring	O
CT	O
,	O
CAD	B-disease
,	O
who	O
was	O
readmitted	O
05-24	O
with	O
ARF	B-disease
and	O
lethargy	B-disease
,	O
found	O
to	O
have	O
a	B-disease
large	I-disease
pericardial	I-disease
effusion	I-disease
and	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
,	O
with	O
echo	O
showing	O
no	O
evidence	O
of	O
tamponade	B-disease
,	O
who	O
is	O
transferred	O
for	O
possible	O
pericardial	O
effusion	O
drainage	O
and	O
treatment	O
of	O
CHF	B-disease
,	O
as	O
well	O
as	O
drainage	O
of	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
.	O

She	O
had	O
a	O
BNP	O
of	O
>	O
5000	O
on	O
admission	O
.	O

Since	O
admission	O
,	O
she	O
ruled	O
out	O
for	O
MI	B-disease
by	O
enzymes	O
,	O
and	O
had	O
a	O
right	O
sided	O
thoracentesis	O
which	O
yielded	O
transudative	B-disease
fluid	I-disease
.	O

WBC	O
s	O
since	O
admission	O
were	O
as	O
high	O
as	O
14,000	O
but	O
normalized	O
.	O

She	O
also	O
had	O
2	O
echocardiograms	O
which	O
revealed	O
persistent	B-disease
pericardial	I-disease
effusions	I-disease
.	O

She	O
has	O
been	O
gently	O
diuresed	O
but	O
has	O
worsening	B-disease
ARF	I-disease
.	O

Her	B-disease
O2	I-disease
requirement	I-disease
has	O
increased	O
despite	O
diuresis	O
.	O

She	O
denies	O
any	O
CP	B-disease
/	O
cough	B-disease
/	O
fever	B-disease
,	O
abdominal	B-disease
pain	I-disease
/	O
diarrhea	B-disease
,	O
black	B-disease
or	I-disease
bloody	I-disease
stools	I-disease
or	O
headache	B-disease
.	O

Her	O
urine	O
output	O
decreased	B-disease
to	O
nearly	O
zero	O
.	O

In	O
the	O
setting	O
of	O
her	B-disease
ongoing	I-disease
pericardial	I-disease
effusion	I-disease
,	O
she	O
was	O
transferred	O
for	O
closer	O
observation	O
to	O
the	O
CCU	O
.	O

The	O
CCU	O
fellow	O
and	O
team	O
declined	O
to	O
do	O
pericardial	O
drainage	O
,	O
as	O
the	O
pt	O
was	O
hemodynamically	O
stable	O
,	O
without	O
change	B-disease
in	I-disease
appearance	I-disease
of	I-disease
effusion	I-disease
by	O
echo	O
performed	O
at	O
bedside	O
by	O
cards	O
fellow	O
.	O

As	O
she	O
was	O
felt	O
by	O
the	O
CCU	O
to	O
be	O
a	O
poor	O
candidate	O
for	O
right	O
heart	O
cath	O
,	O
was	O
hemodynamically	O
stable	O
with	O
blood	O
pressure	O
110	O
s-	O
120	O
s	O
systolic	O
and	O
pulse	O
70	O
s-	O
80	O
s	O
,	O
she	O
was	O
called	O
out	O
of	O
the	O
CCU	O
and	O
back	O
to	O
the	O
cardiac	O
floor	O
without	O
intervention	O
.	O

The	O
procedure	O
team	O
was	O
called	O
to	O
consider	O
doing	O
a	O
left	O
thoracentesis	O
,	O
but	O
she	O
was	O
declined	O
because	O
it	O
was	O
felt	O
that	O
her	B-disease
effusions	I-disease
were	O
transudative	B-disease
,	O
secondary	O
to	O
CHF	B-disease
,	O
and	O
it	O
was	O
recommended	O
to	O
treat	O
CHF	B-disease
.	O

The	O
pt	O
continued	O
to	O
have	O
low	B-disease
urine	I-disease
output	I-disease
.	O

She	O
was	O
given	O
a	O
lasix	O
drip	O
IV	O
upon	O
call-out	O
of	O
the	O
ICU	O
,	O
and	O
additional	O
boluses	O
of	O
IV	O
lasix	O
,	O
200	O
mg	O
then	O
300	O
mg	O
IV	O
were	O
given	O
with	O
a	O
good	O
response	O
,	O
however	O
,	O
she	O
remained	O
net	B-disease
positive	I-disease
fluid	I-disease
balance	I-disease
.	O

Renal	O
consultants	O
did	O
not	O
feel	O
there	O
was	O
an	O
emergent	O
need	O
for	O
dialysis	O
.	O

A	O
nitro	O
drip	O
was	O
started	O
in	O
an	O
effort	O
to	O
decrease	O
her	O
preload	O
and	O
afterload	O
.	O

On	O
call	O
out	O
from	O
the	O
CCU	O
,	O
the	O
pt	O
was	O
satting	O
93%	O
on	O
4-5L	O
NC	O
,	O
and	O
through	O
the	O
following	O
night	O
,	O
her	B-disease
oxygen	I-disease
requirement	I-disease
increased	O
to	O
NRB	O
,	O
wherein	O
she	O
was	O
satting	O
upper	O
80	O
s-	O
low	O
90	O
s.	O

ABG	O
that	O
evening	O
was	O
7.29/51/56	O
on	O
4L	O
NC	O
and	O
early	O
the	O
next	O
morning	O
,	O
was	O
7.25/62/64	O
on	O
NRB	O
.	O

A	O
CXR	O
was	O
performed	O
the	O
evening	O
of	O
5/16	O
,	O
showing	O
moderate	B-disease
sized	I-disease
bilateral	I-disease
pleural	I-disease
effusions	I-disease
,	O
stable	B-disease
cardiomegaly	I-disease
and	O
a	O
possible	O
RLL	B-disease
infiltrate	I-disease
.	O

Vancomycin	O
and	O
Zosyn	O
were	O
started	O
.	O

She	O
was	O
afebrile	B-disease
.	O

The	O
morning	O
of	O
5/17	O
,	O
her	O
pulsus	O
parodoxicus	O
was	O
12	O
.	O

Because	O
of	O
her	O
ABG	O
,	O
and	O
declining	O
clinical	O
status	O
,	O
the	O
CCU	O
was	O
notified	O
for	O
possible	O
transfer	O
.	O

The	O
CMED	O
CSRU	O
Intern	O
called	O
the	O
Murphy	O
,	O
Robert	O
Leigh	O
,	O
to	O
give	O
her	O
the	O
update	O
with	O
regards	O
to	O
the	O
pt	O
's	O
deteriorating	O
clinical	O
status	O
.	O

It	O
was	O
felt	O
that	O
given	O
her	O
age	O
,	O
multiple	B-disease
co-morbidities	I-disease
,	O
that	O
her	O
prognosis	O
was	O
poor	O
even	O
prior	O
to	O
CCU	O
admission	O
,	O
possible	O
pericardial	O
drainage	O
or	O
repeat	O
thoracenteses	O
.	O

Goals	O
of	O
care	O
were	O
clarified	O
with	O
her	O
Murphy	O
,	O
Robert	O
Sanchez	O
.	O

Explained	O
to	O
Lewin	O
that	O
pt	O
will	O
likely	O
need	O
to	O
be	O
intubated	O
,	O
as	O
she	O
cannot	O
lie	O
flat	O
,	O
and	O
most	O
likely	O
cannot	O
undergo	O
pericardial	O
drainage	O
,	O
thoracentesis	O
,	O
or	O
right	O
heart	O
cath	O
with	O
BiPAP	O
(	O
which	O
would	O
have	O
been	O
the	O
next	O
measure	O
after	O
NRB	O
,	O
and	O
prior	O
to	O
intubation	O
).	O

Explained	O
that	O
despite	O
these	O
invasive	O
measures	O
,	O
she	O
still	O
has	O
a	O
very	O
poor	O
prognosis	O
.	O

Odell	O
stated	O
she	O
had	O
been	O
thinking	O
about	O
this	O
all	O
night	O
of	O
2018-05-30	O
,	O
and	O
agreed	O
that	O
this	O
is	O
not	O
what	O
the	O
pt	O
would	O
have	O
wanted	O
.	O

Odell	O
does	O
not	O
believe	O
the	O
pt	O
would	O
want	O
to	O
be	O
intubated	O
,	O
with	O
central	O
line	O
,	O
right	O
heart	O
cath	O
,	O
in	O
the	O
CCU	O
.	O

She	O
requested	O
the	O
patient	O
be	O
made	O
Comfort	O
Measures	O
Only	O
.	O

She	O
was	O
DNR/DNI	O
on	O
admission	O
.	O

This	O
was	O
documented	O
in	O
the	O
computer	O
,	O
confirmed	O
with	O
Cardiology	O
attending	O
and	O
fellow	O
,	O
and	O
conveyed	O
to	O
the	O
CCU	O
staff	O
,	O
who	O
were	O
informed	O
she	O
may	O
need	O
to	O
go	O
for	O
transfer	O
(	O
which	O
was	O
subsequently	O
cancelled	O
).	O

The	O
pt	O
will	O
be	O
made	O
comfortable	O
,	O
with	O
goals	O
of	O
care	O
shifted	O
towards	O
suppressing	O
her	B-disease
air	I-disease
hunger	I-disease
and	O
pain	B-disease
.	O

#.	O
SOB	B-disease
:	O
Most	O
consistent	O
with	O
CHF	B-disease
by	O
exam	O
,	O
although	O
unknown	O
what	O
the	O
severity	O
of	O
her	B-disease
COPD	I-disease
is	O
currently	O
.	O

TTE	O
revealed	O
large	B-disease
pericardial	I-disease
effusion	I-disease
.	O

Pt	O
is	O
now	O
s/p	O
drainage	O
of	O
right	B-disease
pleural	I-disease
effusion	I-disease
,	O
diagnostic	O
and	O
therapeutic	O
,	O
with	O
studies	O
consistent	O
with	O
transudate	B-disease
,	O
etiology	O
most	O
likely	O
02-15	O
CHF	B-disease
.	O

We	O
continued	O
her	O
albuterol	O
/	O
atrovent	O
nebs	O
,	O
diuresis	O
with	O
IV	O
lasix	O
drip	O
and	O
boluses	O
.	O

Her	O
05-27	O
CXR	O
post	O
procedure	O
w/o	O
PNX	B-disease
,	O
effusion	B-disease
much	O
improved	O
,	O
yet	O
her	O
05-28	O
CXR	O
worse	O
than	O
05-27	O
with	O
some	O
reaccumulation	O
of	O
right	B-disease
pleural	I-disease
effusion	I-disease
.	O

Then	O
,	O
on	O
05-29	O
,	O
she	O
demonstrated	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
(	O
reaccumulated	O
),	O
right	B-disease
lower	I-disease
lobe	I-disease
infiltrate	I-disease
(	O
started	O
on	O
vanco	O
/	O
zosyn	O
)->	O
put	O
on	O
face	O
mask	O
,	O
given	O
lasix	O
x	O
1	O
bolus	O
100	O
mg	O
,	O
responded	O
somewhat	O
and	O
o2	O
sat	O
stable	O
in	O
low	O
90	O
s.	O

She	O
was	O
given	O
200	O
mg	O
IV	O
lasix	O
X	O
1	O
with	O
an	O
additional	O
100	O
cc	O
of	O
urine	O
output	O
the	O
evening	O
of	O
5/16	O
.	O

Her	O
lasix	O
gtt	O
continued	O
during	O
this	O
time	O
.	O

Her	O
oxygen	O
sats	O
did	O
not	O
improve	O
.	O

She	O
was	O
then	O
made	O
CMO	O
.	O

See	O
above	O
.	O

#.	O
Pericardial	B-disease
effusion	I-disease
:	O
unclear	O
etiology	O
,	O
OSH	O
had	O
raised	O
question	O
of	O
RV	B-disease
perforation	I-disease
from	O
pacer	O
,	O
however	O
she	O
had	O
a	O
normal	O
echo	O
appearance	O
of	O
lead	O
,	O
no	O
tamponade	B-disease
by	O
exam	O
.	O

This	O
has	O
still	O
be	O
known	O
to	O
occur	O
during	O
the	O
placement	O
of	O
pacemaker	O
.	O

It	O
was	O
felt	O
posthumously	O
that	O
her	B-disease
large	I-disease
pericardial	I-disease
effusion	I-disease
was	O
most	O
likely	O
secondary	O
to	O
a	B-disease
complication	I-disease
of	O
pacer	O
placement	O
,	O
although	O
this	O
was	O
not	O
seen	O
on	O
imaging	O
.	O

In	O
the	O
last	O
12	O
hours	O
of	O
her	O
life	O
,	O
her	O
pulsus	O
was	O
12	O
,	O
and	O
she	O
was	O
felt	O
to	O
likely	O
to	O
have	O
aspect	O
of	O
tamponade	B-disease
physiology	I-disease
,	O
since	O
her	O
preload	O
was	O
reduced	O
.	O

#.	O
CHF	B-disease
:	O
normal	O
EF	O
on	O
TTE	O
so	O
possibly	O
with	O
diastolic	B-disease
dysfunction	I-disease
,	O
ruled	O
out	O
for	O
MI	B-disease

-	O
See	O
course	O
of	O
diuresis	O
above	O
.	O

-	O
We	O
continued	O
ASA	O
/	O
imdur	O
/	O
CCB	O
/	O
hold	O
diovan	O
until	O
pt	O
was	O
made	O
CMO	O
.	O

#.	O
Pleural	B-disease
effusions	I-disease
:	O
Likely	O
due	O
to	O
CHF	B-disease
although	O
had	O
some	B-disease
leukocytosis	I-disease
at	O
admission	O
to	O
OSH	O
.	O

Mary	O
studies	O
c/w	O
transudate	B-disease
.	O

-	O
After	O
she	O
was	O
made	O
CMO	O
,	O
the	O
pt	O
was	O
started	O
on	O
Morphine	O
gtt	O
to	O
maximize	O
comfort	O
and	O
minimize	O
air	B-disease
hunger	I-disease
.	O

#.	O
Afib/SSS	B-disease
:	O
She	O
was	O
A-paced	O
,	O
pacer	O
placed	O
05-08	O
in	O
DDDR	O
mode	O
,	O
complicated	O
by	O
PTX	B-disease
requiring	O
chest	O
tube	O
which	O
resolved	O
and	O
tube	O
was	O
removed	O
during	O
admit	O
for	O
pacer	O
,	O
no	O
evidence	O
of	O
PTX	B-disease
on	O
most	O
recent	O
CXR	O
.	O

Her	O
pacer	O
wires	O
in	O
correct	O
position	O
.	O

We	O
continued	O
amiodarone	O
until	O
pt	O
was	O
made	O
CMO	O
.	O

Anticoagulation	O
has	O
not	O
been	O
given	O
this	O
admission	O
.	O

She	O
was	O
a	O
poor	O
anticoagulation	O
candidate	O
.	O

We	O
started	O
her	O
on	O
dilt	O
for	O
additional	O
a	O
fib	O
control	O
(	O
revert	O
back	O
to	O
a	B-disease
fib	I-disease
on	O
05-29	O
),	O
which	O
was	O
stopped	O
when	O
the	O
pt	O
was	O
made	O
CMO	O
.	O

#.	O
Oliguric	B-disease
ARF	I-disease
:	O
likely	O
prerenal	O
due	O
to	O
n/v	B-disease
poor	B-disease
po	I-disease
intake	I-disease
and	O
poor	B-disease
forward	I-disease
flow	I-disease
,	O
However	O
,	O
need	O
to	O
continue	O
diuresis	O
.	O

Her	O
urine	O
lytes	O
consistent	O
with	O
ATN	B-disease
,	O
FENA	O
4%	O
.	O

Renal	O
u/s	O
negative	O
for	O
hydronephrosis	B-disease
.	O

Renal	O
consultants	O
did	O
not	O
feel	O
that	O
there	O
was	O
an	O
indication	O
for	O
urgent	O
hemodialysis	O
.	O

She	O
continued	O
to	O
put	O
out	O
low	B-disease
amounts	I-disease
of	I-disease
urine	I-disease
throughout	O
the	O
admission	O
,	O
despite	O
aggressive	O
diuresis	O
with	O
IV	O
lasix	O
gtt	O
and	O
boluses	O
.	O

See	O
above	O
.	O

#.	O
ID	O
:	O
initially	O
had	O
leukocytosis	B-disease
at	O
admission	O
,	O
with	O
chest	O
CT	O
showing	O
possible	O
underlying	B-disease
consolidations	I-disease
vs.	O
atelectasis	B-disease
,	O
levoflox	O
started	O
05-24	O
and	O
subsequently	O
stopped	O
(	O
no	O
consolidations	B-disease
on	O
CXR	O
and	O
afebrile	B-disease
).	O

U/A	O
on	O
05-27	O
c/w	O
UTI	B-disease
.	O

Pt	O
now	O
on	O
IV	O
Ceftriaxone	O
(	O
was	O
on	O
levoflox	O
since	O
05-24	O
however	O
UA	O
now	O
floridly	B-disease
positive	I-disease
(	O
more	O
so	O
than	O
UA	O
at	O
OSH	O
)	O
so	O
felt	O
possibly	O
levo-resistant	B-disease
.	O

Pt	O
started	O
on	O
CTX	O
05-27	O
.	O

She	O
was	O
empirically	O
started	O
on	O
vanco/zosyn	O
for	O
empiric	O
hosp	O
acquired	O
pna	O
coverage	O

-	O
possible	O
opacity	B-disease
on	O
CXR	O
-	O
along	O
w/	O
leukocytosis	B-disease
.	O

#.	O
Anemia	B-disease
:	O
Unclear	O
source	O
.	O

She	O
was	O
guiaic	O
negative	O
.	O

-	O
no	O
transfusions	O
,	O
CMO/DNR/DNI	O

#.	O
FEN	O
:	O
check	O
lytes	O
,	O
most	O
recently	O
normal	O
.	O

cardiac/renal	O
diet	O

#.	O
Access	O
:	O
PIV	O

#.	O
Code	O
:	O
DNR/DNI/CMO	O
verified	O
with	O
Robert	O
Marks	O
2018-05-29	O

#.	O
Communication	O
:	O
Guardian	O
Robert	O
Fitzgerald	O
(	O
520	O
)	O
328	O
5499	O
.	O

Medications	O
on	O
Admission	O
:	O

aranesp	O
100	O
mcg	O
(	O
X1	O
05-26	O
)	O

diltiazem	O
CD	O
240	O
mg	O

paxil	O
20	O
mg	O
daily	O

detrol	O
LA	O
4	O
mg	O
daily	O

EC	O
ASA	O
81	O
mg	O
daily	O

pepcid	O
20	O
mg	O
daily	O

amiodarone	O
200	O
mg	O
daily	O

levofloxacin	O
250	O
mg	O
IV	O
daily	O
(	O
started	O
05-24	O
)	O

levothyroxine	O
50	O
mcg	O
daily	O

diovan	O
160	O
mg	O
daily	O

imdur	O
60	O
mg	O
daily	O

albuterol-ipratroprium	O
INH	O
2	O
sprays	O
tid	O
prn	O

Discharge	O
Disposition	O
:	O

Expired	O

Discharge	O
Diagnosis	O
:	O

1.	O
Pulmonary	B-disease
Edema	I-disease
and	O
Hypoxic	B-disease
Respiratory	I-disease
Failure	I-disease

2.	O
Large	B-disease
pericardial	I-disease
effusion	I-disease

3.	O
Moderate	B-disease
bilateral	I-disease
pleural	I-disease
effusions	I-disease

4.	O
Congestive	B-disease
Heart	I-disease
Failure	I-disease

5.	O
Paroxysmal	B-disease
Atrial	I-disease
Fibrillation	I-disease

6.	O
Sick	B-disease
sinus	I-disease
syndrome	I-disease
status	O
post	O
pacer	O
placement	O

7.	O
Coronary	B-disease
Artery	I-disease
Disease	I-disease

Discharge	O
Condition	O
:	O

Expired	O

Discharge	O
Instructions	O
:	O

Not	O
applicable	O

Followup	O
Instructions	O
:	O

Not	O
applicable	O

Jessica	O
Ashley	O
MD	O
19-617	O

Completed	O
by	O
:	O
James	O
Weishaar	O
MD	O
01-503	O
2018-05-31	O
@	O
1428	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Barry	O
Smith	O
on	O
:	O
FRI	O
2018-06-01	O
8:26	O
AM	O

(	O
End	O
of	O
Report	O
)	O

523704694	O

PRGH	O

67119280	O

480282	O

10/23/1999	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

10/23/1999	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

11/02/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Left	B-disease
sided	I-disease
spastic	I-disease
hemiparesis	I-disease
,	O
status	O
post	O
surgical	O
correction	O
of	O
C-1	O
,	O
C-2	O
dural	O
AVM	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Breunlinke	O
is	O
a	O
69	O
year-old	O
right	O
handed	O
woman	O
,	O
status	O
post	O
surgical	O
correction	O
of	O
a	O
C-1	O
to	O
C-2	O
dural	O
AVM	O
in	O
January	O
,	O
1998	O
,	O
now	O
presenting	O
with	O
a	O
one	O
month	O
history	O
of	O
increasing	B-disease
left	I-disease
sided	I-disease
weakness	I-disease
and	O
pain	B-disease
with	O
spasticity	B-disease
,	O
occasional	O
difficulty	B-disease
swallowing	I-disease
and	O
abdominal	B-disease
pain	I-disease
.	O

She	O
was	O
originally	O
admitted	O
to	O
the	O
Verg	O
Medical	O
Center	O
in	O
January	O
,	O
1998	O
,	O
because	O
of	O
a	O
one	O
year	O
history	O
of	O
left	B-disease
sided	I-disease
weakness	I-disease
and	O
spasticity	B-disease
.	O

She	O
was	O
found	O
to	O
have	O
intermedullary	B-disease
lesion	I-disease
at	I-disease
C1-2	I-disease
level	I-disease
which	O
on	O
biopsy	O
showed	O
abnormal	B-disease
vasculature	I-disease
,	O
hemosiderin	B-disease
deposit	I-disease
,	O
leading	O
in	O
turn	O
to	O
the	O
discovery	O
of	O
a	B-disease
dural	I-disease
arteriovenous	I-disease
malformation	I-disease
at	O
that	O
level	O
which	O
was	O
surgically	O
corrected	O
.	O

The	O
postoperative	O
period	O
was	O
complicated	O
by	O
transient	B-disease
swallowing	I-disease
difficulty	I-disease
,	O
increasing	B-disease
left	I-disease
sided	I-disease
weakness	I-disease
and	O
urinary	B-disease
retention	I-disease
.	O

She	O
was	O
discharged	O
to	O
inpatient	O
rehabilitation	O
where	O
she	O
made	O
significant	O
progress	O
toward	O
recovery	O
.	O

As	O
of	O
the	O
beginning	O
of	O
September	O
,	O
1999	O
,	O
she	O
was	O
able	O
to	O
swallow	O
without	O
difficulty	O
,	O
urinate	O
without	O
difficulty	O
(	O
although	O
bowel	O
movements	O
have	O
been	O
problematic	B-disease
)	O
.	O

Functionally	O
,	O
she	O
was	O
at	O
the	O
level	O
of	O
pre-gait	O
training	O
and	O
able	O
to	O
stand	O
and	O
take	O
several	O
steps	O
with	O
upper	O
body	O
support	O
.	O

Over	O
the	O
past	O
4-5	O
weeks	O
her	B-disease
functional	I-disease
level	I-disease
has	O
progressively	O
deteriorated	O
.	O

She	O
is	O
now	O
unable	O
to	O
stand	O
and	O
needs	O
assistance	O
to	O
sit	O
up	O
.	O

Her	O
left	O
arm	O
has	O
developed	O
a	B-disease
flexure	I-disease
contraction	I-disease
and	O
she	O
reports	O
intermitttent	B-disease
pain	I-disease
in	I-disease
the	I-disease
left	I-disease
arm	I-disease
and	I-disease
leg	I-disease
which	O
occurs	O
both	O
spontaneously	O
and	O
is	O
also	O
triggered	O
by	O
contact	O
.	O

She	O
has	O
developed	O
some	O
new	B-disease
swallowing	I-disease
difficulty	I-disease
and	O
since	O
her	O
transfer	O
to	O
a	O
long	O
term	O
inpatient	O
care	O
facility	O
,	O
she	O
has	O
lost	O
ten	O
pounds	O
.	O

She	O
denies	O
dysuria	B-disease
or	O
excessive	B-disease
urinary	I-disease
frequency	I-disease
.	O

Over	O
the	O
past	O
several	O
weeks	O
she	O
has	O
also	O
developed	O
severe	B-disease
intermittent	I-disease
abdominal	I-disease
pain	I-disease
,	O
localized	O
to	O
the	O
suprapubic	O
area	O
,	O
left	O
greater	O
than	O
right	O
,	O
occurring	O
intermittently	O
.	O

The	O
patient	O
feels	O
this	O
is	O
secondary	O
to	O
her	B-disease
hemorrhoids	I-disease
,	O
although	O
it	O
does	O
not	O
clearly	O
localize	O
to	O
the	O
rectum	O
.	O

This	B-disease
pain	I-disease
often	O
follows	O
bowel	O
movement	O
but	O
does	O
occur	O
spontaneously	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
Insulin	B-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease
,	O
atrial	B-disease
fibrillation	I-disease
,	O
hypothyroidism	B-disease
,	O
hypertension	B-disease
,	O
depression	B-disease
,	O
frequent	B-disease
urinary	I-disease
tract	I-disease
infections	I-disease
,	O
neuropathic	B-disease
pain	I-disease
syndrome	I-disease
and	O
osteoporosis	B-disease
.	O

MEDICATION	O
:	O

On	O
admission	O
include	O
Cozaar	O
75	O
mg	O
q.d.	O
,	O
Coumadin	O
2	O
mg/1	O
mg	O
alternate	O
days	O
,	O
Synthroid	O
175	O
mcg	O
q.d.	O
,	O
Zoloft	O
50	O
mg	O
q.d.	O
,	O
Zantac	O
150	O
mg	O
b.i.d.	O
,	O
Diabeta	O
25	O
mg	O
q.d.	O
,	O
Proctofoam	O
1%	O
q.i.d.	O
,	O
Demerol	O
100	O
mg	O
q	O
6	O
p.r.n.	O
,	O
OsCal	O
2	O
tabs	O
t.i.d.	O
,	O
multivitamins	O
and	O
KCl	O
supplements	O
,	O
Dulcolax	O
5	O
mg	O
q.d.	O
,	O
Senokot	O
2	O
tabs	O
q	O
h.s.	O
,	O
Metamucil	O
1	O
tablespoon	O
b.i.d.	O
,	O
Detrol	O
2	O
mg	O
b.i.d.	O
,	O
Neurontin	O
200	O
mg	O
t.i.d.	O
,	O
HydroDIURIL	O
12.5	O
mg	O
q.d.	O
,	O
Valium	O
10	O
mg	O
q	O
8	O
p.r.n.	O
muscle	B-disease
spasm	I-disease
,	O
Insulin	O
by	O
sliding	O
scale	O
and	O
levofloxacin	O
500	O
mg	O
q.d.	O
beginning	O
October	O
23	O
,	O
1999	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-disease
to	O
Hydralazine	O
,	O
codeine	O
,	O
ace	O
inhibitors	O
,	O
Nifedipine	O
and	O
Percocet	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
heart	O
is	O
regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-disease
.	O

Lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Abdomen	O
is	O
soft	O
,	O
with	O
marked	B-disease
suprapubic	I-disease
tenderness	I-disease
and	O
reduced	B-disease
bowel	I-disease
sounds	I-disease
.	O

Anal	O
tone	O
is	O
reduced	B-disease
.	O

Rectal	O
examination	O
is	O
nontender	B-disease
and	O
stool	O
is	O
guaiac	O
negative	O
.	O

Neurologically	O
,	O
the	O
patient	O
is	O
alert	O
and	O
oriented	O
times	O
three	O
with	O
normal	O
speech	O
,	O
language	O
and	O
repetition	O
.	O

Cranial	O
nerves	O
:	O

pupils	O
are	O
4-6	O
mm	O
bilaterally	O
,	O
extraocular	O
movements	O
were	O
full	O
without	O
nystagmus	B-disease
.	O

Eye	O
closure	O
and	O
smile	O
are	O
symmetric	O
.	O

Tongue	O
is	O
midline	O
.	O

Facial	O
sensation	O
is	O
sensation	O
.	O

Strength	O
:	O

The	O
tone	O
is	O
markedly	B-disease
increased	I-disease
in	I-disease
bot	I-disease
legs	I-disease
with	O
left	O
greater	O
than	O
right	O
.	O

Left	O
arm	O
shows	O
a	B-disease
flexor	I-disease
contracture	I-disease
and	O
markedly	B-disease
increased	I-disease
tone	I-disease
.	O

The	O
right	O
arm	O
shows	O
moderate	B-disease
increased	I-disease
tone	I-disease
.	O

Power	O
:	O

The	O
left	O
upper	O
extremity	O
shows	O
reduction	B-disease
in	I-disease
motor	I-disease
power	I-disease
ranging	O
from	O
2/5	O
in	O
the	O
triceps	O
,	O
4/5	O
in	O
the	O
biceps	O
,	O
and	O
3-4/5	O
in	O
the	O
wrists	O
and	O
hand	O
intrinsics	O
.	O

The	O
right	O
upper	O
extremity	O
shows	O
generalized	B-disease
reduction	I-disease
in	I-disease
strength	I-disease
,	O
4/5	O
in	O
all	O
joints	O
.	O

In	O
the	O
lower	O
extremities	O
on	O
the	O
left	O
hip	O
flexor	O
is	O
1/5	O
,	O
knee	O
flexion	O
and	O
extension	O
is	O
3/5	O
and	O
4/5	O
respectively	O
and	O
plantar	O
and	O
dorsiflexion	O
is	O
4/5	O
.	O

The	O
right	O
lower	O
extremity	O
shows	O
a	O
3/5	O
on	O
hip	O
flexion	O
,	O
4/5	O
at	O
knee	O
flexion	O
and	O
extension	O
and	O
full	O
power	O
on	O
dorsi	O
and	O
plantar	O
flexion	O
.	O

Reflexes	O
:	O

Upper	O
extremities	O
are	O
very	O
brisk	O
bilaterally	O
and	O
symmetrical	O
3+.	O
There	O
is	O
positive	B-disease
tremor	I-disease
reflex	I-disease
on	I-disease
the	I-disease
left	I-disease
and	O
absent	B-disease
on	I-disease
the	I-disease
right	I-disease
.	O

Lower	O
extremities	O
show	O
patellar	O
reflexes	O
3+	O
left	O
,	O
4+	O
right	O
,	O
no	O
cross	O
deductor	O
reflexes	O
and	O
absent	O
ankle	O
jerks	O
.	O

There	O
is	O
no	O
clonus	B-disease
on	I-disease
the	I-disease
right	I-disease
but	O
sustained	B-disease
clonus	I-disease
(	I-disease
10-12	I-disease
beats	I-disease
)	I-disease
on	I-disease
the	I-disease
left	I-disease
.	O

Plantar	O
responses	O
:	O

toes	O
are	O
upgoing	O
on	O
the	O
left	O
,	O
down	O
going	O
on	O
the	O
right	O
.	O

Sensory	O
:	O

The	O
patient	O
has	O
diminished	B-disease
vibration	I-disease
and	I-disease
propioception	I-disease
in	I-disease
the	I-disease
left	I-disease
upper	I-disease
and	I-disease
lower	I-disease
extremity	I-disease
and	O
decreased	B-disease
temperature	I-disease
,	O
light	O
touch	O
and	O
pinprick	O
sensation	O
in	O
the	O
right	O
upper	O
and	O
lower	O
extremity	O
consistent	O
with	O
a	B-disease
high	I-disease
cervical	I-disease
spinal	I-disease
sensory	I-disease
level	I-disease
.	O

Cerebellar	O
;	O
The	O
patient	O
demonstrates	O
an	B-disease
intention	I-disease
tremor	I-disease
on	O
finger	O
to	O
nose	O
with	O
the	O
left	O
hand	O
.	O

Fine	O
motor	O
movements	O
are	O
slow	B-disease
but	O
accurate	O
in	O
the	O
left	O
and	O
right	O
hands	O
.	O

LABORATORY	O
DATA	O
:	O

Sodium	O
140	O
,	O
potassium	O
3.8	O
,	O
chloride	O
100	O
,	O
bicarbonate	O
of	O
30	O
,	O
BUN	O
of	O
13	O
,	O
creatinine	O
0.8	O
,	O
serum	O
glucose	O
228	O
.	O

White	O
blood	O
count	O
is	O
7,000	O
.	O

Hematocrit	O
is	O
37.6	O
,	O
platelet	O
count	O
is	O
148,000	O
.	O

Prothrombin	O
time	O
is	O
15.9	O
with	O
an	O
INR	O
of	O
1.7	O
.	O

PTT	O
is	O
24	O
.	O

Urinalysis	O
from	O
October	O
21	O
,	O
is	O
positive	O
for	O
Citrobacter	B-disease
susceptible	O
to	O
ciprofloxacin	O
,	O
gentamycin	O
,	O
nitrofurantoin	O
,	O
tetracycline	O
and	O
Bactrim	O
.	O

Electrocardiogram	O
shows	O
no	O
P-waves	B-disease
.	O

The	O
patient	O
is	O
fully	O
paced	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
admission	O
,	O
a	O
CT	O
scan	O
of	O
the	O
head	O
with	O
and	O
without	O
contrast	O
was	O
performed	O
,	O
showing	O
a	B-disease
missing	I-disease
posterior	I-disease
arch	I-disease
at	I-disease
C-1	I-disease
and	O
metallic	O
clips	O
at	O
the	O
craniocervical	O
junction	O
consistent	O
with	O
prior	O
surgical	O
intervention	O
.	O

No	O
arteriovenous	B-disease
malformations	I-disease
are	O
identified	O
;	O
there	O
is	O
no	O
evidence	O
of	O
recurrence	B-disease
of	O
her	B-disease
former	I-disease
vascular	I-disease
malformation	I-disease
.	O

No	O
intraspinal	B-disease
lesions	I-disease
are	O
identified	O
.	O

Upon	O
further	O
review	O
of	O
Dr.	O
Laymie	O
Fields	O
,	O
Department	O
of	O
Neuroradiology	O
,	O
review	O
of	O
the	O
cervical	O
spine	O
on	O
CT	O
reveals	O
no	O
extrinsic	B-disease
compressive	I-disease
lesions	I-disease
impacting	O
the	O
spinal	O
cord	O
and	O
no	O
enhancing	B-disease
lesions	I-disease
of	I-disease
the	I-disease
spinal	I-disease
cord	I-disease
with	O
contrast	O
.	O

Angiography	O
performed	O
on	O
October	O
31	O
,	O
1999	O
,	O
showed	O
normal	B-disease
vascular	I-disease
distribution	I-disease
of	I-disease
the	I-disease
head	I-disease
and	I-disease
neck	I-disease
with	O
no	O
recurrence	B-disease
of	I-disease
arteriovenous	I-disease
malformation	I-disease
.	O

During	O
this	O
admission	O
,	O
the	O
patient	O
was	O
started	O
on	O
Baclofen	O
10	O
mg	O
p.o.	O
t.i.d.	O
for	O
spasticity	B-disease
.	O

Coumadin	O
was	O
discontinued	O
.	O

The	O
patient	O
was	O
given	O
aspirin	O
325	O
mg	O
p.o.	O
q.d.	O

The	O
patient	O
was	O
also	O
given	O
Valium	O
5-10	O
mg	O
p.o.	O
t.i.d.	O
for	O
muscle	B-disease
spasm	I-disease
.	O

She	O
was	O
continued	O
on	O
Demerol	O
50	O
mg	O
q	O
6-8	O
hours	O
p.r.n.	O
for	O
left	B-disease
arm	I-disease
and	I-disease
leg	I-disease
pain	I-disease
.	O

Upon	O
further	O
review	O
of	O
CT	O
and	O
angiography	O
results	O
with	O
Neuroradiology	O
and	O
Neurology	O
service	O
,	O
it	O
was	O
decided	O
that	O
CT	O
myelography	O
was	O
not	O
indicated	O
at	O
this	O
time	O
.	O

Note	O
,	O
the	O
patient	O
is	O
not	O
a	O
candidate	O
for	O
magnetic	O
resonance	O
imaging	O
secondary	O
to	O
ferromagnetic	O
intracardiac	O
pacing	O
device	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
back	O
to	O
Raka	O
St	O
,	O
Mcape	O
Garl	O
,	O
long	O
term	O
facility	O
.	O

We	O
recommend	O
daily	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
to	O
maximize	O
functional	B-disease
capacity	I-disease
with	O
optimization	O
of	O
pharmacological	O
regimen	O
for	O
spasticity	B-disease
including	O
Baclofen	O
,	O
Valium	O
and	O
adequate	O
analgesia	O
.	O

The	O
patient	O
is	O
to	O
followup	O
in	O
Neurology	O
clinic	O
,	O
Verg	O
Medical	O
Center	O
with	O
Dr.	O
Deida	O
K.	O
Areke	O
and	O
/	O
or	O
Dr.	O
Istranmuna	O
Cord	O
in	O
4-6	O
weeks	O
time	O
.	O

Dictated	O
By	O
:	O

DEIDA	O
K.	O
LONG	O
,	O
M.D.	O

Attending	O
:	O

ISTRANMUNA	O
B.	O
CORD	O
,	O
M.D.	O
VR52	O
PH501/3560	O

Batch	O
:	O

1445	O

Index	O
No.	O
MUZHFDOZK0	O

D	O
:	O

11/02/99	O

T	O
:	O

11/02/99	O
KE9	O

655358166	O
WGH	O

5367777	O

33714	O

8114836	O

10/12/2004	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

JUARISY	O
DUHESMITRE	O

UNIT	O
NUMBER	O
:	O

683-54-33	O

ADMISSION	O
DATE	O
:	O

20041012	O

DISCHARGE	O
DATE	O
:	O

20041015	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	O
Delivery	O
With	O
Second	B-disease
Degree	I-disease
Laceration	I-disease

ASSOCIATED	O
DIAGNOSES	O
:	O

Abnormal	B-disease
Pap	I-disease
Test	I-disease
,	O
history	O
of	O
;	O
Bacterial	B-disease
Vaginitis	I-disease
;	O
Contraception	O
Management	O
;	O
Hiv	O
Counseled	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	O
Vertex	O
Vaginal	O
Delivery	O

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Antimicrobial	O
Therapy	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Srom	B-disease
In	O
Labor	B-disease

PHYSICAL	O
EXAMINATION	O
:	O

MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
thyroid	O
wnl	O
BREASTS	O
NORMAL	O
no	O
distinct	B-disease
masses	I-disease
NIPPLES	O
NORMAL	O
inverted	B-disease
[	O
b	O
]	O
,	O
evert	O
w	O
/	O
stimulation	O
CHEST	O
NORMAL	O
LCTA	O
COR	O
NORMAL	O
RRR	O
ABDOMEN	O
NORMAL	O
gravid	O
EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
no	O
lesions	B-disease
,	O
white	B-disease
d	I-disease
/	I-disease
c	I-disease
at	I-disease
introitus	I-disease
VAGINA	O
NORMAL	O
sml	B-disease
amt	I-disease
thin	I-disease
white	I-disease
d	I-disease
/	I-disease
c	I-disease
ph	O
4.5	O
,	O
koh	O
+amine	O
,	O
NS	O
+clue	O
,	O
neg	O
trich	O
CERVIX	O
NORMAL	O
1/100/0	O
srom	B-disease
clear	O
OS	O
NORMAL	O
closed	O
ADNEXAE	O
NORMAL	O
no	O
palp	B-disease
masses	I-disease
,	O
NT	O
UTERUS	O
NORMAL	O
gravid	O
UTERINE	O
SIZE	O
IN	O
WEEKS	O
NORMAL	O
term	O
RECTUM	O
NORMAL	O
no	O
ext	B-disease
lesions	I-disease

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
21	O
year	O
old	O
Gravida	O
2	O
Para	O
0010	O
was	O
admitted	O
to	O
the	O
Life	O
Valley	O
Medical	O
Center	O
Obstetrical	O
service	O
on	O
10/12/2004	O
at	O
08:41	O
am	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

srom	B-disease
in	O
labor	B-disease
.	O

She	O
delivered	O
a	O
3680	O
gram	O
male	O
infant	O
on	O
10/12/2004	O
at	O
10:17	O
pm	O
with	O
apgar	O
scores	O
of	O
9	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
40.0	O
weeks	O
gestation	O
via	O
spontaneous	O
vertex	O
vaginal	O
delivery	O
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

srom	B-disease
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
10/15/2004	O
at	O
01:52	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
Under	O
Care	O
Of	O
Home	O
Health	O
Agency	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Alle	O
Rehabilitation	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Metronidazole	O
Tablets	O
(	O
Flagyl	O
)	O
;	O
Multivitamins	O
And	O
Folate	O
Capsules	O
(	O
Stuart	O
Prenatal	O
With	O
Folate	O
)	O

Electronically	O
Signed	O
:	O

Thorerogodlethrelf	O
,	O
Cisperna	O
M	O
10/17/2004	O
6:01:02	O
PM	O

910458031	O

NVH	O

23238893	O

1/12/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/12/1991	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/20/1991	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

METASTATIC	B-disease
ADENOCARCINOMA	I-disease
OF	I-disease
UNKNOWN	I-disease
PRIMARY	I-disease
.	O

SECONDARY	O
DIAGNOSIS	O
:	O

INTRAUTERINE	B-disease
PREGNANCY	I-disease
AT	I-disease
23	I-disease
WEEKS	I-disease
.	O

HYPERCALCEMIA	B-disease
.	O

INFERIOR	B-disease
VENA	I-disease
CAVA	I-disease
OBSTRUCTION	I-disease
.	O

IMPENDING	B-disease
SPINAL	I-disease
CORD	I-disease
COMPRESSION	I-disease
.	O

IDENTIFICATION	O
DATA	O
:	O

The	O
patient	O
is	O
a	O
34-year-old	O
female	O
with	O
a	B-disease
22	I-disease
week	I-disease
intrauterine	I-disease
pregnancy	I-disease
who	O
was	O
transferred	O
from	O
Bri	O
Health	O
with	O
diffuse	B-disease
metastatic	I-disease
adenocarcinoma	I-disease
of	I-disease
unknown	I-disease
primary	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
excellent	O
health	O
until	O
July	O
of	O
1991	O
when	O
she	O
first	O
noted	O
a	B-disease
left	I-disease
clavicular	I-disease
mass	I-disease
.	O

Subsequently	O
,	O
the	B-disease
mass	I-disease
continued	O
to	O
increase	O
in	O
size	O
.	O

On	O
12/23	O
,	O
she	O
was	O
seen	O
by	O
Dr.	O
Stonge	O
at	O
Bri	O
Health	O
where	O
a	B-disease
3	I-disease
x	I-disease
7	I-disease
cm	I-disease
left	I-disease
mid	I-disease
clavicular	I-disease
mass	I-disease
was	O
noted	O
.	O

A	O
fine	O
needle	O
aspirate	O
of	O
this	B-disease
mass	I-disease
reportedly	O
revealed	O
giant	B-disease
cell	I-disease
tumor	I-disease
.	O

The	O
patient	O
was	O
initially	O
told	O
that	O
this	O
was	O
a	B-disease
benign	I-disease
tumor	I-disease
and	O
that	O
it	O
could	O
simply	O
be	O
watched	O
and	O
definitively	O
treated	O
after	O
the	O
delivery	O
of	O
her	O
baby	O
.	O

Subsequently	O
,	O
the	B-disease
mass	I-disease
progressively	O
increased	O
in	O
size	O
and	O
the	O
patient	O
had	O
developed	O
significant	B-disease
discomfort	I-disease
in	I-disease
this	I-disease
region	I-disease
.	O

On	O
1/5	O
,	O
the	O
patient	O
underwent	O
a	O
local	O
tumor	O
debulking	O
at	O
Bri	O
Health	O
under	O
local	O
anesthesia	O
.	O

The	O
pathology	O
,	O
unfortunately	O
,	O
revealed	O
an	B-disease
aggressive	I-disease
adenocarcinoma	I-disease
(	O
micropapillary	O
type	O
;	O
mucin	O
producing	O
)	O
.	O

This	O
prompted	O
further	O
staging	O
work-up	O
.	O

The	O
patient	O
subsequently	O
had	O
a	O
limited	O
chest	O
CT	O
at	O
Bri	O
Health	O
which	O
showed	O
diffuse	B-disease
bilateral	I-disease
pulmonary	I-disease
metastases	I-disease
,	O
metastases	B-disease
to	I-disease
the	I-disease
sternum	I-disease
,	I-disease
rib	I-disease
,	I-disease
multiple	I-disease
spinal	I-disease
levels	I-disease
;	O
internal	B-disease
mammary	I-disease
lymphadenopathy	I-disease
.	O

The	O
poor	O
prognosis	O
for	O
the	O
patient	O
and	O
child	O
were	O
discussed	O
and	O
after	O
the	O
patient	O
decided	O
to	O
have	O
an	O
elective	O
abortion	O
,	O
an	O
abdominal	O
CT	O
scan	O
was	O
obtained	O
which	O
revealed	O
diffuse	B-disease
metastatic	I-disease
lesions	I-disease
of	I-disease
the	I-disease
liverspine	I-disease
,	I-disease
ribs	I-disease
and	I-disease
most	I-disease
of	I-disease
the	I-disease
lymph	I-disease
nodes	I-disease
.	O

There	O
was	O
no	O
obvious	B-disease
GIor	I-disease
pancreatic	I-disease
tumor	I-disease
identified	O
.	O

The	O
patient	O
had	O
a	B-disease
very	I-disease
firm	I-disease
nodule	I-disease
at	O
the	O
vertex	O
of	O
her	O
calvarium	O
.	O

A	O
specimen	O
was	O
obtained	O
by	O
fine	O
needle	O
aspiration	O
and	O
the	O
pathology	O
of	O
this	O
was	O
consistent	O
with	O
adenocarcinoma	B-disease
.	O

The	O
patient	O
was	O
transferred	O
to	O
Nimaconwood	O
Valley	O
Hospital	O
for	O
management	O
of	O
her	B-disease
cancer	I-disease
and	O
termination	O
of	O
the	B-disease
pregnancy	I-disease
.	O

Over	O
the	O
past	O
four	O
weeks	O
,	O
the	O
patient	O
reported	O
progressive	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
mid	B-disease
thoracic	I-disease
back	I-disease
pain	I-disease
.	O

She	O
has	O
had	O
no	O
motor	B-disease
weakness	I-disease
,	O
abnormal	B-disease
sensation	I-disease
,	O
numbness	B-disease
,	O
tingling	B-disease
or	O
incontinence	B-disease
of	I-disease
bowel	I-disease
or	I-disease
bladder	I-disease
.	O

She	O
denied	O
fevers	B-disease
,	O
chills	B-disease
or	O
sweats	B-disease
.	O

There	O
has	O
been	O
no	O
GI	B-disease
or	I-disease
GU	I-disease
symptoms	I-disease
except	O
for	O
constipation	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Unremarkable	O
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Percocet	O
for	O
pain	B-disease
and	O
multivitamins	O
.	O

ALLERGIES	O
:	O

NO	O
KNOWN	B-disease
DRUG	I-disease
ALLERGIES	I-disease
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
father	O
died	O
at	O
age	O
69	O
with	O
metastatic	B-disease
prostate	I-disease
cancer	I-disease
.	O

The	O
patient	O
&apos;s	O
sister	O
has	O
a	O
history	O
of	O
cervical	B-disease
cancer	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
and	O
lives	O
with	O
her	O
husband	O
.	O

She	O
has	O
no	O
children	O
.	O

She	O
is	O
a	O
nonsmoker	O
.	O

She	O
drinks	O
socially	O
.	O

She	O
has	O
not	O
had	O
any	O
alcoholic	O
beverages	O
during	O
this	B-disease
pregnancy	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
revealed	O
a	O
pleasant	O
,	O
comfortable	O
,	O
tired	O
appearing	O
female	O
.	O

The	O
patient	O
was	O
afebrile	O
.	O

Blood	O
pressure	O
was	O
98/64	O
.	O

Pulse	O
82	O
.	O

Respiratory	O
rate	O
20	O
.	O

Skin	O
exam	O
revealed	O
a	B-disease
right	I-disease
posterior	I-disease
parietal	I-disease
scalp	I-disease
nodle	I-disease
measuring	O
2	O
x	O
3	O
cm	O
which	O
was	O
very	O
firm	O
.	O

There	O
was	O
a	B-disease
1	I-disease
cm	I-disease
firm	I-disease
nodule	I-disease
at	I-disease
the	I-disease
left	I-disease
upper	I-disease
thoracic	I-disease
region	I-disease
of	O
the	O
back	O
between	O
the	O
midline	O
and	O
the	O
scapula	O
.	O

There	O
was	O
a	B-disease
1	I-disease
cm	I-disease
firm	I-disease
nodule	I-disease
in	O
the	O
right	O
upper	O
quadrant	O
of	O
the	O
abdomen	O
.	O

HEENT	O
exam	O
was	O
unremarkable	O
.	O

Neck	O
was	O
supple	O
.	O

There	O
was	O
no	O
jugular	B-disease
venous	I-disease
distention	I-disease
.	O

There	O
was	O
no	O
lymphadenopathy	B-disease
.	O

Back	O
was	O
without	O
CVA	B-disease
tenderness	I-disease
.	O

There	O
was	O
no	O
scapular	B-disease
tenderness	I-disease
.	O

There	O
was	O
mild	B-disease
lower	I-disease
thoracic	I-disease
tenderness	I-disease
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
.	O

There	O
were	O
no	O
rales	B-disease
or	O
wheezes	B-disease
.	O

There	O
was	O
no	O
egophony	B-disease
.	O

Cardiac	O
exam	O
was	O
tachycardic	B-disease
and	O
regular	O
,	O
normal	O
S1	O
and	O
S2	O
.	O

There	O
was	O
a	B-disease
II	I-disease
/	I-disease
VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
loudest	O
at	O
the	O
left	O
upper	O
sternal	O
border	O
.	O

There	O
was	O
no	O
heave	B-disease
.	O

Abdomen	O
was	O
gravid	B-disease
.	O

Bowel	O
sounds	O
were	O
present	O
.	O

The	O
abdomen	O
was	O
tympanitic	O
and	O
nontender	B-disease
.	O

The	O
liver	O
was	O
11	O
cm	O
by	O
percussion	O
.	O

There	O
was	O
no	O
liver	O
edge	O
palpable	O
,	O
no	O
spleen	O
tip	O
palpable	O
.	O

Rectal	O
revealed	O
normal	O
muscle	O
tone	O
,	O
heme	O
negative	O
stool	O
.	O

Extremities	O
revealed	O
1+	B-disease
bipedal	I-disease
edema	I-disease
on	O
admission	O
.	O

Neurological	O
examination	O
revealed	O
the	O
patient	O
to	O
be	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Cranial	O
nerves	O
II	O
-	O
XII	O
were	O
intact	O
.	O

Motor	O
was	O
5/5	O
.	O

Sensation	O
was	O
intact	O
to	O
light	O
touch	O
.	O

Deep	O
tendon	O
reflexes	O
were	O
1-2+	O
and	O
symmetric	O
bilaterally	O
.	O

Toes	O
were	O
downgoing	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
included	O
an	O
ALT	O
of	O
108	O
,	O
AST	O
of	O
286	O
.	O

Total	O
bilirubin	O
3.0	O
,	O
direct	O
bilirubin	O
of	O
2.0	O
.	O

Alkaline	O
phosphatase	O
1148	O
.	O

LDH	O
806	O
.	O

Calcium	O
11.8	O
.	O

Albumin	O
2.3	O
.	O

Hematocrit	O
was	O
30.6	O
.	O

White	O
blood	O
cell	O
count	O
was	O
11.14	O
.	O

PT	O
was	O
13.2	O
.	O

PTT	O
was	O
29.8	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
had	O
an	O
elective	O
termination	O
of	O
her	B-disease
pregnancy	I-disease
on	O
1/13/91	O
.	O

The	O
work-up	O
for	O
the	O
extent	O
of	O
the	B-disease
patient	I-disease
&apos;s	I-disease
disease	I-disease
included	O
MRI	O
scan	O
of	O
the	O
cervical	O
and	O
thoracic	O
spine	O
which	O
revealed	O
multiple	B-disease
metastatic	I-disease
lesions	I-disease
in	I-disease
the	I-disease
vertebral	I-disease
bodies	I-disease
;	O
a	B-disease
T3	I-disease
lesion	I-disease
extending	O
from	O
the	O
body	O
to	O
the	O
right	O
neural	O
for	O
amina	O
with	O
foraminal	B-disease
obstruction	I-disease
.	O

An	B-disease
epidural	I-disease
mass	I-disease
was	O
present	O
at	O
T10	O
which	O
was	O
extending	O
from	O
the	O
lamina	O
or	O
spinous	O
process	O
anteriorly	O
and	O
almost	O
compressing	O
the	O
spinal	O
cord	O
.	O

An	O
abdominal	O
and	O
pelvic	O
CT	O
scan	O
with	O
IV	O
contrast	O
revealed	O
bilateral	B-disease
pulmonary	I-disease
nodules	I-disease
and	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
,	O
extensive	B-disease
liver	I-disease
metastases	I-disease
,	O
narrowing	B-disease
of	I-disease
the	I-disease
intra	I-disease
hepatic	I-disease
IVC	I-disease
and	O
distention	B-disease
of	I-disease
the	I-disease
azygous	I-disease
system	I-disease
suggestive	O
of	O
IVC	B-disease
obstruction	I-disease
by	O
liver	B-disease
metastases	I-disease
;	O
ascites	B-disease
;	O
multiple	B-disease
bony	I-disease
metastases	I-disease
;	O
and	O
an	B-disease
isolated	I-disease
splenic	I-disease
metastases	I-disease
.	O

A	O
bone	O
scan	O
revealed	O
increased	B-disease
uptake	I-disease
in	I-disease
the	I-disease
left	I-disease
chest	I-disease
wall	I-disease
,	I-disease
left	I-disease
anterior	I-disease
ribs	I-disease
four	I-disease
to	I-disease
six	I-disease
,	O
and	O
increased	B-disease
uptake	I-disease
in	I-disease
the	I-disease
left	I-disease
and	I-disease
right	I-disease
lateral	I-disease
skull	I-disease
in	O
the	O
area	O
of	O
the	O
parotids	O
.	O

Ahead	O
CT	O
scan	O
revealed	O
a	B-disease
metastatic	I-disease
lesion	I-disease
in	O
the	O
right	O
vertex	O
of	O
the	O
calvarium	O
but	O
no	O
intracranial	B-disease
abnormalities	I-disease
.	O

Work-up	O
for	O
the	O
source	O
of	O
the	B-disease
primary	I-disease
tumor	I-disease
which	O
is	O
still	O
unknown	O
included	O
a	O
mammogram	O
which	O
identified	O
no	O
suspicious	B-disease
microcalcifications	I-disease
and	O
no	O
dominant	B-disease
masses	I-disease
.	O

The	O
abdominal	O
and	O
pelvic	O
CT	O
scans	O
showed	O
no	O
suspicious	B-disease
GI	I-disease
masses	I-disease
,	O
no	O
pancreatic	B-disease
mass	I-disease
;	O
a	B-disease
2	I-disease
cm	I-disease
ovarian	I-disease
cyst	I-disease
.	O

The	O
review	O
of	O
the	O
pathology	O
from	O
Bri	O
Health	O
confirmed	O
a	B-disease
high	I-disease
grade	I-disease
adenocarcinoma	I-disease
.	O

Erica	O
and	O
basic	O
cystic	O
protein	O
stains	O
are	O
still	O
pending	O
.	O

Serum	O
markers	O
were	O
normal	O
.	O

The	O
CEA	O
was	O
less	O
than	O
0.7	O
.	O

The	O
hCG	O
on	O
admission	O
was	O
30,710	O
and	O
on	O
1/19	O
was	O
805	O
.	O

The	O
CA-125	O
was	O
still	O
pending	O
and	O
alphafeto	O
protein	O
is	O
still	O
pending	O
.	O

Hypercalcemia	B-disease
:	O

The	O
patient	O
presented	O
with	O
a	O
serum	O
calcium	O
of	O
11.8	O
and	O
an	O
albumin	O
of	O
2.3	O
on	O
admission	O
.	O

She	O
received	O
three	O
days	O
of	O
intravenous	O
etidronate	O
with	O
normal	O
saline	O
diuresis	O
and	O
the	O
serum	O
calcium	O
subsequently	O
decreased	O
to	O
9.0	O
.	O

The	O
patient	O
was	O
then	O
switched	O
to	O
po	O
etidronate	O
.	O

IVC	B-disease
obstruction	I-disease
:	O

The	O
patient	O
has	O
extensive	B-disease
hepatic	I-disease
metastases	I-disease
and	O
by	O
CT	O
scan	O
there	O
is	O
obstruction	B-disease
of	I-disease
the	I-disease
intrahepatic	I-disease
IVC	I-disease
.	O

This	O
has	O
resulted	O
in	O
marked	B-disease
bilateral	I-disease
lower	I-disease
extremity	I-disease
and	I-disease
presacral	I-disease
edema	I-disease
with	O
ascites	B-disease
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
low	I-disease
serum	I-disease
albumin	I-disease
is	O
also	O
contributing	O
to	O
her	B-disease
extensive	I-disease
edema	I-disease
.	O

Hypoxia	B-disease
and	O
shortness	B-disease
of	I-disease
breath	I-disease
:	O

Although	O
the	O
patient	O
&apos;s	O
room	O
air	O
saturation	O
was	O
96%	O
during	O
this	O
admission	O
,	O
she	O
subjectively	O
complained	O
of	O
increased	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
.	O

It	O
was	O
felt	O
that	O
the	B-disease
patient	I-disease
&apos;s	I-disease
extensive	I-disease
pulmonary	I-disease
metastases	I-disease
and	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
resulted	O
in	O
increased	B-disease
work	I-disease
of	I-disease
respiration	I-disease
and	O
a	O
sensation	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

Impending	B-disease
spinal	I-disease
cord	I-disease
compression	I-disease
:	O

The	O
patient	O
had	O
back	B-disease
pain	I-disease
on	O
admission	O
without	O
any	B-disease
focal	I-disease
neurological	I-disease
signs	I-disease
.	O

The	O
MRI	O
scan	O
on	O
admission	O
revealed	O
an	B-disease
impending	I-disease
cord	I-disease
compression	I-disease
at	O
the	O
level	O
of	O
T10	O
.	O

She	O
was	O
started	O
on	O
Decadron	O
and	O
on	O
1/17	O
began	O
the	O
first	O
of	O
ten	O
radiation	O
treatments	O
to	O
two	O
fields	O
(	O
T2	O
to	O
T5	O
and	O
T9	O
to	O
T11	O
)	O
.	O

Per	O
the	O
patient	O
&apos;s	O
wishes	O
,	O
Dr.	O
Dalywoo	O
Droreite	O
the	O
Windgo	O
Hospital	O
was	O
consulted	O
for	O
a	O
second	O
opinion	O
regarding	O
the	O
management	O
of	O
her	B-disease
malignancy	I-disease
.	O

Dr.	O
Linke	O
recommended	O
chemotherapy	O
with	O
PFL	O
.	O

Per	O
the	O
patient	O
&apos;s	O
wishes	O
,	O
she	O
was	O
transferred	O
to	O
the	O
Windgo	O
Hospital	O
for	O
chemotherapy	O
.	O

ALT	O
was	O
53	O
.	O

AST	O
was	O
89	O
.	O

Her	O
LDH	O
was	O
394	O
.	O

Her	O
alkaline	O
phosphatase	O
was	O
1514	O
.	O

Total	O
bilirubin	O
was	O
2.1	O
.	O

Direct	O
bilirubin	O
was	O
1.4	O
.	O

Albumin	O
was	O
2.3	O
.	O

Calcium	O
9.1	O
.	O

Hematocrit	O
was	O
32.5	O
.	O

White	O
blood	O
cell	O
count	O
was	O
16.89	O
.	O

PT	O
was	O
12.9	O
.	O

PTT	O
was	O
27.3	O
.	O

DISPOSITION	O
:	O

MEDICATIONS	O
:	O

On	O
discharge	O
included	O
etidronate	O
,	O
475	O
mg	O
IV	O
q	O
day	O
;	O
heparin	O
,	O
5000	O
units	O
subcutaneously	O
b.i.d.	O
;	O
Decadron	O
,	O
4	O
mg	O
po	O
q	O
six	O
hours	O
;	O
MS	O
Contin	O
,	O
45	O
mg	O
po	O
b.i.d.	O
;	O
Pepcid	O
,	O
20	O
mg	O
po	O
b.i.d.	O
;	O
Senekot	O
,	O
one	O
tablet	O
po	O
t.i.d.	O
;	O
Bronkosol	O
,	O
0.25	O
cc	O
q	O
four	O
hours	O
.	O

It	O
was	O
decided	O
to	O
have	O
the	B-disease
patient	I-disease
&apos;s	I-disease
medical	I-disease
and	I-disease
oncological	I-disease
issues	I-disease
managed	O
at	O
Windgo	O
Hospital	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
&apos;s	O
electrolytes	O
were	O
within	O
normal	O
limits	O
.	O

BD452/5255	O

RUTHU	O
PAIN	O
,	O
M.D.	O
KW25	O

D	O
:	O

01/20/91	O

Batch	O
:	O

8050	O

Report	O
:	O

H7691U2	O

T	O
:	O

01/24/91	O

Dictated	O
By	O
:	O

CEALME	O
PAIN	O
,	O
M.D.	O

498710998	O

CMC	O

14172445	O

04/29/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

04/29/1992	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

05/28/1992	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Carotid	B-disease
stenosis	I-disease
.	O

2.	O
Aortic	B-disease
stenosis	I-disease
.	O

3.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
.	O

PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
76-year-old	O
female	O
who	O
was	O
admitted	O
to	O
the	O
medicine	O
service	O
on	O
04-29-92	O
with	O
a	O
past	O
history	O
significant	O
for	O
aortic	B-disease
stenosis	I-disease
and	O
chest	B-disease
pain	I-disease
who	O
presented	O
for	O
evaluation	O
for	O
aortic	O
valve	O
replace-ment	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
exertional	B-disease
angina	I-disease
and	O
chest	B-disease
pain	I-disease
associated	O
with	O
light-headedness	B-disease
for	O
nine	O
years	O
which	O
was	O
noted	O
to	O
increase	O
in	O
frequency	O
over	O
the	O
past	O
year	O
,	O
then	O
upon	O
admission	O
had	O
light-headedness	B-disease
and	O
chest	B-disease
pain	I-disease
with	O
a	B-disease
dull	I-disease
pressure	I-disease
in	I-disease
her	I-disease
neck	I-disease
to	O
her	O
substernal	O
area	O
,	O
with	O
only	O
minimal	O
exertion	O
such	O
as	O
&quot;	O
walking	O
across	O
the	O
room	O
&quot;	O
.	O

She	O
states	O
this	O
light-headedness	B-disease
is	O
often	O
associated	O
with	O
shortness	B-disease
of	I-disease
breath	I-disease
and	O
diaphoresis	B-disease
occasionally	O
with	O
nausea	B-disease
.	O

She	O
denies	O
any	O
vomiting	B-disease
,	O
states	O
that	O
the	B-disease
episodes	I-disease
usually	O
last	O
about	O
five	O
minutes	O
and	O
are	O
relieved	O
with	O
rest	O
.	O

The	B-disease
pain	I-disease
and	O
light-headedness	B-disease
is	O
now	O
severely	O
lifestyle	O
limiting	O
and	O
the	O
patient	O
requested	O
evaluation	O
for	O
possible	O
aortic	O
valve	O
replacement	O
.	O

Cardiac	O
risk	O
factors	O
hypercholesterolemia	B-disease
,	O
hypertension	B-disease
,	O
no	O
history	O
of	O
tobacco	O
use	O
,	O
diabetes	B-disease
or	O
family	O
history	O
.	O

Past	O
medical	O
history	O
is	O
as	O
stated	O
above	O
,	O
aortic	B-disease
stenosis	I-disease
,	O
found	O
to	O
be	O
critical	O
on	O
echocardiogram	O
on	O
4-13-92	O
,	O
done	O
in	O
Otte	O
A	O
,	O
New	O
Jersey	O
and	O
was	O
found	O
to	O
have	O
left	B-disease
ventricular	I-disease
hypertrophy	I-disease
and	O
ejection	O
fraction	O
of	O
58%	O
,	O
no	O
right	B-disease
heart	I-disease
wall	I-disease
motion	I-disease
abnormali-ties	I-disease
and	O
an	O
aortic	O
valve	O
gradient	O
of	O
greater	O
than	O
100	O
.	O

She	O
also	O
has	O
a	O
history	O
of	O
uterine	B-disease
fibroids	I-disease
,	O
status	O
post	O
total	O
abdominal	O
hysterectomy	O
.	O

She	O
has	O
known	B-disease
bilateral	I-disease
carotid	I-disease
disease	I-disease
,	O
stated	O
to	O
be	O
greater	O
than	O
70%	O
bilaterally	O
.	O

She	O
has	O
a	O
history	O
of	O
glaucoma	B-disease
and	O
a	O
questionable	O
history	O
of	O
claudication	B-disease
in	I-disease
her	I-disease
legs	I-disease
as	O
well	O
as	O
a	O
history	O
of	O
hypertension	B-disease
.	O

Medications	O
on	O
admission	O
were	O
only	O
aspirin	O
p.r.n.	O
and	O
Timoptic	O
solution	O
0.5%	O
to	O
the	O
left	O
eye	O
twice	O
a	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	O
examination	O
she	O
was	O
afebrile	B-disease
with	O
a	O
blood	O
pressure	O
of	O
170/100	O
,	O
heart	O
rate	O
of	O
70	O
.	O

HEENT	O
examination	O
notable	O
for	O
bilateral	B-disease
arcussenilis	I-disease
but	O
otherwise	O
unremarkable	O
.	O

Her	O
neck	O
showed	O
no	O
JVD	B-disease
,	O
there	O
was	O
a	B-disease
slow	I-disease
carotid	I-disease
upstroke	I-disease
bilaterally	I-disease
,	O
there	O
were	O
bilateral	B-disease
carotid	I-disease
bruits	I-disease
versus	O
transmitted	B-disease
murmur	I-disease
.	O

Chest	O
was	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Cardiac	O
examination	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	O
normal	O
S1	O
and	O
S2	O
,	O
3/6	O
systolic	B-disease
murmur	I-disease
at	I-disease
the	I-disease
right	I-disease
upper	I-disease
sternal	I-disease
border	I-disease
,	O
no	O
gallop	B-disease
was	O
detected	O
.	O

Her	O
abdomen	O
was	O
soft	O
,	O
nontender	B-disease
with	O
good	O
bowel	O
sounds	O
.	O

Extremi-ties	O
:	O

There	O
is	O
no	O
clubbing	B-disease
,	O
cyanosis	B-disease
or	O
edema	B-disease
and	O
her	O
peripheral	O
pulses	O
were	O
trace	O
palpable	O
.	O

LAB	O
/	O
X-RAY	O
DATA	O
:	O

Labs	O
on	O
admission	O
:	O

Sodium	O
141	O
,	O
potassium	O
5.0	O
,	O
BUN	O
18	O
,	O
creatinine	O
1.0	O
,	O
PT	O
12.3	O
,	O
PTT	O
24	O
,	O
WBC	O
7.6	O
,	O
hematocrit	O
41	O
,	O
platelets	O
278,000	O
.	O

EKG	O
revealed	O
a	O
normal	O
sinus	O
rhythm	O
with	O
a	O
rate	O
of	O
69	O
,	O
left	B-disease
ventricular	I-disease
hyper-trophy	I-disease
with	O
poor	B-disease
anterior	I-disease
progression	I-disease
of	I-disease
R-waves	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
was	O
admitted	O
and	O
evaluated	O
by	O
the	O
cardiac	O
surgery	O
service	O
after	O
having	O
undergone	O
cardiac	O
catheterization	O
which	O
revealed	O
a	O
70%	B-disease
stenosis	I-disease
of	I-disease
her	I-disease
left	I-disease
circumflex	I-disease
artery	I-disease
,	O
50%	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
left	I-disease
anterior	I-disease
descending	I-disease
and	O
10%	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
right	I-disease
coronary	I-disease
artery	I-disease
.	O

Carotid	O
angiography	O
revealed	O
left	B-disease
internal	I-disease
carotid	I-disease
stenosis	I-disease
of	I-disease
90%	I-disease
,	O
right	B-disease
internal	I-disease
carotid	I-disease
artery	I-disease
&quot;	I-disease
critical	I-disease
stenosis	I-disease
&quot;	I-disease
.	O

On	O
05-01-92	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
at	O
which	O
time	O
she	O
underwent	O
an	O
aortic	O
valve	O
replacement	O
with	O
a	O
#	O
19	O
St.	O
Jude	O
valve	O
,	O
coronary	O
artery	O
bypass	O
graft	O
times	O
one	O
with	O
saphenous	O
vein	O
graft	O
from	O
the	O
posterior	O
descending	O
artery	O
to	O
the	O
obtuse	O
marginal	O
and	O
right	O
carotid	O
endarterectomy	O
.	O

This	O
was	O
performed	O
by	O
Dr.	O
Medicine	O
and	O
Dr.	O
Room	O
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
found	O
postoperatively	O
to	O
have	O
some	B-disease
left	I-disease
upper	I-disease
extremity	I-disease
weakness	I-disease
on	O
proximal	O
greater	O
than	O
distal	O
musculature	O
.	O

She	O
was	O
extubated	O
on	O
postoperative	O
day	O
number	O
one	O
and	O
otherwise	O
had	O
an	O
unremarkable	O
postoperative	O
course	O
with	O
the	O
exception	O
of	O
her	B-disease
left	I-disease
upper	I-disease
extremity	I-disease
weakness	I-disease
.	O

On	O
05-04-92	O
she	O
was	O
evaluated	O
by	O
the	O
neurology	O
service	O
,	O
who	O
recommended	O
a	O
CT	O
scan	O
,	O
however	O
no	O
evidence	O
of	O
infarction	B-disease
was	O
detected	O
.	O

There	O
was	O
only	O
diffuse	B-disease
small	I-disease
vessel	I-disease
disease	I-disease
noted	O
.	O

On	O
05-05-92	O
she	O
was	O
noted	O
to	O
convert	O
to	O
atrial	B-disease
fibrillation	I-disease
which	O
resolved	O
spontaneously	O
a	O
few	O
days	O
later	O
.	O

However	O
,	O
on	O
05-07-92	O
there	O
was	O
a	O
a	O
question	O
of	O
a	B-disease
new	I-disease
event	I-disease
with	O
addition	O
to	O
the	B-disease
left	I-disease
upper	I-disease
extremity	I-disease
weakness	I-disease
,	O
some	B-disease
noted	I-disease
right	I-disease
upper	I-disease
and	I-disease
right	I-disease
lower	I-disease
extremity	I-disease
discoordination	I-disease
.	O

She	O
was	O
begun	O
on	O
a	O
heparin	O
drip	O
.	O

On	O
5-9-92	O
the	B-disease
right-sided	I-disease
symptoms	I-disease
worsened	O
and	O
she	O
also	O
had	O
some	B-disease
elements	I-disease
of	I-disease
aphasia	I-disease
.	O

She	O
underwent	O
angiography	O
on	O
5-9-92	O
which	O
showed	O
the	O
right	O
internal	O
carotid	O
artery	O
to	O
be	O
patent	O
,	O
however	O
there	O
was	O
highly	O
significant	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
left	I-disease
carotid	I-disease
artery	I-disease
and	O
she	O
was	O
taken	O
to	O
the	O
operating	O
room	O
later	O
that	O
day	O
for	O
a	O
left	O
carotid	O
endarterectomy	O
.	O

She	O
was	O
taken	O
postoperatively	O
the	O
ICU	O
where	O
she	O
was	O
extubated	O
on	O
postoperative	O
day	O
number	O
one	O
and	O
by	O
5-11-92	O
she	O
was	O
noted	O
to	O
have	O
markedly	O
increased	O
use	O
of	O
her	O
right	O
side	O
,	O
resolving	O
aphasia	B-disease
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
with	O
the	B-disease
residual	I-disease
deficit	I-disease
only	O
noted	O
to	O
be	O
some	B-disease
left	I-disease
upper	I-disease
extremity	I-disease
weakness	I-disease
.	O

She	O
was	O
worked	O
up	O
aggressively	O
with	O
the	O
physical	O
therapy	O
and	O
occupational	O
services	O
,	O
made	O
good	O
progress	O
and	O
began	O
ambulating	O
with	O
assistance	O
with	O
a	O
walker	O
but	O
with	O
minimal	O
assistance	O
from	O
an	O
aid	O
.	O

She	O
was	O
feeding	O
herself	O
and	O
was	O
very	O
enthusiastic	O
and	O
energetic	O
in	O
her	O
participation	O
in	O
her	O
rehabilitation	O
activities	O
.	O

She	O
was	O
maintained	O
on	O
heparin	O
therapy	O
initially	O
but	O
this	O
was	O
quickly	O
switched	O
over	O
to	O
Coumadin	O
anticoagulation	O
therapy	O
which	O
she	O
will	O
need	O
to	O
be	O
on	O
long-term	O
for	O
her	O
aortic	O
valve	O
replacement	O
.	O

DISPOSITION	O
:	O

She	O
is	O
transferred	O
to	O
Rockdempbanri	O
Hospital	O
on	O
05-28-92	O
to	O
continue	O
her	O
rehabilitation	O
.	O

Discharge	O
medications	O
:	O

Lopressor	O
100	O
mg	O
p.o.	O
b.i.d.	O
;	O
Nifedipine	O
10	O
mg	O
p.o.	O
t.i.d.	O
;	O
Timoptic	O
solution	O
0.5%	O
OS	O
b.i.d.	O
;	O
Coumadin	O
1	O
mg	O
alternating	O
with	O
1.5	O
mg	O
q.o.d.	O
at	O
q.h.s.	O
and	O
Haldol	O
2	O
mg	O
p.o.	O
q.h.s.	O
p.r.n.	O
in	O
the	O
evening	O
,	O
only	O
for	O
agitation	B-disease
associated	O
with	O
confusion	B-disease
.	O

Upon	O
discharge	O
it	O
was	O
the	O
recommendation	O
of	O
the	O
cardiology	O
team	O
that	O
the	O
patient	O
&apos;s	O
prothrombin	O
time	O
be	O
monitored	O
weekly	O
and	O
be	O
kept	O
at	O
a	O
ratio	O
of	O
3-4	O
IU	O
.	O

Dictated	O
By	O
:	O

NIEIE	O
FREIERM	O
,	O
M.D.	O
ZX	O
681	O
/	O
0201	O
/	O
RISHAN	O
MISHON	O
ROOM	O
,	O
M.D.	O

BREUNTIK	O

D	O
:	O

05/26/92	O

T	O
:	O

05/27/92	O

Batch	O
:	O

U886	O

Report	O
:	O

LH486L9	O

346176858	O
SC	O

29574503	O

4164300	O

12/9/2005	O
12:00:00	O
AM	O

SVD	O

DIS	O

Admission	O
Date	O
:	O

12/09/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/12/2005	O

******	O
DISCHARGE	O
ORDERS	O
******	O

CHAFFBITZ	O
,	O
LI	O
183-67-53-0	O
U69	O

Room	O
:	O

DEALPERSANDERSWAUKE	O
MISSJEANES	O
MACOMTOMA	O
GLANDSTATE	O
MEDICAL	O
CENTER	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/12/05	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

GRENDZISKLEEB	O
,	O
DELMRU	O
CENI	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DERMOPLAST	O
TOPICAL	O
TP	O
Q12H	O
PRN	O
Pain	B-disease
DOCUSATE	O
SODIUM	O
100	O
MG	O
PO	O
BID	O
PRN	O
Constipation	B-disease
IBUPROFEN	O
400-600	O
MG	O
PO	O
Q6H	O
PRN	O
Pain	B-disease

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
PRENATAL	O
MULTIVITAMINS	O
(	O
STUARTNATAL	O
1+1	O
)	O
1	O
TAB	O
PO	O
QD	O
TUCKS	O
(	O
WITCH	O
HAZEL	O
)	O
TOPICAL	O
TP	O
Q4H	O
PRN	O
Pain	B-disease

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr	O
Grendziskleeb	O
6	O
weeks	O
,	O

ALLERGY	O
:	O

NKA	B-disease

ADMIT	O
DIAGNOSIS	O
:	O

labor	B-disease
at	I-disease
term	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

SVD	O
OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

SVD	O
OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	O
Vaginal	O
delivery	O
:	O

Spontaneous	O
Episiotomy	O
:	O

Median	O
Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O
Condition	O
:	O

Normal	O

Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

BOORMKAYSSCAJE	O
,	O
PA	O
A.	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T1	O
P0	O
A1	O
L1	O

Estimated	O
EDC	O
:	O

12/09/05	O

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-disease
abnormalities	I-disease

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

BOORMKAYSSCAJE	O
,	O
PA	O
A.	O
,	O
M.D.	O
(	O
TI84	O
)	O
12/10/05	O
02:58	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2011-09-23	O

Discharge	O
Date	O
:	O

2011-10-06	O

Date	O
of	O
Birth	O
:	O

2011-09-23	O

Sex	O
:	O

M	O

Service	O
:	O

NEONATOLOGY	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ken	O
Nansteel-Miller	O
is	O
the	O
triplet	O
#3	O
of	O
a	B-disease
spontaneous	I-disease
triamniotic-trichorionic	I-disease
triplet	I-disease
pregnancy	I-disease
born	O
to	O
a	O
39-year-old	O
G4	O
P1	O
spontaneous	O
abortion	O
2	O
woman	O
.	O

Prenatal	O
screens	O
:	O

Blood	O
type	O
A	O
positive	O
,	O
antibody	O
negative	O
,	O
rubella	O
immune	O
,	O
RPR	O
nonreactive	O
,	O
hepatitis	O
B	O
surface	O
antigen	O
negative	O
,	O
group	O
beta	O
Strep	O
status	O
unknown	O
.	O

The	O
mother	O
was	O
followed	O
closely	O
and	O
received	O
betamethasone	O
2011-08-22	O
.	O

She	O
was	O
admitted	O
on	O
2011-08-25	O
for	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
and	O
a	B-disease
shortened	I-disease
cervix	I-disease
.	O

She	O
was	O
treated	O
with	O
bed	O
rest	O
and	O
prn	O
terbutaline	O
.	O

Other	O
medications	O
including	O
Prozac	O
.	O

The	O
babies	O
were	O
born	O
by	O
elective	O
cesarean	O
section	O
at	O
34	O
weeks	O
gestation	O
.	O

This	O
triplet	O
#3	O
emerged	O
with	O
spontaneous	O
respirations	O
,	O
and	O
required	O
blow-by	O
oxygen	O
in	O
the	O
delivery	O
room	O
.	O

Apgars	O
were	O
seven	O
at	O
one	O
minute	O
and	O
eight	O
at	O
five	O
minutes	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
for	O
treatment	O
of	O
prematurity	B-disease
.	O

PHYSICAL	O
EXAM	O
UPON	O
ADMISSION	O
TO	O
THE	O
NEONATAL	O
INTENSIVE	O
CARE	O
UNIT	O
:	O

Weight	O
1.7	O
kg	O
,	O
length	O
41.5	O
cm	O
,	O
head	O
circumference	O
29	O
cm	O
,	O
all	O
10th-25th	O
percentile	O
for	O
34	O
weeks	O
.	O

General	O
:	O
Nondysmorphic	B-disease
preterm	O
male	O
in	O
mild	B-disease
respiratory	I-disease
distress	I-disease
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
:	O

Anterior	O
fontanel	O
open	O
and	O
flat	O
.	O

Symmetric	O
facial	O
features	O
.	O

Positive	O
red	O
reflex	O
bilaterally	O
.	O

Palate	O
intact	O
.	O

Chest	O
:	O
Mild	B-disease
intercostal	I-disease
and	I-disease
sternal	I-disease
retractions	I-disease
.	O

Breath	O
sounds	O
equal	O
with	O
fair	O
aeration	O
.	O

Cardiovascular	O
:	O
Regular	O
,	O
rate	O
,	O
and	O
rhythm	O
,	O
no	O
murmur	B-disease
.	O

Femoral	O
pulses	O
+2	O
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
no	O
masses	B-disease
,	O
positive	O
bowel	O
sounds	O
.	O

Genitourinary	O
:	O
Normal	O
preterm	O
male	O
.	O

Testes	O
descended	O
bilaterally	O
.	O

Spine	O
straight	O
with	O
normal	O
sacrum	O
.	O

Hips	O
stable	O
.	O

Neurologic	O
:	O
Appropriate	O
tone	O
and	O
reflexes	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
INCLUDING	O
PERTINENT	O
LABORATORY	O
DATA	O
:	O

1.	O
Respiratory	O
:	O
Lincoln	O
required	O
nasal	O
cannula	O
O2	O
for	O
approximately	O
the	O
first	O
8-12	O
hours	O
of	O
life	O
.	O

He	O
weaned	O
to	O
room	O
air	O
and	O
remained	O
on	O
room	O
air	O
the	O
rest	O
of	O
his	O
Neonatal	O
Intensive	O
Care	O
Unit	O
admission	O
.	O

He	O
has	O
had	O
no	O
episodes	O
of	O
spontaneous	B-disease
apnea	I-disease
during	O
admission	O
.	O

2.	O
Cardiovascular	O
:	O
Falmouth	O
has	O
maintained	O
normal	O
heart	O
rates	O
and	O
blood	O
pressures	O
.	O

No	O
murmurs	B-disease
have	O
been	O
noted	O
.	O

3.	O
Fluids	O
,	O
electrolytes	O
,	O
and	O
nutrition	O
:	O

Beverly	O
was	O
initially	O
NPO	O
and	O
maintained	O
on	O
intravenous	O
fluids	O
.	O

Enteral	O
feeds	O
were	O
started	O
on	O
day	O
of	O
life	O
#1	O
,	O
and	O
gradually	O
advanced	O
to	O
full	O
volume	O
.	O

His	O
maximum	O
caloric	O
intake	O
was	O
24	O
calories	O
per	O
ounce	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
he	O
is	O
breastfeeding	O
or	O
taking	O
Enfamil	O
fortified	O
to	O
24	O
calories	O
/	O
ounce	O
with	O
intake	O
approximately	O
150	O
cc	O
/	O
kg	O
/	O
day	O
.	O

Discharge	O
weight	O
is	O
1.89	O
kg	O
.	O

4.	O
Gastrointestinal	O
:	O
Boston	O
required	O
treatment	O
for	O
unconjungated	B-disease
hyperbilirubinemia	I-disease
with	O
phototherapy	O
.	O

His	O
peak	O
serum	O
bilirubin	O
occurred	O
on	O
day	O
of	O
life	O
three	O
with	O
a	O
total	O
of	O
8.3	O
/	O
0.2	O
direct	O
,	O
8.1	O
indirect	O
mg/dl	O
.	O

He	O
received	O
phototherapy	O
for	O
approximately	O
72	O
hours	O
.	O

Rebound	O
bilirubin	O
on	O
day	O
of	O
life	O
#7	O
was	O
6.6	O
,	O
and	O
total	O
was	O
0.2	O
direct	O
.	O

5.	O
Neurological	O
:	O
Wellesley	O
has	O
maintained	O
a	O
normal	O
neurological	O
examination	O
.	O

Throughout	O
admission	O
,	O
there	O
are	O
no	O
neurological	B-disease
concerns	I-disease
at	O
the	O
time	O
of	O
discharge	O
.	O

6.	O
Sensory	O
:	O

Audiology	O
:	O
Hearing	O
screening	O
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Nantucket	O
passed	O
in	O
both	O
ears	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Good	O
.	O

DISCHARGE	O
/	O
DISPOSITION	O
:	O
Home	O
with	O
parents	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O
Dr.	O
Penny	O
Scott	O
,	O
8400	O
S.	O
Maple	O
Blvd.	O
,	O
Arbour-Fuller	O
Hospital	O
,	O
New	O
Hampshire	O
25344	O
,	O
phone	O
number	O
617-6198	O
.	O

Fax	O
number	O
(	O
317	O
)	O
497-7408	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
AT	O
THE	O
TIME	O
OF	O
DISCHARGE	O
:	O

1.	O
Feeding	O
:	O
Breast	O
feeding	O
or	O
Enfamil	O
24	O
calories	O
/	O
ounce	O
.	O

2.	O
Medications	O
:	O
Ferrous	O
sulfate	O
0.15	O
cc	O
po	O
q	O
day	O
25	O
mg	O
/	O
ml	O
dilution	O
.	O

3.	O
Car	O
seat	O
position	O
screening	O
was	O
performed	O
.	O

Waltham	O
was	O
monitored	O
for	O
90	O
minutes	O
without	O
any	O
episodes	O
of	O
apnea	B-disease
or	O
oxygen	B-disease
desaturation	I-disease
.	O

4.	O
State	O
Newborn	O
Screens	O
were	O
sent	O
on	O
09-27	O
and	O
2011-10-05	O
with	O
no	O
notification	O
of	O
abnormal	B-disease
results	I-disease
to	O
date	O
.	O

5.	O
No	O
immunizations	O
administered	O
.	O

Plan	O
is	O
to	O
receive	O
hepatitis	O
B	O
in	O
the	O
pediatrician	O
's	O
office	O
,	O
once	O
he	O
reaches	O
a	O
weight	O
of	O
2	O
kg	O
.	O

6.	O
Immunizations	O
recommended	O
:	O
Synagis	O
RSV	O
prophylaxis	O
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
three	O
criteria	O
:	O

1)	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
,	O

2)	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
daycare	O
during	O
RSV	O
season	O
,	O
with	O
a	O
smoker	O
in	O
the	O
household	O
,	O
or	O
with	O
preschool	O
siblings	O
,	O
or	O

3)	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
.	O

Influenza	O
immunization	O
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
once	O
they	O
reach	O
six	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
,	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	O
against	O
influenza	B-disease
to	O
protect	O
the	O
infant	O
.	O

FOLLOW-UP	O
APPOINTMENTS	O
:	O
Dr.	O
Parramore	O
on	O
10-10	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Prematurity	B-disease
at	I-disease
34	I-disease
weeks	I-disease
gestation	I-disease
.	O

2.	O
Triplet	O
#3	O
of	O
triplet	O
gestation	O
.	O

3.	O
Unconjugated	B-disease
hyperbilirubinemia	I-disease
.	O

Reviewed	O
By	O
:	O
Janna	O
L.	O
Desorbo	O
,	O
M.D.	O

00-112	O

Dictated	O
By	O
:	O
Jeannette	O
D.	O
Rede	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-10-06	O
04:03	O

T	O
:	O
2011-10-06	O
06:19	O

JOB	O
#:	O

02566	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Bernice	O
Jenkins	O
on	O
:	O
FRI	O
2011-10-07	O
4:01	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2015-11-09	O

Discharge	O
Date	O
:	O

2015-11-16	O

Date	O
of	O
Birth	O
:	O

2015-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Baby	O
girl	O
Fritsche	O
is	O
the	O
1670	O
gram	O
product	O
of	O
a	O
31	O
and	O
06-17	O
week	O
gestation	O
born	O
to	O
a	O
34	O
-	O
year-old	O
G2	O
P1	O
now	O
2	O
woman	O
.	O

Fetal	O
screens	O
,	O
O	O
positive	O
,	O
antibody	O
negative	O
,	O
RPR	O
nonreactive	O
,	O
rubella	O
immune	O
,	O
hepatitis	O
surface	O
antigen	O
negative	O
,	O
GBS	O
unknown	O
.	O

IVF	B-disease
pregnancy	I-disease
complicated	O
by	O
IUGR	B-disease
,	O
2	B-disease
vessel	I-disease
cord	I-disease
,	O
normal	O
fetal	O
echo	O
reverse	O
diastolic	O
flow	O
and	O
demise	B-disease
of	I-disease
twin	I-disease
A	I-disease
at	O
27	O
weeks	O
.	O

Twin	O
B	O
with	O
normal	O
fetal	O
survey	O
was	O
transferred	O
to	O
Boston	O
Medical	O
Center	O
at	O
26	O
and	O
2/7	O
weeks	O
with	O
IUGR	B-disease
of	I-disease
twin	I-disease
A	I-disease
was	O
first	O
noted	O
,	O
presented	O
with	O
preterm	B-disease
labor	I-disease
at	O
31	O
weeks	O
.	O

Betamethasone	O
complete	O
at	O
approximately	O
26	O
weeks	O
and	O
31	O
weeks	O
.	O

Mother	O
was	O
on	O
clindamycin	O
since	O
11-04	O
.	O

PPROM	B-disease
with	O
bleeding	B-disease
and	O
transverse	B-disease
lie	I-disease
prompted	O
cesarean	O
section	O
.	O

Abruption	B-disease
noted	O
.	O

Apgars	O
were	O
6	O
and	O
9	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
weight	O
1670	O
grams	O
approximately	O
50	O
th	O
percentile	O
,	O
length	O
43	O
cm	O
50	O
th	O
percentile	O
,	O
head	O
circumference	O
not	O
done	O
.	O

Anterior	O
fontanel	O
soft	O
,	O
flat	O
,	O
cap	O
and	O
prong	O
CPAP	O
in	O
place	O
.	O

Nondysmorphic	B-disease
intact	O
Veliz	O
.	O

Comfortable	O
with	O
good	O
aeration	O
,	O
clear	O
breath	O
sounds	O
,	O
does	O
grunt	O
intermittently	O
when	O
disturbed	O
.	O

No	O
murmur	B-disease
.	O

Normal	O
pulses	O
.	O

Soft	O
abdomen	O
,	O
3	O
vessel	O
cord	O
.	O

No	O
hepatosplenomegaly	B-disease
.	O

Normal	O
female	O
genitalia	O
.	O

Positive	O
vaginal	B-disease
tag	I-disease
.	O

Patent	O
anus	O
.	O

No	O
hip	B-disease
click	I-disease
.	O

No	O
sacral	B-disease
dimple	I-disease
.	O

Moves	O
all	O
extremities	O
.	O

Decrease	B-disease
tone	I-disease
,	O
ruddy	O
,	O
warm	O
,	O
well	O
perfused	O
with	O
peripheral	O
IV	O
in	O
left	O
hand	O
.	O

HOSPITAL	O
COURSE	O
:	O

Respiratory	O
.	O

Mills	O
was	O
admitted	O
to	O
the	O
newborn	O
intensive	O
care	O
unit	O
with	O
moderate	B-disease
respiratory	I-disease
distress	I-disease
.	O

Infant	O
placed	O
on	O
CPAP	O
.	O

X-ray	O
revealed	O
mild	B-disease
respiratory	I-disease
distress	I-disease
syndrome	I-disease
.	O

She	O
remained	O
on	O
CPAP	O
for	O
a	O
total	O
of	O
24	O
hours	O
at	O
which	O
time	O
she	O
transitioned	O
to	O
room	O
air	O
and	O
continues	O
to	O
be	O
stable	O
in	O
room	O
air	O
.	O

Caffeine	O
citrate	O
was	O
initiated	O
on	O
11-14	O
for	O
apnea	B-disease
and	O
bradycardia	B-disease
of	I-disease
prematurity	I-disease
.	O

She	O
is	O
currently	O
receiving	O
11	O
mg	O
po	O
every	O
day	O
.	O

Cardiovascular	O
.	O

Has	O
been	O
cardiovascular	O
stable	O
throughout	O
hospital	O
course	O
.	O

Heart	O
ranges	O
130	O
s	O
to	O
160	O
s.	O

Blood	O
pressure	O
most	O
recently	O
60/37	O
with	O
a	O
mean	O
of	O
44	O
.	O

Fluid	O
and	O
electrolyte	O
.	O

Birth	O
weight	O
was	O
1670	O
grams	O
50	O
th	O
percentile	O
,	O
length	O
43	O
cm	O
50	O
th	O
percentile	O
.	O

Head	O
circumference	O
not	O
done	O
.	O

Infant	O
was	O
initially	O
started	O
on	O
80	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
D10W	O
.	O

Enteral	O
feedings	O
were	O
initiated	O
on	O
day	O
of	O
life	O
#1	O
.	O

Infant	O
achieved	O
full	O
enteral	O
feedings	O
by	O
day	O
of	O
life	O
6	O
.	O

She	O
is	O
currently	O
receiving	O
150	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
Special	O
Care	O
20	O
.	O

Her	O
discharge	O
weight	O
is	O
1477	O
gm	O
.	O

Her	O
most	O
recent	O
set	O
of	O
electrolytes	O
were	O
on	O
2015-11-13	O
with	O
a	O
sodium	O
of	O
143	O
,	O
a	O
potassium	O
of	O
6.3	O
hemolyzed	O
,	O
a	O
chloride	O
of	O
113	O
and	O
a	O
total	O
CO2	O
of	O
17	O
.	O

She	O
will	O
need	O
advance	O
calorie	O
density	O
for	O
better	O
growth	O
.	O

GI	O
.	O
Bilirubin	O
peaked	O
on	O
day	O
of	O
life	O
#2	O
of	O
9.0	O
/	O
0.3	O
.	O

Infant	O
is	O
under	O
phototherapy	O
,	O
which	O
was	O
discontinued	O
on	O
11-13	O
.	O

Most	O
recent	O
bilirubin	O
was	O
on	O
11-14	O
of	O
4.8	O
/	O
0.3	O
.	O

Hematology	O
.	O

Hematocrit	O
on	O
admission	O
was	O
53.7	O
.	O

She	O
has	O
not	O
required	O
any	O
blood	O
transfusions	O
.	O

Infectious	O
disease	O
.	O

A	O
CBC	O
and	O
blood	O
culture	O
obtained	O
on	O
admission	O
.	O

CBC	O
had	O
a	O
white	O
blood	O
cell	O
count	O
of	O
9	O
,	O
17	O
polys	O
,	O
0	O
bands	O
,	O
platelets	O
of	O
326	O
.	O

She	O
received	O
48	O
hours	O
of	O
ampicillin	O
and	O
gentamycin	O
with	O
negative	O
blood	O
cultures	O
and	O
antibiotics	O
were	O
discontinued	O
.	O

Neurological	O
.	O

She	O
has	O
been	O
appropriate	O
for	O
gestational	O
age	O
.	O

Head	O
ultrasound	O
was	O
performed	O
on	O
2015-11-16	O
and	O
was	O
normal	O
.	O

Sensory	O
,	O
hearing	O
screen	O
has	O
not	O
yet	O
been	O
performed	O
,	O
but	O
should	O
be	O
done	O
prior	O
to	O
discharge	O
.	O

CONDITION	O
AT	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
Boston	O
Medical	O
Center	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Kim	O
Adams	O
.	O

Telephone	O
number	O
is	O
(	O
261	O
)	O
564-6894	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Continue	O
150	O
cc	O
per	O
kilo	O
per	O
day	O
of	O
Special	O
Care	O
20	O
calories	O
advancing	O
caloric	O
intake	O
as	O
required	O
to	O
maintain	O
weight	O
gain	O
of	O
3	O
grams	O
per	O
kilogram	O
per	O
day	O
.	O

Medications	O
,	O
continue	O
caffeine	O
citrate	O
of	O
11	O
mg	O
po	O
every	O
day	O
.	O

Car	O
seat	O
position	O
screening	O
has	O
not	O
yet	O
been	O
done	O
.	O

State	O
newborn	O
screen	O
was	O
sent	O
on	O
day	O
of	O
life	O
#3	O
and	O
at	O
discharge	O
.	O

Initial	O
results	O
were	O
within	O
normal	O
limits	O
.	O

Immunizations	O
received	O
,	O
infant	O
has	O
not	O
received	O
any	O
immunizations	O
to	O
date	O
.	O

State	O
newborn	O
screen	O
was	O
sent	O
on	O
2015-11-12	O
.	O

Immunizations	O
:	O
recommended	O
Synagis	O
RSV	O
prophylaxis	O
should	O
be	O
considered	O
from	O
November	O
through	O
March	O
for	O
infants	O
who	O
meet	O
any	O
of	O
the	O
following	O
3	O
criteria	O
,	O
born	O
at	O
less	O
than	O
32	O
weeks	O
,	O
born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
2	O
of	O
the	O
following	O
,	O
daycare	O
during	O
RSV	O
season	O
,	O
a	O
smoker	O
in	O
the	O
household	O
,	O
neuromuscular	B-disease
disease	I-disease
and	O
weight	B-disease
abnormalities	I-disease
or	O
school	O
age	O
siblings	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
.	O

Influenza	O
immunization	O
is	O
recommended	O
annually	O
in	O
the	O
fall	O
for	O
all	O
infants	O
once	O
they	O
reach	O
6	O
months	O
of	O
age	O
.	O

Before	O
this	O
age	O
and	O
for	O
the	O
first	O
24	O
months	O
of	O
the	O
child	O
's	O
life	O
immunizations	O
against	O
influenza	B-disease
is	O
recommended	O
for	O
household	O
contacts	O
and	O
out	O
of	O
home	O
care	O
givers	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Premature	B-disease
infant	I-disease
born	O
at	O
31	O
and	O
6/7	O
weeks	O
gestation	O
,	O
resolved	O
respiratory	B-disease
distress	I-disease
syndrome	I-disease
.	O

Rule	O
out	O
sepsis	B-disease
with	O
antibiotic	O
.	O

Hyperbilirubinemia	B-disease
resolving	O
.	O

Apnea	B-disease
and	O
bradycardia	B-disease
of	I-disease
prematurity	I-disease
.	O

Tai	O
Pamela	O
Wendell	O
,	O
Oklahoma	O
05158	O

Dictated	O
By	O
:	O
Kurt	O
S	O
Imperato	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-11-15	O
21:17:13	O

T	O
:	O
2015-11-16	O
06:38:42	O

Job	O
#:	O

82694	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Debbie	O
TRAN	O
on	O
:	O
MON	O
2015-11-16	O
9:57	O
AM	O

(	O
End	O
of	O
Report	O
)	O

699905656	O
SC	O

06100044	O

921737	O

1/17/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/17/1993	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/21/1993	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
RIGHT	O
SIDED	O
SCIATICA	O
PROCEDURE	O
:	O

Right	O
laminectomy	O
and	O
discectomy	O
by	O
Dr.	O
Small	O
,	O
Neurosurgery	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
42	O
year	O
old	O
gentleman	O
who	O
suffered	O
lower	B-disease
back	I-disease
pain	I-disease
during	O
an	O
accident	O
at	O
work	O
in	O
1990	O
.	O

This	O
gradually	O
increased	O
until	O
June	O
1992	O
where	O
he	O
had	O
recurrent	B-disease
severe	I-disease
right	I-disease
sided	I-disease
sciatica	I-disease
.	O

In	O
September	O
1992	O
CT	O
myelogram	O
showed	O
a	B-disease
lateral	I-disease
L-1	I-disease
S-1	I-disease
disc	I-disease
bulge	I-disease
and	O
small	B-disease
L-4-4	I-disease
bulge	I-disease
.	O

He	O
has	O
had	O
no	O
change	O
in	O
pain	B-disease
in	O
the	O
last	O
few	O
months	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Negative	O
.	O

ALLERGIES	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
found	O
to	O
be	O
healthy	O
.	O

His	O
examination	O
was	O
completely	O
unremarkable	O
.	O

He	O
had	O
5	O
out	O
of	O
5	O
strength	O
diffusely	O
,	O
normal	O
deep	O
tendon	O
reflexes	O
and	O
normal	O
sensation	O
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
admitted	O
,	O
taken	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
L5-S1	O
right	O
hemilaminectomy	O
and	O
discectomy	O
.	O

He	O
tolerated	O
the	O
procedure	O
well	O
,	O
was	O
taken	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

Over	O
the	O
next	O
three	O
days	O
he	O
increased	O
his	O
activity	O
gradually	O
,	O
was	O
able	O
to	O
do	O
stairs	O
with	O
Physical	O
Therapy	O
and	O
had	O
pain	B-disease
which	O
could	O
be	O
controlled	O
with	O
oral	O
analgesics	O
.	O

DISPOSITION	O
:	O

MEDICATIONS	O
:	O

He	O
is	O
discharged	O
on	O
Percocet	O
,	O
Colace	O
and	O
Motrin	O
.	O

Dictated	O
By	O
:	O

NASA	O
R.	O
SMALL	O
,	O
M.D.	O
IX97	O

Attending	O
:	O

VIENNIEZUTACHANT	O
WAVE	O
,	O
M.D.	O
NN08	O
QM838/6096	O

Batch	O
:	O

8704	O

Index	O
No.	O
AFUFB928WZ	O

D	O
:	O

01/20/93	O

T	O
:	O

01/22/93	O

965367286	O
WGH	O

4025213	O

465655	O

9246470	O

12/19/2006	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

CIENNE	O
,	O
GUTAOI	O

MRN	O
:	O

4025213	O

Age	O
:	O

42y	O

REGISTRATION	O
DATE	O
:	O

12/19/2006	O
08:13	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
CIENNE	O
,	O
GUTAOI	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Well	O
General	O
Hospital	O
on	O
12/19/2006	O
08:13	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SOB	B-disease
.	O

Following	O
triage	O
,	O
the	O
patient	O
left	O
without	O
being	O
seen	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
366-686-5449	O
.	O

PCP	O
Name	O
:	O

ELKSOBEBEUCH	O
,	O
IEVE	O

Provider	O
Number	O
:	O

66130	O

